KEGG_pathway,Biochemical_class,Enzyme_class,PDB_structure,Mode_of_action,Outcome
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Modulator,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Agonist,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Antagonist,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Inhibitor,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Modulator (allosteric modulator),1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Antagonist,0.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Modulator,0.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption",Acid anhydrides hydrolase,,,Modulator,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption",Acid anhydrides hydrolase,,,Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Antagonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,CAR-T-Cell-Therapy(Dual specific),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Antagonist,1.0
Gastric acid secretion,Inward rectifier potassium channel,,,Blocker,1.0
Gastric acid secretion,Inward rectifier potassium channel,,,Binder,1.0
"Fat digestion and absorption, Vitamin digestion and absorption",mRNA target,,,.,1.0
"Folate biosynthesis, Metabolic pathways",Phosphoric monoester hydrolase,Hydrolases,,Modulator,1.0
"Folate biosynthesis, Metabolic pathways",Phosphoric monoester hydrolase,Hydrolases,,Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Modulator,1.0
Ubiquinone and other terpenoid-quinone biosynthesis,Short-chain dehydrogenases reductase,Oxidoreductases,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, GnRH signaling pathway",GPCR rhodopsin,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, GnRH signaling pathway",GPCR rhodopsin,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, GnRH signaling pathway",GPCR rhodopsin,,,Antagonist,1.0
"Neuroactive ligand-receptor interaction, GnRH signaling pathway",GPCR rhodopsin,,,Modulator (allosteric modulator),1.0
"Neuroactive ligand-receptor interaction, GnRH signaling pathway",GPCR rhodopsin,,,.,1.0
"Neuroactive ligand-receptor interaction, GnRH signaling pathway",GPCR rhodopsin,,,Agonist,1.0
"Terpenoid backbone biosynthesis, Biosynthesis of antibiotics",Alkyl aryl transferase,,,Inhibitor,1.0
"Terpenoid backbone biosynthesis, Biosynthesis of antibiotics",Alkyl aryl transferase,,,Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Agonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Antagonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Inhibitor,1.0
"Sphingolipid metabolism, Metabolic pathways",Hexosyltransferase,Transferases,,Inhibitor,1.0
"Sphingolipid metabolism, Metabolic pathways",Hexosyltransferase,Transferases,,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway",Cytokine receptor,,,Modulator,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway",Cytokine receptor,,,Agonist,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway",Cytokine receptor,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Inhibitor,1.0
"Glycerolipid metabolism, Retinol metabolism, Metabolic pathways, Fat digestion and absorption",Acyltransferase,Transferases,,Inhibitor,1.0
"Glycerolipid metabolism, Retinol metabolism, Metabolic pathways, Fat digestion and absorption",Acyltransferase,Transferases,,Modulator,1.0
Thyroid hormone signaling pathway,,Oxidoreductases,,Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Agonist,0.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Binder,0.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Viral carcinogenesis",GPCR rhodopsin,,,Inhibitor,0.0
"Citrate cycle (TCA cycle), Glutathione metabolism, Metabolic pathways, Biosynthesis of antibiotics, Carbon metabolism, 2-Oxocarboxylic acid metabolism, Biosynthesis of amino acids, Peroxisome",CH-OH donor oxidoreductase,,,Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease (American trypanosomiasis), Pathways in cancer",GPCR rhodopsin,,,Activator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease (American trypanosomiasis), Pathways in cancer",GPCR rhodopsin,,,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease (American trypanosomiasis), Pathways in cancer",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease (American trypanosomiasis), Pathways in cancer",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Endocrine and other factor-regulated calcium reabsorption, Chagas disease (American trypanosomiasis), Pathways in cancer",GPCR rhodopsin,,,Inhibitor,1.0
"Steroid biosynthesis, Lysosome",Carboxylic ester hydrolase,Hydrolases,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Blocker (channel blocker),1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Immunostimulant,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Antagonist,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,,Modulator (allosteric modulator),1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Binder,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Stimulator,1.0
Dopaminergic synapse,,,,Activator,0.0
"Purine metabolism, Pyrimidine metabolism, Metabolic pathways, RNA polymerase",,,,Inhibitor,1.0
"Purine metabolism, Pyrimidine metabolism, Metabolic pathways, RNA polymerase",,,,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Modulator,1.0
Other glycan degradation,Glycosylase,Hydrolases,,Inhibitor,1.0
Other glycan degradation,Glycosylase,Hydrolases,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Blocker (channel blocker),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Long-term depression, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Binder,1.0
Cytokine-cytokine receptor interaction,Cytokine receptor,,,.,1.0
Cytokine-cytokine receptor interaction,Cytokine receptor,,,Antagonist,1.0
"Salivary secretion, Tuberculosis",Cathelicidin family,,,Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR secretin,,,Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR secretin,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Melanogenesis",GPCR rhodopsin,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Melanogenesis",GPCR rhodopsin,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, Melanogenesis",GPCR rhodopsin,,,Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Modulator (allosteric modulator),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels, Renin secretion, Pathways in cancer",GPCR rhodopsin,,,Inhibitor,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Agonist,0.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Inhibitor,0.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Phosphatidylinositol signaling system, Oocyte meiosis, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Neurotrophin signaling pathway, Dopaminergic synapse, Olfactory transduction, Phototransduction, Inflammatory mediator regulation of TRP channels, Insulin signaling pathway, GnRH signaling pathway, Estrogen signaling pathway, Melanogenesis, Oxytocin signaling pathway, Glucagon signaling pathway, Salivary secretion, Gastric acid secretion, Alzheimer's disease, Amphetamine addiction, Alcoholism, Pertussis, Tuberculosis, Glioma",Calmodulin-dependent secretion,,,Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Phosphatidylinositol signaling system, Oocyte meiosis, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Neurotrophin signaling pathway, Dopaminergic synapse, Olfactory transduction, Phototransduction, Inflammatory mediator regulation of TRP channels, Insulin signaling pathway, GnRH signaling pathway, Estrogen signaling pathway, Melanogenesis, Oxytocin signaling pathway, Glucagon signaling pathway, Salivary secretion, Gastric acid secretion, Alzheimer's disease, Amphetamine addiction, Alcoholism, Pertussis, Tuberculosis, Glioma",Calmodulin-dependent secretion,,,Modulator,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption",Acid anhydrides hydrolase,Translocases,,Inhibitor,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption",Acid anhydrides hydrolase,Translocases,,Binder,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption",Acid anhydrides hydrolase,Translocases,,Blocker,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Insulin secretion, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Proximal tubule bicarbonate reclamation, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Carbohydrate digestion and absorption, Protein digestion and absorption, Bile secretion, Mineral absorption",Acid anhydrides hydrolase,Translocases,,Modulator,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,,Antagonist,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,,Activator,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,,Blocker (channel blocker),1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,,Inhibitor,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Estrogen signaling pathway, Morphine addiction",GPCR glutamate,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Estrogen signaling pathway, Morphine addiction",GPCR glutamate,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Estrogen signaling pathway, Morphine addiction",GPCR glutamate,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Estrogen signaling pathway, Morphine addiction",GPCR glutamate,,,Modulator (allosteric modulator),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Estrogen signaling pathway, Morphine addiction",GPCR glutamate,,,Inhibitor,1.0
"Toll-like receptor signaling pathway, Measles, Influenza A",Toll-like receptor,,,Antagonist,1.0
"Toll-like receptor signaling pathway, Measles, Influenza A",Toll-like receptor,,,Agonist,1.0
"Toll-like receptor signaling pathway, Measles, Influenza A",Toll-like receptor,,,.,1.0
"Toll-like receptor signaling pathway, Measles, Influenza A",Toll-like receptor,,,Modulator,1.0
Fat digestion and absorption,,,,Inhibitor,1.0
Fat digestion and absorption,,,,Modulator,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,,Binder,1.0
"Neuroactive ligand-receptor interaction, Pancreatic secretion, Bile secretion",GPCR secretin,,,Binder,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,,Modulator,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,,Binder,1.0
"Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction",GPCR rhodopsin,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction",GPCR rhodopsin,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction",GPCR rhodopsin,,,Antagonist,1.0
"Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction",GPCR rhodopsin,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Estrogen signaling pathway, Morphine addiction",GPCR rhodopsin,,,.,1.0
"Synaptic vesicle cycle, Serotonergic synapse, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Major facilitator superfamily,,,Antagonist,1.0
"Synaptic vesicle cycle, Serotonergic synapse, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Major facilitator superfamily,,,Inhibitor,1.0
"Synaptic vesicle cycle, Serotonergic synapse, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Major facilitator superfamily,,,Enhancer,1.0
"Synaptic vesicle cycle, Serotonergic synapse, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Major facilitator superfamily,,,Blocker,1.0
"Synaptic vesicle cycle, Serotonergic synapse, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Major facilitator superfamily,,,Modulator,1.0
Mineral absorption,Chloride channel,,,Blocker (channel blocker),1.0
Mineral absorption,Chloride channel,,,Activator,1.0
Mineral absorption,Chloride channel,,,Modulator,1.0
"Tyrosine metabolism, Metabolic pathways, Thyroid hormone synthesis, Autoimmune thyroid disease",Peroxidases,Oxidoreductases,,Modulator,1.0
"Tyrosine metabolism, Metabolic pathways, Thyroid hormone synthesis, Autoimmune thyroid disease",Peroxidases,Oxidoreductases,,Inhibitor,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Axon guidance, Focal adhesion, Platelet activation, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer",Kinase,,,Inhibitor,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, TGF-beta signaling pathway, Axon guidance, Focal adhesion, Platelet activation, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Salmonella infection, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer",Kinase,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,,Blocker (channel blocker),1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,,Modulator (allosteric modulator),1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,,Modulator,1.0
"Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion",Acid anhydrides hydrolase,Translocases,,Modulator,1.0
"Oxidative phosphorylation, Collecting duct acid secretion, Gastric acid secretion",Acid anhydrides hydrolase,Translocases,,Inhibitor,1.0
"Taste transduction, Aldosterone-regulated sodium reabsorption",Epithelial sodium channel,,,Activator,1.0
"Taste transduction, Aldosterone-regulated sodium reabsorption",Epithelial sodium channel,,,Blocker (channel blocker),1.0
"Taste transduction, Aldosterone-regulated sodium reabsorption",Epithelial sodium channel,,,Inhibitor,1.0
"Taste transduction, Aldosterone-regulated sodium reabsorption",Epithelial sodium channel,,,Blocker,1.0
"Pyrimidine metabolism, One carbon pool by folate, Metabolic pathways",Methyltransferase,Transferases,,Inhibitor,1.0
"Pyrimidine metabolism, One carbon pool by folate, Metabolic pathways",Methyltransferase,Transferases,,Modulator,1.0
"Pyrimidine metabolism, One carbon pool by folate, Metabolic pathways",Methyltransferase,Transferases,,Binder,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,,Binder,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,.,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment",Voltage-gated ion channel,,,Antagonist,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment",Voltage-gated ion channel,,,Blocker,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment",Voltage-gated ion channel,,,Inhibitor,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment",Voltage-gated ion channel,,,Blocker (channel blocker),1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment",Voltage-gated ion channel,,,Modulator,1.0
Inflammatory mediator regulation of TRP channels,Amiloride-sensitive sodium channel,,,Blocker,1.0
Inflammatory mediator regulation of TRP channels,Amiloride-sensitive sodium channel,,,Modulator,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,,Inhibitor,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,,.,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,,Agonist,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,,Antagonist,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,,Modulator,1.0
"cAMP signaling pathway, AMPK signaling pathway, Insulin signaling pathway",Carboxylic ester hydrolase,Hydrolases,,Modulator,1.0
"cAMP signaling pathway, AMPK signaling pathway, Insulin signaling pathway",Carboxylic ester hydrolase,Hydrolases,,Inhibitor,1.0
"Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Neurotransmitter:sodium symporter,,,Inhibitor,1.0
"Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Neurotransmitter:sodium symporter,,,Modulator,1.0
"Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Neurotransmitter:sodium symporter,,,Antagonist,1.0
"Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Neurotransmitter:sodium symporter,,,Activator,1.0
"Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Neurotransmitter:sodium symporter,,,Blocker,1.0
"Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Neurotransmitter:sodium symporter,,,Agonist,1.0
"Sphingolipid metabolism, Metabolic pathways",Phosphoric diester hydrolase,Hydrolases,,Inhibitor,0.0
Serotonergic synapse,GPCR rhodopsin,,,Modulator (allosteric modulator),0.0
Serotonergic synapse,GPCR rhodopsin,,,Agonist,0.0
Serotonergic synapse,GPCR rhodopsin,,,Antagonist,0.0
Serotonergic synapse,GPCR rhodopsin,,,Blocker (channel blocker),0.0
Serotonergic synapse,GPCR rhodopsin,,,Inhibitor,0.0
"Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse",Transaminase,Transferases,,Inhibitor,1.0
"Alanine, aspartate and glutamate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, Propanoate metabolism, Butanoate metabolism, Metabolic pathways, GABAergic synapse",Transaminase,Transferases,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Stimulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,,Modulator,1.0
"Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse",Paired donor oxygen oxidoreductase,Oxidoreductases,,Inhibitor,1.0
"Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse",Paired donor oxygen oxidoreductase,Oxidoreductases,,Modulator,1.0
"Arachidonic acid metabolism, Metabolic pathways, Platelet activation, Serotonergic synapse",Paired donor oxygen oxidoreductase,Oxidoreductases,,Agonist,1.0
"Complement and coagulation cascades, Prion diseases, Pertussis, Staphylococcus aureus infection, Herpes simplex infection, Systemic lupus erythematosus",Complement system,,,Inhibitor,1.0
"Complement and coagulation cascades, Prion diseases, Pertussis, Staphylococcus aureus infection, Herpes simplex infection, Systemic lupus erythematosus",Complement system,,,Antagonist,1.0
"Complement and coagulation cascades, Prion diseases, Pertussis, Staphylococcus aureus infection, Herpes simplex infection, Systemic lupus erythematosus",Complement system,,,.,1.0
"Complement and coagulation cascades, Prion diseases, Pertussis, Staphylococcus aureus infection, Herpes simplex infection, Systemic lupus erythematosus",Complement system,,,Modulator,1.0
GABAergic synapse,Neurotransmitter:sodium symporter,,,Inhibitor,1.0
GABAergic synapse,Neurotransmitter:sodium symporter,,,Modulator,1.0
"Purine metabolism, Rap1 signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Oocyte meiosis, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Gap junction, Platelet activation, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Insulin secretion, GnRH signaling pathway, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Melanogenesis, Thyroid hormone synthesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion, Morphine addiction, Chagas disease (American trypanosomiasis), Amoebiasis, HTLV-I infection, Pathways in cancer, Dilated cardiomyopathy",Phosphorus-oxygen lyase,Lyases,,Binder,1.0
Serotonergic synapse,GPCR rhodopsin,,,Blocker (channel blocker),1.0
Serotonergic synapse,GPCR rhodopsin,,,Modulator (allosteric modulator),1.0
Serotonergic synapse,GPCR rhodopsin,,,Agonist,1.0
Serotonergic synapse,GPCR rhodopsin,,,Antagonist,1.0
Serotonergic synapse,GPCR rhodopsin,,,Inhibitor,1.0
Serotonergic synapse,GPCR rhodopsin,,,Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Binder,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,.,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Agonis; Inverse agonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Inverse agonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,,Ligand,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Type II diabetes mellitus",Voltage-gated ion channel,,,Blocker (channel blocker),1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Type II diabetes mellitus",Voltage-gated ion channel,,,Inhibitor,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Type II diabetes mellitus",Voltage-gated ion channel,,,Blocker,1.0
"MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Type II diabetes mellitus",Voltage-gated ion channel,,,Modulator,1.0
"D-Alanine metabolism, Peptidoglycan biosynthesis, Metabolic pathways, Vancomycin resistance",Carbon-nitrogen ligase,Ligases,,,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Parkinson's disease, Huntington's disease, HTLV-I infection",Mitochondrial carrier,,,Inhibitor,1.0
"N-Glycan biosynthesis, Metabolic pathways",Glycosylase,Hydrolases,,Inhibitor,0.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Agonist,1.0
"Steroid hormone biosynthesis, Prostate cancer",CH-CH donor oxidoreductase,Oxidoreductases,,Inhibitor,1.0
"Starch and sucrose metabolism, MAPK signaling pathway - yeast",Hexosyltransferase,Transferases,,Modulator,1.0
"Starch and sucrose metabolism, MAPK signaling pathway - yeast",Hexosyltransferase,Transferases,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Binder,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Antagonist,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Suppressor,1.0
"Neuroactive ligand-receptor interaction, HTLV-I infection",Cholesterol/porphyrin uptake translocator,,,Ligand,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,,Inhibitor,1.0
"Fatty acid degradation, Fatty acid metabolism, PPAR signaling pathway, AMPK signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway",Acyltransferase,Transferases,,Activator,1.0
"Fatty acid degradation, Fatty acid metabolism, PPAR signaling pathway, AMPK signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway",Acyltransferase,Transferases,,Inhibitor,1.0
"Fatty acid degradation, Fatty acid metabolism, PPAR signaling pathway, AMPK signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway",Acyltransferase,Transferases,,Modulator,1.0
"Pyrimidine metabolism, beta-Alanine metabolism, Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Metabolic pathways",CH/CH donor oxidoreductase,Oxidoreductases,,Inhibitor,1.0
"Pyrimidine metabolism, beta-Alanine metabolism, Pantothenate and CoA biosynthesis, Drug metabolism - other enzymes, Metabolic pathways",CH/CH donor oxidoreductase,Oxidoreductases,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Modulator (allosteric modulator),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Binder,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,.,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,,Ligand,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,,Blocker (channel blocker),1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,,Binder,1.0
"Phagosome, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Fc gamma R-mediated phagocytosis, Leishmaniasis, Staphylococcus aureus infection, Tuberculosis, Systemic lupus erythematosus",Immunoglobulin,,,Inhibitor,1.0
"Phagosome, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, Fc gamma R-mediated phagocytosis, Leishmaniasis, Staphylococcus aureus infection, Tuberculosis, Systemic lupus erythematosus",Immunoglobulin,,,Antagonist,1.0
"MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Legionellosis, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis",,,,Activator,1.0
"MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Legionellosis, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis",,,,Inhibitor,1.0
"MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Legionellosis, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis",,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Antagonist,1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Blocker,1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Blocker (channel blocker),1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Activator,1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",Transient receptor potential catioin channel,,,Modulator,1.0
"MAPK signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,,Inhibitor,1.0
"MAPK signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,,Modulator,1.0
"MAPK signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,,Agonist,1.0
"MAPK signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Oxytocin signaling pathway, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,,Blocker,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Oxytocin signaling pathway",GPCR rhodopsin,,,Modulator,1.0
"Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Alcoholism",GPCR rhodopsin,,,Agonist,1.0
"Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Alcoholism",GPCR rhodopsin,,,Inhibitor,1.0
"Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Alcoholism",GPCR rhodopsin,,,Antagonist,1.0
"Rap1 signaling pathway, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Alcoholism",GPCR rhodopsin,,,Modulator,1.0
Ubiquinone and other terpenoid-quinone biosynthesis,Carbon-carbon lyase,Lyases,,Cofactor,1.0
cAMP signaling pathway,GPCR rhodopsin,,,Binder,1.0
cAMP signaling pathway,GPCR rhodopsin,,,Agonist,1.0
cAMP signaling pathway,GPCR rhodopsin,,,Modulator (allosteric modulator),1.0
cAMP signaling pathway,GPCR rhodopsin,,,Inhibitor,1.0
cAMP signaling pathway,GPCR rhodopsin,,,Modulator,1.0
"Purine metabolism, Pyrimidine metabolism, Metabolic pathways, RNA polymerase",Kinase,Transferases,,Inhibitor,1.0
"Purine metabolism, Pyrimidine metabolism, Metabolic pathways, RNA polymerase",Kinase,Transferases,,Modulator,1.0
"Proximal tubule bicarbonate reclamation, Protein digestion and absorption, Bile secretion, Mineral absorption",Monovalent cation:proton antiporter,,,Inhibitor,1.0
"Proximal tubule bicarbonate reclamation, Protein digestion and absorption, Bile secretion, Mineral absorption",Monovalent cation:proton antiporter,,,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion",GPCR rhodopsin,,,.,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,,.,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,,Modulator,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,,Inhibitor,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,,Antagonist,1.0
"cAMP signaling pathway, Insulin secretion",GPCR rhodopsin,,,Agonist,1.0
"cAMP signaling pathway, Insulin secretion",GPCR rhodopsin,,,Modulator,1.0
"Salivary secretion, Pancreatic secretion, Vibrio cholerae infection",Cation-chloride cotransporter,,,Modulator,1.0
"Salivary secretion, Pancreatic secretion, Vibrio cholerae infection",Cation-chloride cotransporter,,,Blocker,1.0
"Sphingolipid signaling pathway, Fc epsilon RI signaling pathway, Asthma",Immunoglobulin,,,Inhibitor,1.0
"Sphingolipid signaling pathway, Fc epsilon RI signaling pathway, Asthma",Immunoglobulin,,,Binder,1.0
"Sphingolipid signaling pathway, Fc epsilon RI signaling pathway, Asthma",Immunoglobulin,,,Modulator,1.0
"Glycerolipid metabolism, Metabolic pathways, Fat digestion and absorption",Acyltransferase,Transferases,,Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Blocker (channel blocker),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Retrograde endocannabinoid signaling, Glutamatergic synapse, Dopaminergic synapse, Amphetamine addiction, Nicotine addiction",Glutamate-gated ion channel,,,Inhibitor,1.0
"Tyrosine metabolism, Riboflavin metabolism, Metabolic pathways, Melanogenesis",Paired donor oxygen oxidoreductase,Oxidoreductases,,Inhibitor,1.0
"Tyrosine metabolism, Riboflavin metabolism, Metabolic pathways, Melanogenesis",Paired donor oxygen oxidoreductase,Oxidoreductases,,.,1.0
"Tyrosine metabolism, Riboflavin metabolism, Metabolic pathways, Melanogenesis",Paired donor oxygen oxidoreductase,Oxidoreductases,,Modulator,1.0
"Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways",Short-chain dehydrogenases reductase,Transferases,,Inhibitor,1.0
"Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways",Short-chain dehydrogenases reductase,Transferases,,Breaker,1.0
"Bile secretion, Hepatitis B",Bile acid:sodium symporter (BASS) (TC 2.A.28) family,,,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation",GPCR rhodopsin,,,Modulator,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation",GPCR rhodopsin,,,Agonist,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation",GPCR rhodopsin,,,Antagonist,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Platelet activation",GPCR rhodopsin,,,Inhibitor,1.0
,ABC transporter,,,Blocker,1.0
,ABC transporter,,,Modulator,1.0
,ABC transporter,,,Activator,1.0
,Paired donor oxygen oxidoreductase,,,Modulator,1.0
,Paired donor oxygen oxidoreductase,,,Inhibitor,1.0
,Paired donor oxygen oxidoreductase,,,Binder,1.0
,,Isomerases,,Modulator,0.0
,mRNA target,,,.,1.0
,mRNA target,,,Modulator,1.0
,Integrin,,,Modulator,1.0
,Nucleobase ascorbate transporter,,,Activator,1.0
,Nucleobase ascorbate transporter,,,Modulator,1.0
,Short-chain dehydrogenases reductase,,,Activator,1.0
,Carbon-nitrogen ligase,,,Inhibitor,0.0
,Racemases and epimerases,Isomerases,,Inhibitor,1.0
,Ion transport,,,Activator,1.0
,Ion transport,,,Modulator,1.0
,,Transferases,,Modulator,1.0
,Voltage-gated ion channel,,,Opener,1.0
,Voltage-gated ion channel,,,Antagonist,1.0
,Voltage-gated ion channel,,,Blocker (channel blocker),1.0
,Voltage-gated ion channel,,,Blocker,1.0
,Voltage-gated ion channel,,,Inhibitor,1.0
,Voltage-gated ion channel,,,Modulator,1.0
,Neurotransmitter:sodium symporter,,,Inhibitor,1.0
,Neurotransmitter:sodium symporter,,,Modulator,1.0
,Neurotransmitter:sodium symporter,,,Agonist,1.0
,Neurotransmitter:sodium symporter,,,Activator,1.0
,Neurotransmitter:sodium symporter,,,Blocker,1.0
,Neurotransmitter:sodium symporter,,,Enhancer,1.0
,Neurotransmitter:sodium symporter,,,Antagonist,1.0
,ATP-hydrolyzing DNA topoisomerase,,,Inhibitor,1.0
,ATP-hydrolyzing DNA topoisomerase,,,Modulator,1.0
,Peptidase,Hydrolases,,Inhibitor,1.0
,Peptidase,Hydrolases,,Modulator,1.0
,CH-CH donor oxidoreductase,,,Modulator,1.0
,CH-CH donor oxidoreductase,,,Inhibitor,1.0
,Carbon-oxygen ligase,Ligases,,Modulator,1.0
,Carbon-oxygen ligase,Ligases,,Inhibitor,1.0
,Endoribonucleases,,,Modulator,0.0
,Kinase,Transferases,,Inhibitor,0.0
,Solute:sodium symporter,,,Inhibitor,1.0
,Solute:sodium symporter,,,Modulator,1.0
,CH-CH donor oxidoreductase,Oxidoreductases,,Inhibitor,1.0
,Hexosyltransferase,Hydrolases,,Antagonist,1.0
,Hexosyltransferase,Hydrolases,,Inhibitor,1.0
,Hexosyltransferase,Hydrolases,,Binder,1.0
,Hexosyltransferase,Hydrolases,,Modulator,1.0
,DNA polymerase type-B,,,Inhibitor,1.0
,DNA polymerase type-B,,,Modulator,1.0
,Aldehyde/oxo donor oxidoreductase,Oxidoreductases,,Modulator,1.0
,Kinase,,,Inhibitor,1.0
,Kinase,,,Modulator,1.0
,Voltage-gated ion channel,,,Activator,1.0
,Voltage-gated ion channel,,,Binder,1.0
,mRNA target,Hydrolases,,.,0.0
,Glycosyltransferases,Transferases,,.,1.0
,CH-CH donor oxidoreductase,Oxidoreductases,,Binder,1.0
,Neurotransmitter receptor,,,Antagonist,0.0
,Neurotransmitter receptor,,,Agonist,0.0
,DNA-directed DNA polymerase,Transferases,,Modulator,1.0
,DNA-directed DNA polymerase,Transferases,,Inhibitor,1.0
,Peptidase,Hydrolases,,Inhibitor,0.0
,Phosphorus-oxygen lyase,,,Activator,1.0
,Phosphorus-oxygen lyase,,,Agonist,1.0
,Phosphorus-oxygen lyase,,,Stimulator,1.0
,Phosphorus-oxygen lyase,,,Modulator,1.0
,Glutamate-gated ion channel,,,Blocker (channel blocker),1.0
,Glutamate-gated ion channel,,,Modulator,1.0
,Glutamate-gated ion channel,,,Antagonist,1.0
,Glutamate-gated ion channel,,,Agonist,1.0
,Glutamate-gated ion channel,,,Inhibitor,1.0
,CH/CH(2) oxidoreductase,,,Inhibitor,0.0
,Neurotransmitter receptor,,,Modulator,1.0
,Neurotransmitter receptor,,,Antagonist,1.0
,GPCR rhodopsin,,,Antagonist,1.0
,GPCR rhodopsin,,,Agonist,1.0
,GPCR rhodopsin,,,Modulator,1.0
,Nuclear hormone receptor,,,Modulator,1.0
,Nuclear hormone receptor,,,Agonist,1.0
,Major facilitator superfamily,,,Inhibitor,1.0
,Major facilitator superfamily,,,Blocker,1.0
,Phosphorus-oxygen lyase,Lyases,,Agonist,1.0
,Phosphorus-oxygen lyase,Lyases,,Activator,1.0
,Phosphorus-oxygen lyase,Lyases,,Modulator,1.0
,Phosphorus-oxygen lyase,Lyases,,Binder,1.0
,DNA-directed DNA polymerase,,,Inhibitor,1.0
,CH/CH(2) oxidoreductase,,,Inhibitor,1.0
,Cation-chloride cotransporter,,,Blocker,1.0
,Acid anhydrides hydrolase,,,Inhibitor,1.0
,,Transferases,,Inhibitor,1.0
,Major facilitator,,,Inhibitor,1.0
,Major facilitator,,,Modulator,1.0
,"Ryanodine-inositol 1,4,5-triphosphate receptor calcium channel",,,Antagonist,0.0
,"Ryanodine-inositol 1,4,5-triphosphate receptor calcium channel",,,Inhibitor,0.0
,"Ryanodine-inositol 1,4,5-triphosphate receptor calcium channel",,,Modulator,0.0
,Integrin,,,Modulator,0.0
,Short-chain dehydrogenases reductase,Oxidoreductases,,Activator,1.0
,Herpesviridae UL28,,,Inhibitor,1.0
,ATP-hydrolyzing DNA topoisomerase,,,Intercalator,1.0
,ATP-hydrolyzing DNA topoisomerase,,,Binder,1.0
,CH-NH(2) donor oxidoreductase,Oxidoreductases,,Inhibitor,1.0
,Growth factor,,,.,1.0
,Growth factor,,,Inhibitor,1.0
,Growth factor,,,Blocker,1.0
,Growth factor,,,Modulator,1.0
,,Isomerases,,Inhibitor,1.0
,Phosphorus-oxygen lyase,Lyases,,Inhibitor,1.0
,Immunoglobulin,,,CAR-T-Cell-Therapy,1.0
,Immunoglobulin,,,Inhibitor,1.0
,Immunoglobulin,,,.,1.0
,Immunoglobulin,,,Modulator,1.0
,Aldehyde/oxo donor oxidoreductase,,,Inhibitor,1.0
"Arachidonic acid metabolism, Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis",Oxygenase,Oxidoreductases,"3V99, 3V98, 3V92, 3O8Y, 2ABV",Modulator,1.0
"Arachidonic acid metabolism, Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis",Oxygenase,Oxidoreductases,"3V99, 3V98, 3V92, 3O8Y, 2ABV",Inhibitor,1.0
"Arachidonic acid metabolism, Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis",Oxygenase,Oxidoreductases,"3V99, 3V98, 3V92, 3O8Y, 2ABV",Antagonist,1.0
"Arachidonic acid metabolism, Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis",mRNA target,Oxidoreductases,"3V99, 3V98, 3V92, 3O8Y, 2ABV",.,0.0
"Arachidonic acid metabolism, Metabolic pathways, Serotonergic synapse, Ovarian steroidogenesis, Toxoplasmosis",mRNA target,Oxidoreductases,"3V99, 3V98, 3V92, 3O8Y, 2ABV",Inhibitor,0.0
"ABC transporters, Fat digestion and absorption",ABC transporter,Translocases,5XJY,Modulator,1.0
"ABC transporters, Fat digestion and absorption",ABC transporter,Translocases,5XJY,Inducer,1.0
"ABC transporters, Insulin secretion, Type II diabetes mellitus",ABC transporter,,"6C3P, 6C3O",Modulator,1.0
"ABC transporters, Insulin secretion, Type II diabetes mellitus",ABC transporter,,"6C3P, 6C3O",Inhibitor,1.0
"ABC transporters, Insulin secretion, Type II diabetes mellitus",ABC transporter,,"6C3P, 6C3O",Blocker,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"2LNL, 1ILQ, 1ILP",Agonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"2LNL, 1ILQ, 1ILP",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"2LNL, 1ILQ, 1ILP",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"2LNL, 1ILQ, 1ILP",Modulator,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Tight junction, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Inflammatory mediator regulation of TRP channels, Type II diabetes mellitus, MicroRNAs in cancer",Kinase,Transferases,"5LIH, 2WH0",Activator,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Tight junction, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Inflammatory mediator regulation of TRP channels, Type II diabetes mellitus, MicroRNAs in cancer",Kinase,Transferases,"5LIH, 2WH0",Inhibitor,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Vascular smooth muscle contraction, Tight junction, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Inflammatory mediator regulation of TRP channels, Type II diabetes mellitus, MicroRNAs in cancer",Kinase,Transferases,"5LIH, 2WH0",Stimulator,1.0
"Pyrimidine metabolism, Metabolic pathways",CH-CH donor oxidoreductase,Oxidoreductases,"6GJG, 6E0B, 5TBO, 5FI8, 5DEL",Inhibitor,1.0
"Purine metabolism, cAMP signaling pathway, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,"6NJJ, 6NJI, 6NJH, 6FW3, 6FTW",Inhibitor,1.0
"Purine metabolism, cAMP signaling pathway, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,"6NJJ, 6NJI, 6NJH, 6FW3, 6FTW",Modulator,1.0
"Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis",Cytokine: tumor necrosis factor,,"6FXN, 5Y9J, 4ZCH, 4V46, 3V56",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis",Cytokine: tumor necrosis factor,,"6FXN, 5Y9J, 4ZCH, 4V46, 3V56",.,1.0
"Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis",Cytokine: tumor necrosis factor,,"6FXN, 5Y9J, 4ZCH, 4V46, 3V56",Modulator,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway",Cytokine receptor,,"5OHD, 5OEK, 3HHR, 2AEW, 1KF9",Modulator,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway",Cytokine receptor,,"5OHD, 5OEK, 3HHR, 2AEW, 1KF9",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway",Cytokine receptor,,"5OHD, 5OEK, 3HHR, 2AEW, 1KF9",Agonist,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway",Cytokine receptor,,"5OHD, 5OEK, 3HHR, 2AEW, 1KF9",Binder,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Antagonist,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Agonist,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Modulator (allosteric modulator),1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Modulator,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Binder,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Partial agonist,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,3PBL,Ligand,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Chagas disease (American trypanosomiasis), Tuberculosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection",Cytokine: interferon,,1AU1,Modulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Chagas disease (American trypanosomiasis), Tuberculosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection",Cytokine: interferon,,1AU1,Blocker,1.0
"Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Measles, HTLV-I infection",Cytokine receptor,,"3NFP, 3IU3, 2ERJ, 2B5I, 1Z92",.,1.0
"Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Measles, HTLV-I infection",Cytokine receptor,,"3NFP, 3IU3, 2ERJ, 2B5I, 1Z92",Modulator,1.0
"Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Measles, HTLV-I infection",Cytokine receptor,,"3NFP, 3IU3, 2ERJ, 2B5I, 1Z92",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Inflammatory bowel disease (IBD)",Cytokine receptor,,"5E4E, 3BPO, 3BPN, 3BPL, 1ITE",Antagonist,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Inflammatory bowel disease (IBD)",Cytokine receptor,,"5E4E, 3BPO, 3BPN, 3BPL, 1ITE",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Inflammatory bowel disease (IBD)",Cytokine receptor,,"5E4E, 3BPO, 3BPN, 3BPL, 1ITE",Agonist,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Inflammatory bowel disease (IBD)",Cytokine receptor,,"5E4E, 3BPO, 3BPN, 3BPL, 1ITE",.,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Inflammatory bowel disease (IBD)",Cytokine receptor,,"5E4E, 3BPO, 3BPN, 3BPL, 1ITE",Modulator,1.0
"Purine metabolism, Metabolic pathways, Primary immunodeficiency",Carbon-nitrogen hydrolase,Hydrolases,"3IAR, 1M7M",Inhibitor,1.0
"Purine metabolism, Metabolic pathways, Primary immunodeficiency",Carbon-nitrogen hydrolase,Hydrolases,"3IAR, 1M7M",Modulator,1.0
"Purine metabolism, Metabolic pathways, Primary immunodeficiency",Carbon-nitrogen hydrolase,Hydrolases,"3IAR, 1M7M",Replacement,1.0
"Arachidonic acid metabolism, Metabolic pathways",Ether bond hydrolase,Hydrolases,"6END, 6ENC, 6ENB, 5NIE, 5NID",Inhibitor,1.0
"PPAR signaling pathway, AMPK signaling pathway, Osteoclast differentiation, Huntington's disease, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer",Nuclear hormone receptor,,"6MD4, 6MD2, 6MD1, 6MD0, 6MCZ",Agonist,1.0
"PPAR signaling pathway, AMPK signaling pathway, Osteoclast differentiation, Huntington's disease, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer",Nuclear hormone receptor,,"6MD4, 6MD2, 6MD1, 6MD0, 6MCZ",Modulator,1.0
"PPAR signaling pathway, AMPK signaling pathway, Osteoclast differentiation, Huntington's disease, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer",Nuclear hormone receptor,,"6MD4, 6MD2, 6MD1, 6MD0, 6MCZ",Inhibitor,1.0
"PPAR signaling pathway, AMPK signaling pathway, Osteoclast differentiation, Huntington's disease, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer",Nuclear hormone receptor,,"6MD4, 6MD2, 6MD1, 6MD0, 6MCZ",Ligand,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Chemokine signaling pathway, FoxO signaling pathway, Sphingolipid signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, VEGF signaling pathway, Focal adhesion, Tight junction, Gap junction, Signaling pathways regulating pluripotency of stem cells, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Long-term potentiation, Neurotrophin signaling pathway, Cholinergic synapse, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, GnRH signaling pathway, Estrogen signaling pathway, Melanogenesis, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Alcoholism, Hepatitis C, Hepatitis B, HTLV-I infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Endometrial cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia, Acute myeloid leukemia, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",mRNA target,,"821P, 721P, 6Q21, 6D5W, 6D5V",.,0.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,1L4T,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,1L4T,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,1L4T,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gastric acid secretion",GPCR rhodopsin,,1L4T,Agonist,1.0
"Base excision repair, NF-kappa B signaling pathway",Glycosyltransferases,Transferases,"6GHK, 6BHV, 5XSU, 5XST, 5XSR",Inhibitor,1.0
"Base excision repair, NF-kappa B signaling pathway",Glycosyltransferases,Transferases,"6GHK, 6BHV, 5XSU, 5XST, 5XSR",Modulator,1.0
"Base excision repair, NF-kappa B signaling pathway",Glycosyltransferases,Transferases,"6GHK, 6BHV, 5XSU, 5XST, 5XSR",Binder,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection",Cytokine receptor,,"3SE4, 3SE3, 3S9D, 3S8W, 2LAG",Stimulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection",Cytokine receptor,,"3SE4, 3SE3, 3S9D, 3S8W, 2LAG",Antagonist,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection",Cytokine receptor,,"3SE4, 3SE3, 3S9D, 3S8W, 2LAG",.,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Osteoclast differentiation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection",Cytokine receptor,,"3SE4, 3SE3, 3S9D, 3S8W, 2LAG",Binder,1.0
"ErbB signaling pathway, Calcium signaling pathway, Endocytosis, Proteoglycans in cancer",Kinase,Transferases,"3U9U, 3U7U, 3U2P, 3BCE, 3BBW",Inhibitor,1.0
"ErbB signaling pathway, Calcium signaling pathway, Endocytosis, Proteoglycans in cancer",Kinase,Transferases,"3U9U, 3U7U, 3U2P, 3BCE, 3BBW",Modulator,1.0
"ErbB signaling pathway, Calcium signaling pathway, Endocytosis, Proteoglycans in cancer",Kinase,Transferases,"3U9U, 3U7U, 3U2P, 3BCE, 3BBW",Antagonist,1.0
Nitrogen metabolism,Alpha-carbonic anhydrase,Lyases,3FE4,Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Jak-STAT signaling pathway, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"5NJD, 5MZV, 5MXA, 5MJ4, 5MJ3",.,1.0
"Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Jak-STAT signaling pathway, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"5NJD, 5MZV, 5MXA, 5MJ4, 5MJ3",Replacement,1.0
"Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Jak-STAT signaling pathway, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"5NJD, 5MZV, 5MXA, 5MJ4, 5MJ3",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Jak-STAT signaling pathway, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"5NJD, 5MZV, 5MXA, 5MJ4, 5MJ3",Modulator,1.0
"Ubiquinone and other terpenoid-quinone biosynthesis, Tyrosine metabolism, Phenylalanine metabolism, Metabolic pathways",Single donor oxidoreductase,Oxidoreductases,"5EC3, 3ISQ",Inhibitor,1.0
"MAPK signaling pathway, Endocytosis, Apoptosis, Neurotrophin signaling pathway, Inflammatory mediator regulation of TRP channels, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6NSS, 6NSP, 6NPT, 6DKW, 6DKI",Inhibitor,1.0
"MAPK signaling pathway, Endocytosis, Apoptosis, Neurotrophin signaling pathway, Inflammatory mediator regulation of TRP channels, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6NSS, 6NSP, 6NPT, 6DKW, 6DKI",Antagonist,1.0
"MAPK signaling pathway, Endocytosis, Apoptosis, Neurotrophin signaling pathway, Inflammatory mediator regulation of TRP channels, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6NSS, 6NSP, 6NPT, 6DKW, 6DKI",Agonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Focal adhesion",Kinase,Transferases,"4BSK, 4BSJ",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Focal adhesion",Kinase,Transferases,"4BSK, 4BSJ",Modulator,1.0
"Purine metabolism, cGMP-PKG signaling pathway",Phosphoric diester hydrolase,Hydrolases,"6ACB, 5ZZ2, 5JO3, 4OEX, 4OEW",Inhibitor,1.0
"Purine metabolism, cGMP-PKG signaling pathway",Phosphoric diester hydrolase,Hydrolases,"6ACB, 5ZZ2, 5JO3, 4OEX, 4OEW",Modulator,1.0
"Purine metabolism, cGMP-PKG signaling pathway",Phosphoric diester hydrolase,Hydrolases,"6ACB, 5ZZ2, 5JO3, 4OEX, 4OEW",Binder,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,"6G79, 5V54, 4IAR, 4IAQ, 2G1X",Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,"6G79, 5V54, 4IAR, 4IAQ, 2G1X",Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,"6G79, 5V54, 4IAR, 4IAQ, 2G1X",Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,"6G79, 5V54, 4IAR, 4IAQ, 2G1X",Modulator,1.0
B cell receptor signaling pathway,Immunoglobulin,,3KG5,.,1.0
B cell receptor signaling pathway,Immunoglobulin,,3KG5,Modulator,1.0
B cell receptor signaling pathway,Immunoglobulin,,3KG5,Agonist,1.0
"Chemokine signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, Leishmaniasis, Toxoplasmosis, Tuberculosis, Measles, Influenza A, Herpes simplex infection",Kinase,Transferases,"6M9H, 6E2Q, 6E2P, 6DRW, 6BSS",Inhibitor,1.0
"Chemokine signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Cholinergic synapse, Prolactin signaling pathway, Adipocytokine signaling pathway, Leishmaniasis, Toxoplasmosis, Tuberculosis, Measles, Influenza A, Herpes simplex infection",Kinase,Transferases,"6M9H, 6E2Q, 6E2P, 6DRW, 6BSS",Modulator,1.0
Complement and coagulation cascades,Growth factor,,"5TO3, 3GIS, 2ADX, 1ZAQ, 1TMR",Modulator,0.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,"6I53, 6HUP, 6HUO, 6HUK, 6HUJ",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,"6I53, 6HUP, 6HUO, 6HUK, 6HUJ",Blocker (channel blocker),1.0
"Fatty acid biosynthesis, Pyruvate metabolism, Propanoate metabolism, Metabolic pathways, Fatty acid metabolism, AMPK signaling pathway, Insulin signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway",Carbon-carbon ligase,Ligases,"5KKN, 4HQ6, 3TDC, 3JRX, 3JRW",Inhibitor,1.0
"Fatty acid biosynthesis, Pyruvate metabolism, Propanoate metabolism, Metabolic pathways, Fatty acid metabolism, AMPK signaling pathway, Insulin signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway",Carbon-carbon ligase,Ligases,"5KKN, 4HQ6, 3TDC, 3JRX, 3JRW",Activator,1.0
"Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Renin-angiotensin system",GPCR rhodopsin,,"5UNH, 5UNG, 5UNF",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Renin-angiotensin system",GPCR rhodopsin,,"5UNH, 5UNG, 5UNF",Agonist,1.0
"Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Renin-angiotensin system",GPCR rhodopsin,,"5UNH, 5UNG, 5UNF",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Renin-angiotensin system",GPCR rhodopsin,,"5UNH, 5UNG, 5UNF",Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",GPCR rhodopsin,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",GPCR rhodopsin,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",GPCR rhodopsin,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",GPCR rhodopsin,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",.,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",GPCR rhodopsin,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",Binder,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",mRNA target,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Toxoplasmosis, Viral carcinogenesis",mRNA target,,"6MET, 6MEO, 6FGP, 5YY4, 5YD5",.,1.0
"Cell adhesion molecules (CAMs), Antigen processing and presentation, Hematopoietic cell lineage, T cell receptor signaling pathway, Primary immunodeficiency",Immunoglobulin,,"6MET, 6MEO, 6EDU, 6CM3, 5VN3",.,1.0
"Cell adhesion molecules (CAMs), Antigen processing and presentation, Hematopoietic cell lineage, T cell receptor signaling pathway, Primary immunodeficiency",Immunoglobulin,,"6MET, 6MEO, 6EDU, 6CM3, 5VN3",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Antigen processing and presentation, Hematopoietic cell lineage, T cell receptor signaling pathway, Primary immunodeficiency",Immunoglobulin,,"6MET, 6MEO, 6EDU, 6CM3, 5VN3",Binder,1.0
"Cell adhesion molecules (CAMs), Antigen processing and presentation, Hematopoietic cell lineage, T cell receptor signaling pathway, Primary immunodeficiency",Immunoglobulin,,"6MET, 6MEO, 6EDU, 6CM3, 5VN3",Modulator,1.0
"Nicotinate and nicotinamide metabolism, Metabolic pathways, Calcium signaling pathway, Hematopoietic cell lineage, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion, Epstein-Barr virus infection",Glycosylase,Hydrolases,"6EDR, 5F21, 5F1O, 5F1K, 4XJT",CAR-T-Cell-Therapy,1.0
"Nicotinate and nicotinamide metabolism, Metabolic pathways, Calcium signaling pathway, Hematopoietic cell lineage, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion, Epstein-Barr virus infection",Glycosylase,Hydrolases,"6EDR, 5F21, 5F1O, 5F1K, 4XJT",Modulator,1.0
"Nicotinate and nicotinamide metabolism, Metabolic pathways, Calcium signaling pathway, Hematopoietic cell lineage, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion, Epstein-Barr virus infection",Glycosylase,Hydrolases,"6EDR, 5F21, 5F1O, 5F1K, 4XJT",.,1.0
"Nicotinate and nicotinamide metabolism, Metabolic pathways, Calcium signaling pathway, Hematopoietic cell lineage, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion, Epstein-Barr virus infection",Glycosylase,Hydrolases,"6EDR, 5F21, 5F1O, 5F1K, 4XJT",Inhibitor,1.0
"Nicotinate and nicotinamide metabolism, Metabolic pathways, Calcium signaling pathway, Hematopoietic cell lineage, Oxytocin signaling pathway, Salivary secretion, Pancreatic secretion, Epstein-Barr virus infection",Glycosylase,Hydrolases,"6EDR, 5F21, 5F1O, 5F1K, 4XJT",CAR-T-Cell-Therapy(Dual specific),1.0
Metabolic pathways,Paired donor oxygen oxidoreductase,Oxidoreductases,4ZYO,.,1.0
Metabolic pathways,Paired donor oxygen oxidoreductase,Oxidoreductases,4ZYO,Inhibitor,1.0
Metabolic pathways,Paired donor oxygen oxidoreductase,Oxidoreductases,4ZYO,Binder,1.0
"Cell adhesion molecules (CAMs), Malaria, Staphylococcus aureus infection",,,"1KJD, 1HES, 1G1S, 1G1R, 1G1Q",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Malaria, Staphylococcus aureus infection",,,"1KJD, 1HES, 1G1S, 1G1R, 1G1Q",Modulator,1.0
"Cell adhesion molecules (CAMs), Malaria, Staphylococcus aureus infection",,,"1KJD, 1HES, 1G1S, 1G1R, 1G1Q",.,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Antagonist,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Agonist,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Modulator,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Inhibitor,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Binder,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Degrader,1.0
"Oocyte meiosis, Pathways in cancer, Prostate cancer",Nuclear hormone receptor,,"5VO4, 5V8Q, 5T8J, 5T8E, 5JJM",Enhancer,1.0
"MAPK signaling pathway, VEGF signaling pathway, Amoebiasis, Epstein-Barr virus infection",mRNA target,,"4MJH, 3Q9Q, 3Q9P, 2N3J",.,0.0
"MAPK signaling pathway, VEGF signaling pathway, Amoebiasis, Epstein-Barr virus infection",mRNA target,,"4MJH, 3Q9Q, 3Q9P, 2N3J",Inhibitor,0.0
"ABC transporters, Sphingolipid signaling pathway, Vitamin digestion and absorption, MicroRNAs in cancer",ABC transporter,Translocases,"4C3Z, 2CBZ",Inhibitor,1.0
"ABC transporters, Sphingolipid signaling pathway, Vitamin digestion and absorption, MicroRNAs in cancer",ABC transporter,Translocases,"4C3Z, 2CBZ",Stimulator,1.0
"ABC transporters, Sphingolipid signaling pathway, Vitamin digestion and absorption, MicroRNAs in cancer",ABC transporter,Translocases,"4C3Z, 2CBZ",Modulator,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"1HOF, 1HOD, 1HO9, 1HLL",Agonist,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"1HOF, 1HOD, 1HO9, 1HLL",Inhibitor,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"1HOF, 1HOD, 1HO9, 1HLL",Antagonist,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"1HOF, 1HOD, 1HO9, 1HLL",Modulator,1.0
"D-Alanine metabolism, Peptidoglycan biosynthesis, Metabolic pathways, Vancomycin resistance",Carbon-nitrogen ligase,Ligases,3LWB,Inhibitor,1.0
"NF-kappa B signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, HTLV-I infection, Primary immunodeficiency",Kinase,Transferases,"6H6A, 5MTN, 5MTM, 4D8K, 4C3F",Inhibitor,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Wnt signaling pathway, VEGF signaling pathway, Focal adhesion, Tight junction, Gap junction, Natural killer cell mediated cytotoxicity, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Leukocyte transendothelial migration, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Inflammatory mediator regulation of TRP channels, Insulin secretion, GnRH signaling pathway, Melanogenesis, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Amphetamine addiction, Morphine addiction, Vibrio cholerae infection, Pathogenic Escherichia coli infection, African trypanosomiasis, Amoebiasis, Hepatitis B, Influenza A, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Glioma, Non-small cell lung cancer, Choline metabolism in cancer",Kinase,Transferases,"4RA4, 4DNL, 3IW4, 2ELI",Inhibitor,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Wnt signaling pathway, VEGF signaling pathway, Focal adhesion, Tight junction, Gap junction, Natural killer cell mediated cytotoxicity, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Leukocyte transendothelial migration, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Inflammatory mediator regulation of TRP channels, Insulin secretion, GnRH signaling pathway, Melanogenesis, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Amphetamine addiction, Morphine addiction, Vibrio cholerae infection, Pathogenic Escherichia coli infection, African trypanosomiasis, Amoebiasis, Hepatitis B, Influenza A, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Glioma, Non-small cell lung cancer, Choline metabolism in cancer",Kinase,Transferases,"4RA4, 4DNL, 3IW4, 2ELI",Modulator,1.0
"p53 signaling pathway, Ubiquitin mediated proteolysis",Acyltransferase,Transferases,"5IGQ, 5HQG",Modulator,1.0
"Calcium signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",,,"6MV3, 5WCL, 5W88, 5VLN, 4Y99",Stimulator,1.0
Nitrogen metabolism,Alpha-carbonic anhydrase,Lyases,"6HWZ, 6G3V, 6FAG, 6FAF, 6F3B",Inhibitor,1.0
Nitrogen metabolism,Alpha-carbonic anhydrase,Lyases,"6HWZ, 6G3V, 6FAG, 6FAF, 6F3B",Modulator,1.0
"Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Jak-STAT signaling pathway, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"3HMX, 1F45",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Jak-STAT signaling pathway, Type I diabetes mellitus, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"3HMX, 1F45",.,1.0
"Alanine, aspartate and glutamate metabolism, Butanoate metabolism, Metabolic pathways",Aldehyde/oxo donor oxidoreductase,Oxidoreductases,"2W8R, 2W8Q, 2W8P, 2W8O, 2W8N",Inhibitor,1.0
"Alanine, aspartate and glutamate metabolism, Butanoate metabolism, Metabolic pathways",Aldehyde/oxo donor oxidoreductase,Oxidoreductases,"2W8R, 2W8Q, 2W8P, 2W8O, 2W8N",Modulator,1.0
"Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis",Paired donor oxygen oxidoreductase,Oxidoreductases,"5JL9, 5JL7, 5JL6, 5JKW, 5JKV",Inhibitor,1.0
"Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis",Paired donor oxygen oxidoreductase,Oxidoreductases,"5JL9, 5JL7, 5JL6, 5JKW, 5JKV",Modulator,1.0
"PPAR signaling pathway, PI3K-Akt signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Bile secretion, Hepatitis C, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"6HN6, 6FBR, 6FBQ, 6A60, 6A5Z",Antagonist,1.0
"PPAR signaling pathway, PI3K-Akt signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Bile secretion, Hepatitis C, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"6HN6, 6FBR, 6FBQ, 6A60, 6A5Z",Agonist,1.0
"PPAR signaling pathway, PI3K-Akt signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Bile secretion, Hepatitis C, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"6HN6, 6FBR, 6FBQ, 6A60, 6A5Z",Inhibitor,1.0
"PPAR signaling pathway, PI3K-Akt signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Bile secretion, Hepatitis C, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"6HN6, 6FBR, 6FBQ, 6A60, 6A5Z",Modulator,1.0
"FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"3V2Y, 3V2W",Agonist,1.0
"FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"3V2Y, 3V2W",Inhibitor,1.0
"FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"3V2Y, 3V2W",Antagonist,1.0
"FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"3V2Y, 3V2W",Modulator,1.0
"FoxO signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"3V2Y, 3V2W",.,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Integrin,,"3V4V, 3V4P, 2BRQ",Antagonist,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules (CAMs), Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Transcriptional misregulation in cancer, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Integrin,,"3V4V, 3V4P, 2BRQ",.,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",CAR-T-Cell-Therapy,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",Binder,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",.,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",Inhibitor,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",Modulator,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",Enhancer,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",Immunomodulator,1.0
"ErbB signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Focal adhesion, Adherens junction, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Prostate cancer, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6OGE, 6J71, 6BGT, 6ATT, 5TQS",Antagonist,1.0
Complement and coagulation cascades,,,"5K8D, 4XZU, 4PT6, 4KI5, 4BDV",Inhibitor,1.0
Complement and coagulation cascades,,,"5K8D, 4XZU, 4PT6, 4KI5, 4BDV",Modulator,1.0
Complement and coagulation cascades,,,"5K8D, 4XZU, 4PT6, 4KI5, 4BDV",Stimulator,1.0
Complement and coagulation cascades,,,"5K8D, 4XZU, 4PT6, 4KI5, 4BDV",Replacement,1.0
Complement and coagulation cascades,,,"5K8D, 4XZU, 4PT6, 4KI5, 4BDV",.,1.0
,mRNA target,,"6OVC, 6OQN, 6OQD, 6OQC, 6OQB",.,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis",Immunoglobulin,,"5XJ3, 5TRU, 5GGV, 3OSK, 3BX7",.,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis",Immunoglobulin,,"5XJ3, 5TRU, 5GGV, 3OSK, 3BX7",Inhibitor,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis",Immunoglobulin,,"5XJ3, 5TRU, 5GGV, 3OSK, 3BX7",Modulator,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis",Immunoglobulin,,"5XJ3, 5TRU, 5GGV, 3OSK, 3BX7",Agonist,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Autoimmune thyroid disease, Rheumatoid arthritis",Immunoglobulin,,"5XJ3, 5TRU, 5GGV, 3OSK, 3BX7",Antagonist,1.0
"Axon guidance, HTLV-I infection",Neuropilin and tolloid-like,,"6FMF, 6FMC, 5L73, 5JHK, 5JGQ",Inhibitor,1.0
"Axon guidance, HTLV-I infection",Neuropilin and tolloid-like,,"6FMF, 6FMC, 5L73, 5JHK, 5JGQ",Modulator,1.0
"Axon guidance, HTLV-I infection",Neuropilin and tolloid-like,,"6FMF, 6FMC, 5L73, 5JHK, 5JGQ",.,1.0
"Valine, leucine and isoleucine degradation, Glyoxylate and dicarboxylate metabolism, Propanoate metabolism, Metabolic pathways, Carbon metabolism",Intramolecular transferases,Isomerases,"3BIC, 2XIQ, 2XIJ",Replacement,1.0
"Valine, leucine and isoleucine degradation, Glyoxylate and dicarboxylate metabolism, Propanoate metabolism, Metabolic pathways, Carbon metabolism",Intramolecular transferases,Isomerases,"3BIC, 2XIQ, 2XIJ",Cofactor,1.0
"Adherens junction, Insulin signaling pathway",mRNA target,Hydrolases,"6CWV, 6CWU, 6BAI, 6B95, 6B90",Inhibitor,1.0
"Adherens junction, Insulin signaling pathway",mRNA target,Hydrolases,"6CWV, 6CWU, 6BAI, 6B95, 6B90",.,1.0
"Adherens junction, Insulin signaling pathway",mRNA target,Hydrolases,"6CWV, 6CWU, 6BAI, 6B95, 6B90",Modulator,1.0
"Fatty acid biosynthesis, Metabolic pathways, Fatty acid metabolism, AMPK signaling pathway, Insulin signaling pathway",Acyltransferase,Transferases,"6NNA, 5C37, 4Z49, 4W9N, 4W82",Inhibitor,1.0
"Fatty acid biosynthesis, Metabolic pathways, Fatty acid metabolism, AMPK signaling pathway, Insulin signaling pathway",Acyltransferase,Transferases,"6NNA, 5C37, 4Z49, 4W9N, 4W82",.,1.0
Nitrogen metabolism,Alpha-carbonic anhydrase,Lyases,"6G7A, 6G5L, 5MSB, 5MSA, 5LLP",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Jak-STAT signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,"6E2P, 3V6O",Modulator,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Jak-STAT signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,"6E2P, 3V6O",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Jak-STAT signaling pathway, Adipocytokine signaling pathway, Non-alcoholic fatty liver disease (NAFLD)",Cytokine receptor,,"6E2P, 3V6O",Agonist,1.0
"One carbon pool by folate, Folate biosynthesis, Metabolic pathways",CH-NH donor oxidoreductase,Oxidoreductases,"6DE4, 6DAV, 6A7E, 6A7C, 5HVE",Modulator,1.0
"One carbon pool by folate, Folate biosynthesis, Metabolic pathways",CH-NH donor oxidoreductase,Oxidoreductases,"6DE4, 6DAV, 6A7E, 6A7C, 5HVE",Inhibitor,1.0
Histidine metabolism,Methyltransferase,Transferases,"2AOX, 2AOW, 2AOV, 2AOU, 2AOT",Inhibitor,1.0
"NF-kappa B signaling pathway, Complement and coagulation cascades, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer",Peptidase,Hydrolases,"6NMB, 5ZC5, 5ZAJ, 5ZAH, 5ZAG",Inhibitor,1.0
"NF-kappa B signaling pathway, Complement and coagulation cascades, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer",Peptidase,Hydrolases,"6NMB, 5ZC5, 5ZAJ, 5ZAH, 5ZAG",Activator,1.0
"NF-kappa B signaling pathway, Complement and coagulation cascades, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer",Peptidase,Hydrolases,"6NMB, 5ZC5, 5ZAJ, 5ZAH, 5ZAG",Modulator,1.0
"Sphingolipid signaling pathway, Axon guidance, Osteoclast differentiation, Focal adhesion, Adherens junction, Platelet activation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Cholinergic synapse, Prion diseases, Pathogenic Escherichia coli infection, Measles, Viral myocarditis",Kinase,Transferases,"6IPZ, 6IPY, 6EDF, 4ZNX, 4U1P",Inhibitor,1.0
"Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Antigen processing and presentation, NOD-like receptor signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Pathways in cancer, Prostate cancer",Heat shock protein,,"6GR5, 6GR4, 6GR3, 6GR1, 6GQU",Inhibitor,1.0
"Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Antigen processing and presentation, NOD-like receptor signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Pathways in cancer, Prostate cancer",Heat shock protein,,"6GR5, 6GR4, 6GR3, 6GR1, 6GQU",Modulator,1.0
"Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Antigen processing and presentation, NOD-like receptor signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Pathways in cancer, Prostate cancer",Heat shock protein,,"6GR5, 6GR4, 6GR3, 6GR1, 6GQU",.,1.0
GnRH signaling pathway,Gonadotropin-releasing hormone,,4D5M,Inhibitor,1.0
GnRH signaling pathway,Gonadotropin-releasing hormone,,4D5M,Modulator,1.0
GnRH signaling pathway,Gonadotropin-releasing hormone,,4D5M,.,1.0
GnRH signaling pathway,Gonadotropin-releasing hormone,,4D5M,Activator,1.0
"Arachidonic acid metabolism, Metabolic pathways",Intramolecular oxidoreductases,Isomerases,"6N4E, 5YX1, 5YWX, 5YWE, 5AIX",Inhibitor,1.0
"Arachidonic acid metabolism, Metabolic pathways",Intramolecular oxidoreductases,Isomerases,"6N4E, 5YX1, 5YWX, 5YWE, 5AIX",Stimulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Malaria",Cytokine: interleukin,,"5ZO6, 5GW9, 2D9Q, 1RHG, 1PGR",Modulator,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Influenza A, HTLV-I infection, Herpes simplex infection, Proteoglycans in cancer, Asthma, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",Cytokine: tumor necrosis factor,,"5YOY, 5WUX, 5UUI, 5TSW, 5MU8",Inhibitor,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Influenza A, HTLV-I infection, Herpes simplex infection, Proteoglycans in cancer, Asthma, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",Cytokine: tumor necrosis factor,,"5YOY, 5WUX, 5UUI, 5TSW, 5MU8",Modulator,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Influenza A, HTLV-I infection, Herpes simplex infection, Proteoglycans in cancer, Asthma, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",Cytokine: tumor necrosis factor,,"5YOY, 5WUX, 5UUI, 5TSW, 5MU8",.,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Sphingolipid signaling pathway, mTOR signaling pathway, Apoptosis, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis C, Hepatitis B, Influenza A, HTLV-I infection, Herpes simplex infection, Proteoglycans in cancer, Asthma, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",Cytokine: tumor necrosis factor,,"5YOY, 5WUX, 5UUI, 5TSW, 5MU8",Suppressor,1.0
,mRNA target,,"5YOY, 5WUX, 5UUI, 5TSW, 5MU8",.,0.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,2HE6,Antagonist,0.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,2HE6,Inhibitor,0.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,2HE6,Agonist,0.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia",Kinase,Transferases,"4WRM, 4WRL, 4R7I, 4R7H, 4LIQ",Antagonist,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia",Kinase,Transferases,"4WRM, 4WRL, 4R7I, 4R7H, 4LIQ",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor, PI3K-Akt signaling pathway, Osteoclast differentiation, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia",Kinase,Transferases,"4WRM, 4WRL, 4R7I, 4R7H, 4LIQ",.,1.0
"Nitrogen metabolism, Proximal tubule bicarbonate reclamation, Collecting duct acid secretion, Gastric acid secretion, Pancreatic secretion, Bile secretion",Alpha-carbonic anhydrase,Lyases,"9CA2, 8CA2, 7CA2, 6QEB, 6MBY",Inhibitor,1.0
"Porphyrin and chlorophyll metabolism, Metabolic pathways",Alpha-carbonic anhydrase,Lyases,"5HNR, 5HMS, 1PV8, 1.00E+51",Inhibitor,1.0
"Purine metabolism, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,1LXW,Inhibitor,0.0
"Purine metabolism, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,1LXW,Modulator,0.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6D9H, 5DSG",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6D9H, 5DSG",Agonist,1.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6D9H, 5DSG",Modulator,1.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6D9H, 5DSG",Antagonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",Stablizer,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",Binder,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",Disrupter,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Pancreatic cancer, Bladder cancer, Rheumatoid arthritis",Growth factor,,"6D3O, 6BFT, 5T89, 5O4E, 5HHD",Blocker,1.0
"Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Prolactin signaling pathway, Rheumatoid arthritis",Cytokine: tumor necrosis factor,,"5BNQ, 3URF",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Prolactin signaling pathway, Rheumatoid arthritis",Cytokine: tumor necrosis factor,,"5BNQ, 3URF",.,1.0
"Galactose metabolism, Glycerolipid metabolism, Sphingolipid metabolism, Glycosphingolipid biosynthesis - globo series, Lysosome",Glycosylase,Hydrolases,"4NXS, 3TV8, 3S5Z, 3S5Y, 3LXC",Inhibitor,1.0
"Galactose metabolism, Glycerolipid metabolism, Sphingolipid metabolism, Glycosphingolipid biosynthesis - globo series, Lysosome",Glycosylase,Hydrolases,"4NXS, 3TV8, 3S5Z, 3S5Y, 3LXC",Modulator,1.0
"Galactose metabolism, Glycerolipid metabolism, Sphingolipid metabolism, Glycosphingolipid biosynthesis - globo series, Lysosome",Glycosylase,Hydrolases,"4NXS, 3TV8, 3S5Z, 3S5Y, 3LXC",.,1.0
"Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), Rheumatoid arthritis",Cytokine: interleukin,,"5VB9, 5NAN, 5N92, 5N7W, 5HI5",.,1.0
"Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), Rheumatoid arthritis",Cytokine: interleukin,,"5VB9, 5NAN, 5N92, 5N7W, 5HI5",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Inflammatory bowel disease (IBD), Rheumatoid arthritis",Cytokine: interleukin,,"5VB9, 5NAN, 5N92, 5N7W, 5HI5",Modulator,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism",GPCR rhodopsin,,1OZ5,Agonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism",GPCR rhodopsin,,1OZ5,Antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism",GPCR rhodopsin,,1OZ5,Inhibitor,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism",GPCR rhodopsin,,1OZ5,Modulator,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Morphine addiction, Alcoholism",GPCR rhodopsin,,1OZ5,Binder,1.0
"Phagosome, Osteoclast differentiation, Platelet activation, Fc gamma R-mediated phagocytosis, Leishmaniasis, Staphylococcus aureus infection, Tuberculosis, Systemic lupus erythematosus",Immunoglobulin,,"3RY6, 3RY5, 3RY4, 3D5O, 1H9V",Antagonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Agonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Blocker (channel blocker),1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Antagonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Modulator (allosteric modulator),1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Agonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Antagonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism",Glutamate-gated ion channel,,"6IRH, 6IRG, 6IRF, 6IRA, 5TPA",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Epithelial cell signaling in Helicobacter pylori infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Chagas disease (American trypanosomiasis), Malaria, Amoebiasis, Hepatitis C, Hepatitis B, Influenza A, Pathways in cancer, Transcriptional misregulation in cancer, Bladder cancer, Rheumatoid arthritis",Cytokine: interleukin,,"5WDZ, 5D14, 4XDX, 3IL8, 2IL8",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Epithelial cell signaling in Helicobacter pylori infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Chagas disease (American trypanosomiasis), Malaria, Amoebiasis, Hepatitis C, Hepatitis B, Influenza A, Pathways in cancer, Transcriptional misregulation in cancer, Bladder cancer, Rheumatoid arthritis",Cytokine: interleukin,,"5WDZ, 5D14, 4XDX, 3IL8, 2IL8",Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Epithelial cell signaling in Helicobacter pylori infection, Shigellosis, Salmonella infection, Pertussis, Legionellosis, Chagas disease (American trypanosomiasis), Malaria, Amoebiasis, Hepatitis C, Hepatitis B, Influenza A, Pathways in cancer, Transcriptional misregulation in cancer, Bladder cancer, Rheumatoid arthritis",Cytokine: interleukin,,"5WDZ, 5D14, 4XDX, 3IL8, 2IL8",.,1.0
"Oocyte meiosis, Progesterone-mediated oocyte maturation",Nuclear hormone receptor,,"5CC0, 4OAR, 4APU, 4A2J, 3ZRB",Agonist,1.0
"Oocyte meiosis, Progesterone-mediated oocyte maturation",Nuclear hormone receptor,,"5CC0, 4OAR, 4APU, 4A2J, 3ZRB",Antagonist,1.0
"Oocyte meiosis, Progesterone-mediated oocyte maturation",Nuclear hormone receptor,,"5CC0, 4OAR, 4APU, 4A2J, 3ZRB",Inhibitor,1.0
"Oocyte meiosis, Progesterone-mediated oocyte maturation",Nuclear hormone receptor,,"5CC0, 4OAR, 4APU, 4A2J, 3ZRB",Modulator,1.0
"Oocyte meiosis, Progesterone-mediated oocyte maturation",Nuclear hormone receptor,,"5CC0, 4OAR, 4APU, 4A2J, 3ZRB",Inducer,1.0
"Oocyte meiosis, Progesterone-mediated oocyte maturation",Nuclear hormone receptor,,"5CC0, 4OAR, 4APU, 4A2J, 3ZRB",Binder,1.0
"Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis",Paired donor oxygen oxidoreductase,Oxidoreductases,"3NA1, 3NA0, 3N9Z, 3N9Y",Inhibitor,1.0
"Chemokine signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Measles, HTLV-I infection, Epstein-Barr virus infection, Viral carcinogenesis, Primary immunodeficiency",Kinase,Transferases,"6NY4, 6GLB, 6GLA, 6GL9, 6DUD",Inhibitor,1.0
"Chemokine signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Measles, HTLV-I infection, Epstein-Barr virus infection, Viral carcinogenesis, Primary immunodeficiency",Kinase,Transferases,"6NY4, 6GLB, 6GLA, 6GL9, 6DUD",Modulator,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Lysosome",Sulfuric ester hydrolase,Hydrolases,"4FDJ, 4FDI",Modulator,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation",,,"6N29, 6FWN, 5BV8, 4NT5, 4DMU",Inhibitor,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation",,,"6N29, 6FWN, 5BV8, 4NT5, 4DMU",Modulator,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation",,,"6N29, 6FWN, 5BV8, 4NT5, 4DMU",Binder,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Complement and coagulation cascades, Platelet activation",,,"6N29, 6FWN, 5BV8, 4NT5, 4DMU",Replacement,1.0
"Rap1 signaling pathway, Phagosome, PI3K-Akt signaling pathway, Osteoclast differentiation, Focal adhesion, ECM-receptor interaction, Platelet activation, Hematopoietic cell lineage, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Proteoglycans in cancer, MicroRNAs in cancer, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",mRNA target,,"6CKB, 6BXJ, 6BXF, 6BXB, 6AVU",.,0.0
"Rap1 signaling pathway, Phagosome, PI3K-Akt signaling pathway, Osteoclast differentiation, Focal adhesion, ECM-receptor interaction, Platelet activation, Hematopoietic cell lineage, Regulation of actin cytoskeleton, Thyroid hormone signaling pathway, Proteoglycans in cancer, MicroRNAs in cancer, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",mRNA target,,"6CKB, 6BXJ, 6BXF, 6BXB, 6AVU",Inhibitor,0.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Salivary secretion",GPCR rhodopsin,,"6MXT, 5X7D, 5JQH, 5D6L, 5D5B",Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Salivary secretion",GPCR rhodopsin,,"6MXT, 5X7D, 5JQH, 5D6L, 5D5B",Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Salivary secretion",GPCR rhodopsin,,"6MXT, 5X7D, 5JQH, 5D6L, 5D5B",Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Salivary secretion",GPCR rhodopsin,,"6MXT, 5X7D, 5JQH, 5D6L, 5D5B",Modulator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"4DT7, 3JTC, 3F6U, 2PCT, 1PCU",Inhibitor,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"4DT7, 3JTC, 3F6U, 2PCT, 1PCU",Modulator,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,"5WIV, 5WIU",Modulator,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,"5WIV, 5WIU",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,"5WIV, 5WIU",Agonist,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,"5WIV, 5WIU",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,"5WIV, 5WIU",Binder,1.0
"Neuroactive ligand-receptor interaction, Dopaminergic synapse",GPCR rhodopsin,,"5WIV, 5WIU",Partial agonist,1.0
"NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Primary immunodeficiency",Kinase,Transferases,"6O8I, 6NFI, 6NFH, 6N9P, 6HRT",Inhibitor,1.0
"NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Primary immunodeficiency",Kinase,Transferases,"6O8I, 6NFI, 6NFH, 6N9P, 6HRT",Modulator,1.0
"Alanine, aspartate and glutamate metabolism, Arginine and proline metabolism, Nitrogen metabolism, Metabolic pathways, Carbon metabolism, Biosynthesis of amino acids",Carbon-nitrogen ligase,Ligases,"5OJO, 5DOU, 5DOT, 4UUB, 4UUA",Activator,1.0
"Alanine, aspartate and glutamate metabolism, Arginine and proline metabolism, Nitrogen metabolism, Metabolic pathways, Carbon metabolism, Biosynthesis of amino acids",Carbon-nitrogen ligase,Ligases,"5OJO, 5DOU, 5DOT, 4UUB, 4UUA",Modulator,1.0
"ABC transporters, Bile secretion, MicroRNAs in cancer",ABC transporter,Translocases,"6QEX, 6FN4, 6FN1, 6C0V",Modulator,1.0
"ABC transporters, Bile secretion, MicroRNAs in cancer",ABC transporter,Translocases,"6QEX, 6FN4, 6FN1, 6C0V",Inhibitor,1.0
MicroRNAs in cancer,Methyltransferase,Transferases,"6C24, 6C23, 5WUK, 5WG6, 5U62",Inhibitor,1.0
MicroRNAs in cancer,Methyltransferase,Transferases,"6C24, 6C23, 5WUK, 5WG6, 5U62",Degrader,1.0
MicroRNAs in cancer,Methyltransferase,Transferases,"6C24, 6C23, 5WUK, 5WG6, 5U62",Modulator,1.0
"MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, Oocyte meiosis, Apoptosis, Wnt signaling pathway, Axon guidance, VEGF signaling pathway, Osteoclast differentiation, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Oxytocin signaling pathway, Glucagon signaling pathway, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Amphetamine addiction, Tuberculosis, HTLV-I infection",Phosphoric monoester hydrolase,Hydrolases,"5SVE, 5C1V, 4Q5U, 4F0Z, 3LL8",Inhibitor,1.0
"NF-kappa B signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, TNF signaling pathway, Leukocyte transendothelial migration, African trypanosomiasis, Malaria, Staphylococcus aureus infection, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Immunoglobulin,,"6EIT, 5MZA, 3TCX, 2OZ4, 1Z7Z",Antagonist,1.0
"NF-kappa B signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, TNF signaling pathway, Leukocyte transendothelial migration, African trypanosomiasis, Malaria, Staphylococcus aureus infection, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Immunoglobulin,,"6EIT, 5MZA, 3TCX, 2OZ4, 1Z7Z",Modulator,1.0
"NF-kappa B signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, TNF signaling pathway, Leukocyte transendothelial migration, African trypanosomiasis, Malaria, Staphylococcus aureus infection, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Immunoglobulin,,"6EIT, 5MZA, 3TCX, 2OZ4, 1Z7Z",.,1.0
"NF-kappa B signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, TNF signaling pathway, Leukocyte transendothelial migration, African trypanosomiasis, Malaria, Staphylococcus aureus infection, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Immunoglobulin,,"6EIT, 5MZA, 3TCX, 2OZ4, 1Z7Z",Inhibitor,1.0
"NF-kappa B signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, TNF signaling pathway, Leukocyte transendothelial migration, African trypanosomiasis, Malaria, Staphylococcus aureus infection, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",mRNA target,,"6EIT, 5MZA, 3TCX, 2OZ4, 1Z7Z",.,1.0
"NF-kappa B signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, TNF signaling pathway, Leukocyte transendothelial migration, African trypanosomiasis, Malaria, Staphylococcus aureus infection, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",mRNA target,,"6EIT, 5MZA, 3TCX, 2OZ4, 1Z7Z",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6A96, 5OJM, 5O8F",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6A96, 5OJM, 5O8F",Agonist,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6A96, 5OJM, 5O8F",Modulator (allosteric modulator),1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6A96, 5OJM, 5O8F",Blocker (channel blocker),1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6A96, 5OJM, 5O8F",Modulator,1.0
"Pentose and glucuronate interconversions, Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Metabolic pathways",Short-chain dehydrogenases reductase,Oxidoreductases,"6F8O, 6F84, 6F82, 6F81, 6F7R",Modulator,1.0
"Pentose and glucuronate interconversions, Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Metabolic pathways",Short-chain dehydrogenases reductase,Oxidoreductases,"6F8O, 6F84, 6F82, 6F81, 6F7R",Inhibitor,1.0
"Pentose and glucuronate interconversions, Fructose and mannose metabolism, Galactose metabolism, Glycerolipid metabolism, Metabolic pathways",Short-chain dehydrogenases reductase,Oxidoreductases,"6F8O, 6F84, 6F82, 6F81, 6F7R",.,1.0
"Calcium signaling pathway, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Long-term depression, Estrogen signaling pathway",GPCR glutamate,,"4OR2, 3KS9",Modulator (allosteric modulator),0.0
"Calcium signaling pathway, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Long-term depression, Estrogen signaling pathway",GPCR glutamate,,"4OR2, 3KS9",Agonist,0.0
"Calcium signaling pathway, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Long-term depression, Estrogen signaling pathway",GPCR glutamate,,"4OR2, 3KS9",Antagonist,0.0
"Calcium signaling pathway, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Long-term depression, Estrogen signaling pathway",GPCR glutamate,,"4OR2, 3KS9",Inhibitor,0.0
"Calcium signaling pathway, FoxO signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Long-term depression, Estrogen signaling pathway",GPCR glutamate,,"4OR2, 3KS9",Modulator,0.0
"Neuroactive ligand-receptor interaction, Pancreatic secretion, Protein digestion and absorption, Influenza A",Peptidase,Hydrolases,"4WXV, 4WWY, 2RA3, 1TRN, 1FXY",Modulator,1.0
"Neuroactive ligand-receptor interaction, Pancreatic secretion, Protein digestion and absorption, Influenza A",Peptidase,Hydrolases,"4WXV, 4WWY, 2RA3, 1TRN, 1FXY",Inhibitor,1.0
Serotonergic synapse,Neurotransmitter:sodium symporter,,"6DZZ, 6DZY, 6DZW, 6DZV, 6AWQ",Inhibitor,1.0
Serotonergic synapse,Neurotransmitter:sodium symporter,,"6DZZ, 6DZY, 6DZW, 6DZV, 6AWQ",Binder,1.0
Serotonergic synapse,Neurotransmitter:sodium symporter,,"6DZZ, 6DZY, 6DZW, 6DZV, 6AWQ",Modulator,1.0
Serotonergic synapse,Neurotransmitter:sodium symporter,,"6DZZ, 6DZY, 6DZW, 6DZV, 6AWQ",.,1.0
Serotonergic synapse,Neurotransmitter:sodium symporter,,"6DZZ, 6DZY, 6DZW, 6DZV, 6AWQ",Activator,1.0
Serotonergic synapse,Neurotransmitter:sodium symporter,,"6DZZ, 6DZY, 6DZW, 6DZV, 6AWQ",Antagonist,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Melanoma",Heparin-binding growth factors family,,1IJT,Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Melanoma",Heparin-binding growth factors family,,1IJT,Replacement,1.0
Complement and coagulation cascades,Serpin protein,,"9API, 8API, 7API, 5NBV, 5NBU",Inhibitor,1.0
Complement and coagulation cascades,Serpin protein,,"9API, 8API, 7API, 5NBV, 5NBU",Modulator,1.0
"Glycerolipid metabolism, PPAR signaling pathway, Alzheimer's disease",Carboxylic ester hydrolase,Hydrolases,"6OB0, 6OAZ, 6OAU, 6E7K",Modulator,1.0
"Glycerolipid metabolism, PPAR signaling pathway, Alzheimer's disease",Carboxylic ester hydrolase,Hydrolases,"6OB0, 6OAZ, 6OAU, 6E7K",Activator,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIJ, 5CXV",Agonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIJ, 5CXV",Inhibitor,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIJ, 5CXV",Modulator,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIJ, 5CXV",Antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIJ, 5CXV",Binder,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Lysosome",Sulfuric ester hydrolase,Hydrolases,"6IOZ, 5FQL",Replacement,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Lysosome",Sulfuric ester hydrolase,Hydrolases,"6IOZ, 5FQL",Modulator,1.0
"Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Prolactin signaling pathway, Adipocytokine signaling pathway, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Acute myeloid leukemia, Inflammatory bowel disease (IBD)",Transcription factor,,"5U5S, 5AX3",Inhibitor,1.0
"Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Prolactin signaling pathway, Adipocytokine signaling pathway, Toxoplasmosis, Hepatitis C, Hepatitis B, Measles, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Acute myeloid leukemia, Inflammatory bowel disease (IBD)",Transcription factor,,"5U5S, 5AX3",Modulator,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"1I8L, 1DR9",.,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"1I8L, 1DR9",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"1I8L, 1DR9",CAR-T-Cell-Therapy,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"1I8L, 1DR9",Binder,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer",Growth factor,,"2XAC, 2VWE, 2C7W",Modulator,1.0
"Glycerophospholipid metabolism, Cholinergic synapse",Carboxylic ester hydrolase,Hydrolases,"6O69, 6F25, 6CQZ, 6CQY, 6CQX",Inhibitor,1.0
"Glycerophospholipid metabolism, Cholinergic synapse",Carboxylic ester hydrolase,Hydrolases,"6O69, 6F25, 6CQZ, 6CQY, 6CQX",Activator,1.0
"Glycerophospholipid metabolism, Cholinergic synapse",Carboxylic ester hydrolase,Hydrolases,"6O69, 6F25, 6CQZ, 6CQY, 6CQX",Modulator,1.0
"Glycerophospholipid metabolism, Cholinergic synapse",Carboxylic ester hydrolase,Hydrolases,"6O69, 6F25, 6CQZ, 6CQY, 6CQX",.,1.0
"Glycerophospholipid metabolism, Cholinergic synapse",Carboxylic ester hydrolase,Hydrolases,"6O69, 6F25, 6CQZ, 6CQY, 6CQX",Reactivator,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Osteoclast differentiation, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Salmonella infection, Leishmaniasis, Chagas disease (American trypanosomiasis), Toxoplasmosis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD)",Cytokine receptor,,"6E3L, 6E3K, 5EH1",Binder,1.0
Neuroactive ligand-receptor interaction,Nuclear hormone receptor,,"6EL9, 6EL7, 6EL6, 6DXK, 6CFN",Inhibitor,1.0
Neuroactive ligand-receptor interaction,Nuclear hormone receptor,,"6EL9, 6EL7, 6EL6, 6DXK, 6CFN",Antagonist,1.0
Neuroactive ligand-receptor interaction,Nuclear hormone receptor,,"6EL9, 6EL7, 6EL6, 6DXK, 6CFN",Agonist,1.0
Neuroactive ligand-receptor interaction,Nuclear hormone receptor,,"6EL9, 6EL7, 6EL6, 6DXK, 6CFN",Modulator,1.0
Neuroactive ligand-receptor interaction,Nuclear hormone receptor,,"6EL9, 6EL7, 6EL6, 6DXK, 6CFN",Binder,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6DS0, 6DRZ, 6DRY, 6DRX, 5TVN",Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6DS0, 6DRZ, 6DRY, 6DRX, 5TVN",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6DS0, 6DRZ, 6DRY, 6DRX, 5TVN",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6DS0, 6DRZ, 6DRY, 6DRX, 5TVN",Modulator,1.0
"NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, Focal adhesion, Neurotrophin signaling pathway, Cholinergic synapse, Amyotrophic lateral sclerosis (ALS), Toxoplasmosis, Tuberculosis, Hepatitis B, Epstein-Barr virus infection, Pathways in cancer, MicroRNAs in cancer, Colorectal cancer, Prostate cancer, Small cell lung cancer",B-cell lymphoma Bcl-2,,"6GL8, 5VAY, 5VAX, 5VAU, 5JSN",Modulator,1.0
"NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, Focal adhesion, Neurotrophin signaling pathway, Cholinergic synapse, Amyotrophic lateral sclerosis (ALS), Toxoplasmosis, Tuberculosis, Hepatitis B, Epstein-Barr virus infection, Pathways in cancer, MicroRNAs in cancer, Colorectal cancer, Prostate cancer, Small cell lung cancer",B-cell lymphoma Bcl-2,,"6GL8, 5VAY, 5VAX, 5VAU, 5JSN",Inhibitor,1.0
"NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, Focal adhesion, Neurotrophin signaling pathway, Cholinergic synapse, Amyotrophic lateral sclerosis (ALS), Toxoplasmosis, Tuberculosis, Hepatitis B, Epstein-Barr virus infection, Pathways in cancer, MicroRNAs in cancer, Colorectal cancer, Prostate cancer, Small cell lung cancer",B-cell lymphoma Bcl-2,,"6GL8, 5VAY, 5VAX, 5VAU, 5JSN",Agonist,1.0
"NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, Focal adhesion, Neurotrophin signaling pathway, Cholinergic synapse, Amyotrophic lateral sclerosis (ALS), Toxoplasmosis, Tuberculosis, Hepatitis B, Epstein-Barr virus infection, Pathways in cancer, MicroRNAs in cancer, Colorectal cancer, Prostate cancer, Small cell lung cancer",B-cell lymphoma Bcl-2,,"6GL8, 5VAY, 5VAX, 5VAU, 5JSN",.,1.0
"NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, Focal adhesion, Neurotrophin signaling pathway, Cholinergic synapse, Amyotrophic lateral sclerosis (ALS), Toxoplasmosis, Tuberculosis, Hepatitis B, Epstein-Barr virus infection, Pathways in cancer, MicroRNAs in cancer, Colorectal cancer, Prostate cancer, Small cell lung cancer",B-cell lymphoma Bcl-2,,"6GL8, 5VAY, 5VAX, 5VAU, 5JSN",Regulator,1.0
"NF-kappa B signaling pathway, HIF-1 signaling pathway, Sphingolipid signaling pathway, Protein processing in endoplasmic reticulum, PI3K-Akt signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, Focal adhesion, Neurotrophin signaling pathway, Cholinergic synapse, Amyotrophic lateral sclerosis (ALS), Toxoplasmosis, Tuberculosis, Hepatitis B, Epstein-Barr virus infection, Pathways in cancer, MicroRNAs in cancer, Colorectal cancer, Prostate cancer, Small cell lung cancer",B-cell lymphoma Bcl-2,,"6GL8, 5VAY, 5VAX, 5VAU, 5JSN",Regulator (upregulator),1.0
Protein digestion and absorption,Peptidase,Hydrolases,"6B1O, 6B1E, 5ZID, 5Y7K, 5Y7J",Inhibitor,1.0
Protein digestion and absorption,Peptidase,Hydrolases,"6B1O, 6B1E, 5ZID, 5Y7K, 5Y7J",Modulator,1.0
Protein digestion and absorption,Peptidase,Hydrolases,"6B1O, 6B1E, 5ZID, 5Y7K, 5Y7J",.,1.0
"Glycerophospholipid metabolism, Ether lipid metabolism, Arachidonic acid metabolism, Linoleic acid metabolism, alpha-Linolenic acid metabolism, Metabolic pathways, Ras signaling pathway, Vascular smooth muscle contraction, Pancreatic secretion, Fat digestion and absorption",Carboxylic ester hydrolase,Hydrolases,"3ELO, 1YSK",Modulator,1.0
"Glycerophospholipid metabolism, Ether lipid metabolism, Arachidonic acid metabolism, Linoleic acid metabolism, alpha-Linolenic acid metabolism, Metabolic pathways, Ras signaling pathway, Vascular smooth muscle contraction, Pancreatic secretion, Fat digestion and absorption",Carboxylic ester hydrolase,Hydrolases,"3ELO, 1YSK",Inhibitor,1.0
"Glycerophospholipid metabolism, Ether lipid metabolism, Arachidonic acid metabolism, Linoleic acid metabolism, alpha-Linolenic acid metabolism, Metabolic pathways, Ras signaling pathway, Vascular smooth muscle contraction, Pancreatic secretion, Fat digestion and absorption",Carboxylic ester hydrolase,Hydrolases,"3ELO, 1YSK",Binder,1.0
"Glycerophospholipid metabolism, Ether lipid metabolism, Arachidonic acid metabolism, Linoleic acid metabolism, alpha-Linolenic acid metabolism, Metabolic pathways, Ras signaling pathway, Vascular smooth muscle contraction, Pancreatic secretion, Fat digestion and absorption",Carboxylic ester hydrolase,Hydrolases,"3ELO, 1YSK",Inducer,1.0
PPAR signaling pathway,mRNA target,,2JQ3,.,1.0
PPAR signaling pathway,mRNA target,,2JQ3,Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Melanoma",Growth factor,,"5X1O, 4OEG, 4OEF, 4OEE, 4FGF",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Melanoma",Growth factor,,"5X1O, 4OEG, 4OEF, 4OEE, 4FGF",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Melanoma",Growth factor,,"5X1O, 4OEG, 4OEF, 4OEE, 4FGF",Antagonist,1.0
Nitrogen metabolism,Alpha-carbonic anhydrase,Lyases,"5CJF, 4LU3",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Binder,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Ligand,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6A94, 6A93",Partial agonist,1.0
"Neuroactive ligand-receptor interaction, Osteoclast differentiation",GPCR secretin,,"6NIY, 5UZ7, 5II0",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Osteoclast differentiation",GPCR secretin,,"6NIY, 5UZ7, 5II0",Modulator,1.0
"Neuroactive ligand-receptor interaction, Osteoclast differentiation",GPCR secretin,,"6NIY, 5UZ7, 5II0",Agonist,1.0
"Neuroactive ligand-receptor interaction, Osteoclast differentiation",GPCR secretin,,"6NIY, 5UZ7, 5II0",Binder,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR secretin,,"6E3Y, 6D1U, 5V6Y, 4RWG, 4RWF",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR secretin,,"6E3Y, 6D1U, 5V6Y, 4RWG, 4RWF",.,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR secretin,,"6E3Y, 6D1U, 5V6Y, 4RWG, 4RWF",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR secretin,,"6E3Y, 6D1U, 5V6Y, 4RWG, 4RWF",Modulator,1.0
"Cytokine-cytokine receptor interaction, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Prolactin signaling pathway",Somatotropin/prolactin,,"3NPZ, 3NCF, 3NCE, 3NCC, 3NCB",Modulator,0.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease (NAFLD), Prion diseases, Salmonella infection, Pertussis, Legionellosis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Hepatitis B, Measles, Influenza A, HTLV-I infection, Herpes simplex infection, Pathways in cancer, Transcriptional misregulation in cancer, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM)",Cytokine: interleukin,,"5FUC, 4ZS7, 4O9H, 4NI9, 4NI7",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease (NAFLD), Prion diseases, Salmonella infection, Pertussis, Legionellosis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Hepatitis B, Measles, Influenza A, HTLV-I infection, Herpes simplex infection, Pathways in cancer, Transcriptional misregulation in cancer, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM)",Cytokine: interleukin,,"5FUC, 4ZS7, 4O9H, 4NI9, 4NI7",Modulator,1.0
"Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, TNF signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease (NAFLD), Prion diseases, Salmonella infection, Pertussis, Legionellosis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Hepatitis B, Measles, Influenza A, HTLV-I infection, Herpes simplex infection, Pathways in cancer, Transcriptional misregulation in cancer, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease, Hypertrophic cardiomyopathy (HCM)",Cytokine: interleukin,,"5FUC, 4ZS7, 4O9H, 4NI9, 4NI7",.,1.0
"MAPK signaling pathway, Neurotrophin signaling pathway",Growth factor,,"3BUK, 1NT3, 1BND, 1B8K",Inhibitor,0.0
"MAPK signaling pathway, Neurotrophin signaling pathway",Growth factor,,"3BUK, 1NT3, 1BND, 1B8K",Modulator,0.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, Hepatitis C, Pathways in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Choline metabolism in cancer",Growth factor,,"3NJP, 2KV4, 1P9J, 1NQL, 1JL9",Modulator,1.0
Steroid hormone biosynthesis,Sulfuric ester hydrolase,Hydrolases,1P49,Inhibitor,1.0
,,Oxidoreductases,"4J14, 4FIA, 4ENH, 3MDV, 3MDT",Inhibitor,0.0
Fat digestion and absorption,,,3QNT,Inhibitor,1.0
"Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis",Nuclear hormone receptor,,"5YT2, 5YSY, 5V39, 5GT4, 4ITF",Antagonist,1.0
"Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis",Nuclear hormone receptor,,"5YT2, 5YSY, 5V39, 5GT4, 4ITF",Agonist,1.0
"Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis",Nuclear hormone receptor,,"5YT2, 5YSY, 5V39, 5GT4, 4ITF",Inhibitor,1.0
"Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis",Nuclear hormone receptor,,"5YT2, 5YSY, 5V39, 5GT4, 4ITF",Modulator,1.0
"Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis",Nuclear hormone receptor,,"5YT2, 5YSY, 5V39, 5GT4, 4ITF",Stimulator,1.0
"Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Tuberculosis",Nuclear hormone receptor,,"5YT2, 5YSY, 5V39, 5GT4, 4ITF",Binder,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis",Neurotransmitter receptor,,"5AFN, 5AFM, 5AFL, 5AFK, 5AFJ",Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis",Neurotransmitter receptor,,"5AFN, 5AFM, 5AFL, 5AFK, 5AFJ",Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis",Neurotransmitter receptor,,"5AFN, 5AFM, 5AFL, 5AFK, 5AFJ",Modulator (allosteric modulator),1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis",Neurotransmitter receptor,,"5AFN, 5AFM, 5AFL, 5AFK, 5AFJ",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis",Neurotransmitter receptor,,"5AFN, 5AFM, 5AFL, 5AFK, 5AFJ",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction, Chemical carcinogenesis",Neurotransmitter receptor,,"5AFN, 5AFM, 5AFL, 5AFK, 5AFJ",Binder,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,3BXK,Modulator,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,3BXK,Blocker (channel blocker),1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,3BXK,Blocker,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,3BXK,Inhibitor,1.0
Adherens junction,,,"4JJH, 4GJT, 4FRW",.,1.0
Adherens junction,,,"4JJH, 4GJT, 4FRW",Inhibitor,1.0
"Rap1 signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Integrin,,"6CKB, 6BXJ, 6BXF, 6BXB, 5E6U",Modulator,1.0
"Rap1 signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Integrin,,"6CKB, 6BXJ, 6BXF, 6BXB, 5E6U",Inhibitor,1.0
"Rap1 signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Integrin,,"6CKB, 6BXJ, 6BXF, 6BXB, 5E6U",.,1.0
"Rap1 signaling pathway, Cell adhesion molecules (CAMs), Natural killer cell mediated cytotoxicity, Leukocyte transendothelial migration, Regulation of actin cytoskeleton, Malaria, Staphylococcus aureus infection, HTLV-I infection, Epstein-Barr virus infection, Rheumatoid arthritis, Viral myocarditis",Integrin,,"6CKB, 6BXJ, 6BXF, 6BXB, 5E6U",Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",.,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",Modulator (allosteric modulator),1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",Inhibitor,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",Stimulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Insulin secretion",GPCR secretin,,"6GB1, 6B3J, 5VEX, 5VEW, 5OTX",Binder,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathways in cancer",GPCR rhodopsin,,"3VW7, 3LU9, 3HKJ, 3HKI, 3BEF",Antagonist,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathways in cancer",GPCR rhodopsin,,"3VW7, 3LU9, 3HKJ, 3HKI, 3BEF",Inhibitor,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Complement and coagulation cascades, Platelet activation, Regulation of actin cytoskeleton, Pathways in cancer",GPCR rhodopsin,,"3VW7, 3LU9, 3HKJ, 3HKI, 3BEF",Modulator,1.0
Porphyrin and chlorophyll metabolism,CH-CH donor oxidoreductase,Oxidoreductases,2H63,Inhibitor,1.0
Porphyrin and chlorophyll metabolism,CH-CH donor oxidoreductase,Oxidoreductases,2H63,Activator,1.0
Complement and coagulation cascades,,,"3S9C, 3P70, 3P6Z, 1Y61, 1FV4",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",CAR-T-Cell-Therapy(Dual specific),1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",.,1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",Modulator,1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",CAR-T-Cell-Therapy,1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",Immunomodulator,1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Hematopoietic cell lineage, B cell receptor signaling pathway",Immunoglobulin,,"5VL3, 5VKM, 5VKJ",Binder,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5ZTY, 2KI9",Activator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5ZTY, 2KI9",Agonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5ZTY, 2KI9",Antagonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5ZTY, 2KI9",Inhibitor,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5ZTY, 2KI9",Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5ZTY, 2KI9",.,1.0
"Alanine, aspartate and glutamate metabolism, Arginine and proline metabolism, Glyoxylate and dicarboxylate metabolism, Nitrogen metabolism, Metabolic pathways, Biosynthesis of amino acids, Glutamatergic synapse, GABAergic synapse",Carbon-nitrogen ligase,Ligases,"2QC8, 2OJW",Modulator,0.0
"NF-kappa B signaling pathway, PI3K-Akt signaling pathway, Osteoclast differentiation, Platelet activation, Natural killer cell mediated cytotoxicity, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Tuberculosis, Epstein-Barr virus infection, Viral carcinogenesis",Kinase,Transferases,"6HM7, 6HM6, 5Y5U, 5Y5T, 5TT7",Inhibitor,1.0
"NF-kappa B signaling pathway, PI3K-Akt signaling pathway, Osteoclast differentiation, Platelet activation, Natural killer cell mediated cytotoxicity, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, Tuberculosis, Epstein-Barr virus infection, Viral carcinogenesis",Kinase,Transferases,"6HM7, 6HM6, 5Y5U, 5Y5T, 5TT7",Modulator,1.0
"Purine metabolism, Pyrimidine metabolism, Glutathione metabolism, Metabolic pathways, p53 signaling pathway",CH/CH(2) oxidoreductase,Oxidoreductases,"3VPO, 3VPN, 3VPM, 3OLJ, 2UW2",.,1.0
"Purine metabolism, Pyrimidine metabolism, Glutathione metabolism, Metabolic pathways, p53 signaling pathway",CH/CH(2) oxidoreductase,Oxidoreductases,"3VPO, 3VPN, 3VPM, 3OLJ, 2UW2",Binder,1.0
"Purine metabolism, Pyrimidine metabolism, Glutathione metabolism, Metabolic pathways, p53 signaling pathway",CH/CH(2) oxidoreductase,Oxidoreductases,"3VPO, 3VPN, 3VPM, 3OLJ, 2UW2",Modulator,1.0
"Purine metabolism, Pyrimidine metabolism, Glutathione metabolism, Metabolic pathways, p53 signaling pathway",CH/CH(2) oxidoreductase,Oxidoreductases,"3VPO, 3VPN, 3VPM, 3OLJ, 2UW2",Inhibitor,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,2LCM,Modulator,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,2LCM,Blocker (channel blocker),1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,2LCM,Inhibitor (gating inhibitor),1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,2LCM,Inhibitor,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,2LCM,Blocker,1.0
"MAPK signaling pathway, Calcium signaling pathway, Synaptic vesicle cycle, Retrograde endocannabinoid signaling, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Taste transduction, Type II diabetes mellitus, Morphine addiction, Nicotine addiction",Voltage-gated ion channel,,2LCM,Antagonist,1.0
Hematopoietic cell lineage,Immunoglobulin,,"6D4A, 6D49, 6D48, 5J0B, 5J06",.,1.0
Hematopoietic cell lineage,Immunoglobulin,,"6D4A, 6D49, 6D48, 5J0B, 5J06",CAR-T-Cell-Therapy,1.0
Hematopoietic cell lineage,Immunoglobulin,,"6D4A, 6D49, 6D48, 5J0B, 5J06",Modulator,1.0
Hematopoietic cell lineage,Immunoglobulin,,"6D4A, 6D49, 6D48, 5J0B, 5J06",Inhibitor,1.0
Hematopoietic cell lineage,Immunoglobulin,,"6D4A, 6D49, 6D48, 5J0B, 5J06",Antagonist,1.0
"Purine metabolism, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,"4Y2B, 4PM0, 3G3N, 1ZKL",Modulator,0.0
Adrenergic signaling in cardiomyocytes,Voltage-gated ion channel,,"6MUD, 5DBR, 4OVN, 4JQ0, 4DJC",Activator,1.0
Adrenergic signaling in cardiomyocytes,Voltage-gated ion channel,,"6MUD, 5DBR, 4OVN, 4JQ0, 4DJC",Inhibitor,1.0
Adrenergic signaling in cardiomyocytes,Voltage-gated ion channel,,"6MUD, 5DBR, 4OVN, 4JQ0, 4DJC",Blocker,1.0
"Purine metabolism, Pyrimidine metabolism, Glutathione metabolism, Metabolic pathways",mRNA target,Oxidoreductases,"6AUI, 5TUS, 5D1Y, 4X3V, 3HNF",.,0.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Malaria, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6I04, 6GCU, 5YA5, 5UAF, 5UAD",CAR-T-Cell-Therapy(Dual specific),1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Malaria, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6I04, 6GCU, 5YA5, 5UAF, 5UAD",CAR-T-Cell-Therapy,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Malaria, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6I04, 6GCU, 5YA5, 5UAF, 5UAD",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Malaria, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6I04, 6GCU, 5YA5, 5UAF, 5UAD",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Malaria, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6I04, 6GCU, 5YA5, 5UAF, 5UAD",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Malaria, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Renal cell carcinoma, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6I04, 6GCU, 5YA5, 5UAF, 5UAD",Stimulator,1.0
"Purine metabolism, Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome",CH/CH(2) oxidoreductase,,"2E1Q, 2CKJ",Inhibitor,1.0
"Purine metabolism, Caffeine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Peroxisome",CH/CH(2) oxidoreductase,,"2E1Q, 2CKJ",Cofactor,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,2CVA,Antagonist,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,2CVA,Agonist,1.0
"cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,2CVA,Inhibitor,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Apoptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Hematopoietic cell lineage, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Prion diseases, Salmonella infection, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease",Cytokine: interleukin,,"9ILB, 7I1B, 6I1B, 5MVZ, 5I1B",Modulator,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Apoptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Hematopoietic cell lineage, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Prion diseases, Salmonella infection, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease",Cytokine: interleukin,,"9ILB, 7I1B, 6I1B, 5MVZ, 5I1B",Suppressor,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Apoptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Hematopoietic cell lineage, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Prion diseases, Salmonella infection, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease",Cytokine: interleukin,,"9ILB, 7I1B, 6I1B, 5MVZ, 5I1B",Inhibitor,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Apoptosis, Osteoclast differentiation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Hematopoietic cell lineage, TNF signaling pathway, Inflammatory mediator regulation of TRP channels, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Alzheimer's disease, Prion diseases, Salmonella infection, Pertussis, Legionellosis, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Graft-versus-host disease",Cytokine: interleukin,,"9ILB, 7I1B, 6I1B, 5MVZ, 5I1B",.,1.0
"Porphyrin and chlorophyll metabolism, Metabolic pathways",Ferrochelatase,Lyases,"4MK4, 4KMM, 4KLR, 4KLC, 4KLA",Inhibitor,1.0
"Porphyrin and chlorophyll metabolism, Metabolic pathways",Ferrochelatase,Lyases,"4MK4, 4KMM, 4KLR, 4KLC, 4KLA",Activator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"5U6J, 5TQG, 5TQF, 5TQE, 5PB6",Modulator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"5U6J, 5TQG, 5TQF, 5TQE, 5PB6",Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Gap junction, Salivary secretion, Dilated cardiomyopathy",GPCR rhodopsin,,2LSQ,Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Gap junction, Salivary secretion, Dilated cardiomyopathy",GPCR rhodopsin,,2LSQ,Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Gap junction, Salivary secretion, Dilated cardiomyopathy",GPCR rhodopsin,,2LSQ,Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Gap junction, Salivary secretion, Dilated cardiomyopathy",GPCR rhodopsin,,2LSQ,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Adrenergic signaling in cardiomyocytes, Gap junction, Salivary secretion, Dilated cardiomyopathy",GPCR rhodopsin,,2LSQ,Stimulator,1.0
"Neuroactive ligand-receptor interaction, Long-term depression",GPCR secretin,,"4Z9G, 4K5Y, 3EHU, 3EHT, 3EHS",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Long-term depression",GPCR secretin,,"4Z9G, 4K5Y, 3EHU, 3EHT, 3EHS",Inhibitor,1.0
"Complement and coagulation cascades, Transcriptional misregulation in cancer",Peptidase,Hydrolases,"5ZLZ, 5BRR, 1TPN, 1TPM, 1TPK",Inhibitor,1.0
"Phagosome, Staphylococcus aureus infection",,,"1UCT, 1OW0, 1OVZ",.,0.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIK, 5ZKC, 5ZKB, 5ZK8, 5ZK3",Antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIK, 5ZKC, 5ZKB, 5ZK8, 5ZK3",Inhibitor,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIK, 5ZKC, 5ZKB, 5ZK8, 5ZK3",Agonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Cholinergic synapse, Regulation of actin cytoskeleton",GPCR rhodopsin,,"6OIK, 5ZKC, 5ZKB, 5ZK8, 5ZK3",Modulator,1.0
"PPAR signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,2GL8,Antagonist,1.0
"PPAR signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,2GL8,Inhibitor,1.0
"PPAR signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,2GL8,Modulator,1.0
"PPAR signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,2GL8,Binder,1.0
"PPAR signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Pathways in cancer, Transcriptional misregulation in cancer, Thyroid cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,2GL8,Agonist,1.0
Platelet activation,GPCR rhodopsin,,"4PY0, 4PXZ, 4NTJ, 1Y9C, 1VZ1",Antagonist,1.0
Platelet activation,GPCR rhodopsin,,"4PY0, 4PXZ, 4NTJ, 1Y9C, 1VZ1",Agonist,1.0
Platelet activation,GPCR rhodopsin,,"4PY0, 4PXZ, 4NTJ, 1Y9C, 1VZ1",Inhibitor,1.0
Platelet activation,GPCR rhodopsin,,"4PY0, 4PXZ, 4NTJ, 1Y9C, 1VZ1",Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Measles",GPCR rhodopsin,,"6HLP, 6HLO, 6HLL, 6.00E+59, 2KSB",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Measles",GPCR rhodopsin,,"6HLP, 6HLO, 6HLL, 6.00E+59, 2KSB",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Measles",GPCR rhodopsin,,"6HLP, 6HLO, 6HLL, 6.00E+59, 2KSB",Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Measles",GPCR rhodopsin,,"6HLP, 6HLO, 6HLL, 6.00E+59, 2KSB",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6MZW, 6MZQ, 6C1O, 6C1C, 6C1B",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6MZW, 6MZQ, 6C1O, 6C1C, 6C1B",.,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6MZW, 6MZQ, 6C1O, 6C1C, 6C1B",Agonist,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6MZW, 6MZQ, 6C1O, 6C1C, 6C1B",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6MZW, 6MZQ, 6C1O, 6C1C, 6C1B",Binder,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Proteoglycans in cancer, Prostate cancer, Melanoma, Central carbon metabolism in cancer",Kinase,Transferases,"6MZW, 6MZQ, 6C1O, 6C1C, 6C1B",Antagonist,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, HIF-1 signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, Vascular smooth muscle contraction, Wnt signaling pathway, VEGF signaling pathway, Focal adhesion, Tight junction, Gap junction, Natural killer cell mediated cytotoxicity, Fc gamma R-mediated phagocytosis, Leukocyte transendothelial migration, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Long-term depression, Inflammatory mediator regulation of TRP channels, Insulin secretion, Melanogenesis, Thyroid hormone synthesis, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Aldosterone-regulated sodium reabsorption, Endocrine and other factor-regulated calcium reabsorption, Salivary secretion, Gastric acid secretion, Pancreatic secretion, Amphetamine addiction, Morphine addiction, Vibrio cholerae infection, African trypanosomiasis, Amoebiasis, Hepatitis B, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Glioma, Non-small cell lung cancer, Choline metabolism in cancer",Kinase,Transferases,"2UZP, 2.00E+73",Inhibitor,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Proteoglycans in cancer",Glycosylase,Hydrolases,"5LA7, 5LA4, 5L9Z, 5L9Y, 5E9C",Inhibitor,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Proteoglycans in cancer",Glycosylase,Hydrolases,"5LA7, 5LA4, 5L9Z, 5L9Y, 5E9C",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Oocyte meiosis, Endocytosis, PI3K-Akt signaling pathway, AMPK signaling pathway, Focal adhesion, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Long-term depression, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Glioma, Prostate cancer, Melanoma",Kinase,Transferases,"5U8R, 5U8Q, 5HZN, 5FXS, 5FXR",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Oocyte meiosis, Endocytosis, PI3K-Akt signaling pathway, AMPK signaling pathway, Focal adhesion, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Long-term depression, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Glioma, Prostate cancer, Melanoma",Kinase,Transferases,"5U8R, 5U8Q, 5HZN, 5FXS, 5FXR",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Oocyte meiosis, Endocytosis, PI3K-Akt signaling pathway, AMPK signaling pathway, Focal adhesion, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Long-term depression, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Glioma, Prostate cancer, Melanoma",Kinase,Transferases,"5U8R, 5U8Q, 5HZN, 5FXS, 5FXR",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Oocyte meiosis, Endocytosis, PI3K-Akt signaling pathway, AMPK signaling pathway, Focal adhesion, Adherens junction, Signaling pathways regulating pluripotency of stem cells, Long-term depression, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Pathways in cancer, Transcriptional misregulation in cancer, Proteoglycans in cancer, Glioma, Prostate cancer, Melanoma",Kinase,Transferases,"5U8R, 5U8Q, 5HZN, 5FXS, 5FXR",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME9, 6ME8, 6ME7, 6ME6",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME9, 6ME8, 6ME7, 6ME6",Modulator,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME9, 6ME8, 6ME7, 6ME6",Agonist,1.0
HTLV-I infection,mRNA target,Transferases,"5UGW, 5MER, 5MEQ, 5MEP, 5MEO",.,1.0
HTLV-I infection,mRNA target,Transferases,"5UGW, 5MER, 5MEQ, 5MEP, 5MEO",Inhibitor,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",Inhibitor,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",Modulator,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",Enhancer,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",Antagonist,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",.,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",Inducer,1.0
"African trypanosomiasis, Malaria",Pore-forming globin,,"6NBD, 6NBC, 6HBW, 6HAL, 6DI4",Activator,1.0
"Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection",Voltage-gated ion channel,,"4V0C, 4UMO, 3HFE, 3HFC, 3BJ4",Blocker (channel blocker),1.0
"Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection",Voltage-gated ion channel,,"4V0C, 4UMO, 3HFE, 3HFC, 3BJ4",Activator,1.0
"Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection",Voltage-gated ion channel,,"4V0C, 4UMO, 3HFE, 3HFC, 3BJ4",Blocker,1.0
"Adrenergic signaling in cardiomyocytes, Cholinergic synapse, Gastric acid secretion, Pancreatic secretion, Protein digestion and absorption, Vibrio cholerae infection",Voltage-gated ion channel,,"4V0C, 4UMO, 3HFE, 3HFC, 3BJ4",Inhibitor,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,"4X5T, 2M6I, 2M6B, 1VRY, 1MOT",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Transcriptional misregulation in cancer, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",Immunoglobulin,,"5YXK, 1NCN, 1I85",.,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Transcriptional misregulation in cancer, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",Immunoglobulin,,"5YXK, 1NCN, 1I85",Inhibitor,1.0
"Cell adhesion molecules (CAMs), Toll-like receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Transcriptional misregulation in cancer, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",Immunoglobulin,,"5YXK, 1NCN, 1I85",Binder,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Neurotrophin signaling pathway, Transcriptional misregulation in cancer",Cytokine receptor,,"5ZGG, 3EWV, 2N97, 2N83, 2N80",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Neurotrophin signaling pathway, Transcriptional misregulation in cancer",Cytokine receptor,,"5ZGG, 3EWV, 2N97, 2N83, 2N80",Agonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Neurotrophin signaling pathway, Transcriptional misregulation in cancer",Cytokine receptor,,"5ZGG, 3EWV, 2N97, 2N83, 2N80",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Neurotrophin signaling pathway, Transcriptional misregulation in cancer",Cytokine receptor,,"5ZGG, 3EWV, 2N97, 2N83, 2N80",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Neurotrophin signaling pathway, Transcriptional misregulation in cancer",Cytokine receptor,,"5ZGG, 3EWV, 2N97, 2N83, 2N80",Antagonist,1.0
"MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Type II diabetes mellitus, Alzheimer's disease, Amphetamine addiction, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,"6DAF, 6DAE, 6DAD, 6C0A, 5V2Q",Modulator,1.0
"MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Type II diabetes mellitus, Alzheimer's disease, Amphetamine addiction, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,"6DAF, 6DAE, 6DAD, 6C0A, 5V2Q",Activator,1.0
"MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Type II diabetes mellitus, Alzheimer's disease, Amphetamine addiction, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,"6DAF, 6DAE, 6DAD, 6C0A, 5V2Q",Blocker (channel blocker),1.0
"MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Type II diabetes mellitus, Alzheimer's disease, Amphetamine addiction, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,"6DAF, 6DAE, 6DAD, 6C0A, 5V2Q",Inhibitor (gating inhibitor),1.0
"MAPK signaling pathway, Calcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Cardiac muscle contraction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Circadian entrainment, Long-term potentiation, Retrograde endocannabinoid signaling, Glutamatergic synapse, Cholinergic synapse, Serotonergic synapse, GABAergic synapse, Dopaminergic synapse, Insulin secretion, GnRH signaling pathway, Oxytocin signaling pathway, Type II diabetes mellitus, Alzheimer's disease, Amphetamine addiction, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Voltage-gated ion channel,,"6DAF, 6DAE, 6DAD, 6C0A, 5V2Q",Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Salivary secretion",GPCR rhodopsin,,2CDW,Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Salivary secretion",GPCR rhodopsin,,2CDW,Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Salivary secretion",GPCR rhodopsin,,2CDW,Blocker,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Salivary secretion",GPCR rhodopsin,,2CDW,Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Endocytosis, Salivary secretion",GPCR rhodopsin,,2CDW,Inhibitor,1.0
Bile secretion,Nuclear hormone receptor,,"6A60, 6A5Z, 6A5Y, 6A5X, 6A5W",Agonist,1.0
Bile secretion,Nuclear hormone receptor,,"6A60, 6A5Z, 6A5Y, 6A5X, 6A5W",Inhibitor,1.0
Bile secretion,Nuclear hormone receptor,,"6A60, 6A5Z, 6A5Y, 6A5X, 6A5W",Modulator,1.0
Bile secretion,Nuclear hormone receptor,,"6A60, 6A5Z, 6A5Y, 6A5X, 6A5W",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6I53, 6D6U, 6D6T, 6D1S, 6CDU",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6I53, 6D6U, 6D6T, 6D1S, 6CDU",Modulator,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6I53, 6D6U, 6D6T, 6D1S, 6CDU",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction",Ligand-gated ion channel,,"6I53, 6D6U, 6D6T, 6D1S, 6CDU",Agonist,1.0
"Citrate cycle (TCA cycle), Metabolic pathways, Biosynthesis of antibiotics",Acyltransferase,Transferases,"6QFB, 6O0H, 6HXM, 6HXL, 6HXK",Inhibitor,1.0
"PPAR signaling pathway, Pathways in cancer, Bladder cancer, Rheumatoid arthritis",Peptidase,Hydrolases,"966C, 4AYK, 4AUO, 3SHI, 3AYK",Inhibitor,1.0
"PPAR signaling pathway, Pathways in cancer, Bladder cancer, Rheumatoid arthritis",Peptidase,Hydrolases,"966C, 4AYK, 4AUO, 3SHI, 3AYK",Modulator,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Lysosome",Glycosylase,Hydrolases,4XWH,.,1.0
"Glycosaminoglycan degradation, Metabolic pathways, Lysosome",Glycosylase,Hydrolases,4XWH,Activator,1.0
"Nitrogen metabolism, Proximal tubule bicarbonate reclamation",Alpha-carbonic anhydrase,Lyases,"5KU6, 5JNC, 5JNA, 5JN9, 5JN8",Inhibitor,1.0
"Nitrogen metabolism, Proximal tubule bicarbonate reclamation",Alpha-carbonic anhydrase,Lyases,"5KU6, 5JNC, 5JNA, 5JN9, 5JN8",.,1.0
"Nitrogen metabolism, Proximal tubule bicarbonate reclamation",Alpha-carbonic anhydrase,Lyases,"5KU6, 5JNC, 5JNA, 5JN9, 5JN8",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, HTLV-I infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"5K5X, 5GRN, 1GQ5",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, HTLV-I infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"5K5X, 5GRN, 1GQ5",.,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, HTLV-I infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"5K5X, 5GRN, 1GQ5",Modulator,1.0
"Terpenoid backbone biosynthesis, Metabolic pathways, Biosynthesis of antibiotics, AMPK signaling pathway, Bile secretion",CH-OH donor oxidoreductase,Oxidoreductases,"3CDB, 3CDA, 3CD7, 3CD5, 3CD0",Inhibitor,1.0
"Terpenoid backbone biosynthesis, Metabolic pathways, Biosynthesis of antibiotics, AMPK signaling pathway, Bile secretion",CH-OH donor oxidoreductase,Oxidoreductases,"3CDB, 3CDA, 3CD7, 3CD5, 3CD0",Modulator,1.0
"Terpenoid backbone biosynthesis, Metabolic pathways, Biosynthesis of antibiotics, AMPK signaling pathway, Bile secretion",CH-OH donor oxidoreductase,Oxidoreductases,"3CDB, 3CDA, 3CD7, 3CD5, 3CD0",Antagonist,1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Activator,1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Blocker (channel blocker),1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Modulator,1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Regulator,1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Inhibitor,1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Enhancer,1.0
"ABC transporters, cAMP signaling pathway, AMPK signaling pathway, Gastric acid secretion, Pancreatic secretion, Bile secretion, Vibrio cholerae infection",ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Binder,1.0
,ABC transporter,Isomerases,"6MSM, 6HEP, 5UAK, 5TGK, 5TFJ",Enhancer,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,5FJV,Modulator (allosteric modulator),1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,5FJV,Agonist,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,5FJV,Inhibitor,1.0
Neuroactive ligand-receptor interaction,Neurotransmitter receptor,,5FJV,Antagonist,1.0
"Cysteine and methionine metabolism, Arginine and proline metabolism, Metabolic pathways",Carbon-carbon lyase,Lyases,"3H0W, 3H0V, 3EPB, 3EPA, 3EP9",Inhibitor,1.0
"Cysteine and methionine metabolism, Arginine and proline metabolism, Metabolic pathways",Carbon-carbon lyase,Lyases,"3H0W, 3H0V, 3EPB, 3EPA, 3EP9",Modulator,1.0
"PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency",Immunoglobulin,,6AL5,CAR-T-Cell-Therapy(Dual specific),1.0
"PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency",Immunoglobulin,,6AL5,CAR-T-Cell-Therapy,1.0
"PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency",Immunoglobulin,,6AL5,.,1.0
"PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency",Immunoglobulin,,6AL5,Inhibitor,1.0
"PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency",Immunoglobulin,,6AL5,Modulator,1.0
"PI3K-Akt signaling pathway, Hematopoietic cell lineage, B cell receptor signaling pathway, Epstein-Barr virus infection, Primary immunodeficiency",Immunoglobulin,,6AL5,Immunostimulant,1.0
Non-small cell lung cancer,Kinase,Transferases,"6MX8, 6EDL, 6EBW, 6E0R, 6CDT",Inhibitor,1.0
Non-small cell lung cancer,Kinase,Transferases,"6MX8, 6EDL, 6EBW, 6E0R, 6CDT",.,1.0
Non-small cell lung cancer,Kinase,Transferases,"6MX8, 6EDL, 6EBW, 6E0R, 6CDT",Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"5TYT, 4Q3H",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"5TYT, 4Q3H",Agonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"5TYT, 4Q3H",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Epithelial cell signaling in Helicobacter pylori infection",GPCR rhodopsin,,"5TYT, 4Q3H",Modulator,1.0
"Metabolism of xenobiotics by cytochrome P450, Drug metabolism - cytochrome P450, Serotonergic synapse",Paired donor oxygen oxidoreductase,Oxidoreductases,"6CSD, 6CSB, 5TFU, 5TFT, 4XRZ",Inhibitor,1.0
"Metabolism of xenobiotics by cytochrome P450, Drug metabolism - cytochrome P450, Serotonergic synapse",Paired donor oxygen oxidoreductase,Oxidoreductases,"6CSD, 6CSB, 5TFU, 5TFT, 4XRZ",Inducer,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Melanogenesis, Pathways in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6GQM, 6GQL, 6GQK, 6GQJ, 4U0I",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Melanogenesis, Pathways in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6GQM, 6GQL, 6GQK, 6GQJ, 4U0I",CAR-T-Cell-Therapy,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, Hematopoietic cell lineage, Melanogenesis, Pathways in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6GQM, 6GQL, 6GQK, 6GQJ, 4U0I",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Central carbon metabolism in cancer",Kinase,Transferases,"5UI0, 5UHN, 5UGX, 5UGL, 5EG3",Binder,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Central carbon metabolism in cancer",Kinase,Transferases,"5UI0, 5UHN, 5UGX, 5UGL, 5EG3",.,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Central carbon metabolism in cancer",Kinase,Transferases,"5UI0, 5UHN, 5UGX, 5UGL, 5EG3",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Central carbon metabolism in cancer",Kinase,Transferases,"5UI0, 5UHN, 5UGX, 5UGL, 5EG3",Antagonist,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Central carbon metabolism in cancer",Kinase,Transferases,"5UI0, 5UHN, 5UGX, 5UGL, 5EG3",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, Prostate cancer, Central carbon metabolism in cancer",Kinase,Transferases,"5UI0, 5UHN, 5UGX, 5UGL, 5EG3",Activator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, Sphingolipid signaling pathway, Endocytosis, Vascular smooth muscle contraction, Wnt signaling pathway, TGF-beta signaling pathway, Axon guidance, Focal adhesion, Adherens junction, Tight junction, Platelet activation, T cell receptor signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Regulation of actin cytoskeleton, Oxytocin signaling pathway, Pancreatic secretion, Bacterial invasion of epithelial cells, Pathogenic Escherichia coli infection, Pertussis, Tuberculosis, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Colorectal cancer",Small GTPase,Hydrolases,"6R3V, 6BCB, 6BCA, 6BC0, 5ZHX",Inhibitor,0.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"4RWD, 4RWA, 4N6H, 2IQM, 1OZC",Agonist,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"4RWD, 4RWA, 4N6H, 2IQM, 1OZC",Antagonist,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"4RWD, 4RWA, 4N6H, 2IQM, 1OZC",Inhibitor,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"4RWD, 4RWA, 4N6H, 2IQM, 1OZC",Modulator,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"4RWD, 4RWA, 4N6H, 2IQM, 1OZC",.,1.0
"cGMP-PKG signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction",GPCR rhodopsin,,"4RWD, 4RWA, 4N6H, 2IQM, 1OZC",Binder,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, HTLV-I infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"3MJG, 2PLE, 2PLD, 2L6W, 2IUI",.,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, HTLV-I infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"3MJG, 2PLE, 2PLD, 2L6W, 2IUI",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Focal adhesion, Gap junction, Regulation of actin cytoskeleton, HTLV-I infection, Pathways in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Melanoma, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"3MJG, 2PLE, 2PLD, 2L6W, 2IUI",Modulator,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",Antagonist,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",.,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",Inhibitor,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",Modulator,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",CAR-T-Cell-Therapy,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",Activator,1.0
"MAPK signaling pathway, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Calcium signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, FoxO signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Dorso-ventral axis formation, Focal adhesion, Adherens junction, Gap junction, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Epithelial cell signaling in Helicobacter pylori infection, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Bladder cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6D8E, 6B3S, 6ARU, 5ZWJ, 5YU9",Suppressor,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway",Immunoglobulin,,"5WT9, 5JXE, 5IUS, 5GGS, 5GGR",Inhibitor,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway",Immunoglobulin,,"5WT9, 5JXE, 5IUS, 5GGS, 5GGR",.,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway",Immunoglobulin,,"5WT9, 5JXE, 5IUS, 5GGS, 5GGR",Modulator,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway",Immunoglobulin,,"5WT9, 5JXE, 5IUS, 5GGS, 5GGR",Antagonist,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway",Immunoglobulin,,"5WT9, 5JXE, 5IUS, 5GGS, 5GGR",antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,5EM9,Agonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,5EM9,Modulator,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,5EM9,Antagonist,1.0
"Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse",GPCR rhodopsin,,5EM9,Inhibitor,1.0
"Pyrimidine metabolism, Drug metabolism - other enzymes, Metabolic pathways, Bladder cancer",Pentosyltransferase,Transferases,"2WK6, 2WK5, 2J0F, 1UOU",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Agonist,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Binder,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Modulator,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Blocker,1.0
"Neuroactive ligand-receptor interaction, Glucagon signaling pathway",GPCR secretin,,"5XEZ, 5EE7, 4LF3, 4L6R, 4ERS",Co-agonist,1.0
Hematopoietic cell lineage,Immunoglobulin,,"5J1A, 4X6F, 4X6E, 4X6D, 4X6C",Binder,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Thyroid hormone synthesis, Autoimmune thyroid disease",GPCR rhodopsin,,"3G04, 2XWT, 1XUM",Agonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Thyroid hormone synthesis, Autoimmune thyroid disease",GPCR rhodopsin,,"3G04, 2XWT, 1XUM",Binder,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Thyroid hormone synthesis, Autoimmune thyroid disease",GPCR rhodopsin,,"3G04, 2XWT, 1XUM",Modulator,1.0
"Endocytosis, Pathways in cancer, Thyroid cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6FEK, 5FM3, 5FM2, 5AMN, 4UX8",Inhibitor,1.0
"Endocytosis, Pathways in cancer, Thyroid cancer, Central carbon metabolism in cancer",Kinase,Transferases,"6FEK, 5FM3, 5FM2, 5AMN, 4UX8",Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"6B73, 4DJH, 2IQN, 2A0D",Agonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"6B73, 4DJH, 2IQN, 2A0D",Antagonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"6B73, 4DJH, 2IQN, 2A0D",Inhibitor,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"6B73, 4DJH, 2IQN, 2A0D",Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"6B73, 4DJH, 2IQN, 2A0D",.,1.0
Wnt signaling pathway,,,"3SOV, 2K8P",Modulator,1.0
Wnt signaling pathway,,,"3SOV, 2K8P",.,1.0
"Steroid hormone biosynthesis, Arachidonic acid metabolism, Metabolic pathways, Ovarian steroidogenesis",Short-chain dehydrogenases reductase,Oxidoreductases,"6GXK, 6F78, 6F2U, 5JM5, 5HNU",Inhibitor,1.0
"Steroid hormone biosynthesis, Arachidonic acid metabolism, Metabolic pathways, Ovarian steroidogenesis",Short-chain dehydrogenases reductase,Oxidoreductases,"6GXK, 6F78, 6F2U, 5JM5, 5HNU",Modulator,1.0
"Steroid hormone biosynthesis, Arachidonic acid metabolism, Metabolic pathways, Ovarian steroidogenesis",Short-chain dehydrogenases reductase,Oxidoreductases,"6GXK, 6F78, 6F2U, 5JM5, 5HNU",Inhibitor; Antagonist; Blocker,1.0
"Pyrimidine metabolism, Metabolic pathways",CH-CH donor oxidoreductase,Oxidoreductases,"6FMD, 6ET4, 6CJG, 6CJF, 5ZFB",Modulator,1.0
"Pyrimidine metabolism, Metabolic pathways",CH-CH donor oxidoreductase,Oxidoreductases,"6FMD, 6ET4, 6CJG, 6CJF, 5ZFB",Inhibitor,1.0
Renin-angiotensin system,Peptidase,Hydrolases,"6I3F, 5VRP, 5VPM, 5V8V, 5TMK",Inhibitor,1.0
Renin-angiotensin system,Peptidase,Hydrolases,"6I3F, 5VRP, 5VPM, 5V8V, 5TMK",Modulator,1.0
Renin-angiotensin system,Peptidase,Hydrolases,"6I3F, 5VRP, 5VPM, 5V8V, 5TMK",Agonist,1.0
"Pathways in cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"5UAN, 4JYI, 4JYH, 4JYG, 4DM8",Agonist,1.0
"Pathways in cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"5UAN, 4JYI, 4JYH, 4JYG, 4DM8",Antagonist,1.0
"Pathways in cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"5UAN, 4JYI, 4JYH, 4JYG, 4DM8",Inhibitor,1.0
"Pathways in cancer, Small cell lung cancer, Non-small cell lung cancer",Nuclear hormone receptor,,"5UAN, 4JYI, 4JYH, 4JYG, 4DM8",Modulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Autoimmune thyroid disease, Inflammatory bowel disease (IBD), Allograft rejection, Graft-versus-host disease",Cytokine: interleukin,,"5UTZ, 5M5E, 5LQB, 4NEM, 4NEJ",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Autoimmune thyroid disease, Inflammatory bowel disease (IBD), Allograft rejection, Graft-versus-host disease",Cytokine: interleukin,,"5UTZ, 5M5E, 5LQB, 4NEM, 4NEJ",Modulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Autoimmune thyroid disease, Inflammatory bowel disease (IBD), Allograft rejection, Graft-versus-host disease",Cytokine: interleukin,,"5UTZ, 5M5E, 5LQB, 4NEM, 4NEJ",.,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Autoimmune thyroid disease, Inflammatory bowel disease (IBD), Allograft rejection, Graft-versus-host disease",Cytokine: interleukin,,"5UTZ, 5M5E, 5LQB, 4NEM, 4NEJ",Agonist,1.0
"Purine metabolism, cAMP signaling pathway, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,"3TVX, 3I8V, 2QYK",Inhibitor,1.0
"Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",Carbon-carbon lyase,Lyases,"3RCH, 3RBL, 3RBF",Inhibitor,1.0
"Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",Carbon-carbon lyase,Lyases,"3RCH, 3RBL, 3RBF",Activator,1.0
"Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",Carbon-carbon lyase,Lyases,"3RCH, 3RBL, 3RBF",Modulator,1.0
"Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",Carbon-carbon lyase,Lyases,"3RCH, 3RBL, 3RBF",.,1.0
"Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",Carbon-carbon lyase,Lyases,"3RCH, 3RBL, 3RBF",Replacement,1.0
"Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",Carbon-carbon lyase,Lyases,"3RCH, 3RBL, 3RBF",Cofactor,1.0
"Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse, Prolactin signaling pathway, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Paired donor oxygen oxidoreductase,Oxidoreductases,"4J6S, 2XSN",Inhibitor,1.0
"Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse, Prolactin signaling pathway, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Paired donor oxygen oxidoreductase,Oxidoreductases,"4J6S, 2XSN",Modulator,1.0
"Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse, Prolactin signaling pathway, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Paired donor oxygen oxidoreductase,Oxidoreductases,"4J6S, 2XSN",.,1.0
"Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse, Prolactin signaling pathway, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Paired donor oxygen oxidoreductase,Oxidoreductases,"4J6S, 2XSN",Binder,1.0
"Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse, Prolactin signaling pathway, Parkinson's disease, Cocaine addiction, Amphetamine addiction, Alcoholism",Paired donor oxygen oxidoreductase,Oxidoreductases,"4J6S, 2XSN",Cofactor,1.0
"PI3K-Akt signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Herpes simplex infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer",Kinase,Transferases,"6N7D, 6N7C, 6N7B, 6N7A, 6N79",Inhibitor,1.0
"PI3K-Akt signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Jak-STAT signaling pathway, Leishmaniasis, Toxoplasmosis, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Herpes simplex infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer",Kinase,Transferases,"6N7D, 6N7C, 6N7B, 6N7A, 6N79",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Regulation of actin cytoskeleton, Pathways in cancer, Melanoma",Growth factor,,1NUN,Modulator,0.0
"Pentose phosphate pathway, Glutathione metabolism, Metabolic pathways, Biosynthesis of antibiotics, Carbon metabolism, Central carbon metabolism in cancer",CH-OH donor oxidoreductase,Oxidoreductases,"6.00E+08, 6.00E+07, 5UKW, 2BHL, 2BH9",Inhibitor,1.0
"Pentose phosphate pathway, Glutathione metabolism, Metabolic pathways, Biosynthesis of antibiotics, Carbon metabolism, Central carbon metabolism in cancer",CH-OH donor oxidoreductase,Oxidoreductases,"6.00E+08, 6.00E+07, 5UKW, 2BHL, 2BH9",Modulator,1.0
"ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Pathways in cancer, MicroRNAs in cancer, Chronic myeloid leukemia, Viral myocarditis",Kinase,Transferases,"6NPV, 6NPU, 6NPE, 6BL8, 6AMW",Inhibitor,1.0
"ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Pathways in cancer, MicroRNAs in cancer, Chronic myeloid leukemia, Viral myocarditis",Kinase,Transferases,"6NPV, 6NPU, 6NPE, 6BL8, 6AMW",.,1.0
"ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Pathways in cancer, MicroRNAs in cancer, Chronic myeloid leukemia, Viral myocarditis",Kinase,Transferases,"6NPV, 6NPU, 6NPE, 6BL8, 6AMW",Modulator,1.0
"ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Pathways in cancer, MicroRNAs in cancer, Chronic myeloid leukemia, Viral myocarditis",mRNA target,Transferases,"6NPV, 6NPU, 6NPE, 6BL8, 6AMW",Inhibitor,0.0
"ErbB signaling pathway, Ras signaling pathway, Cell cycle, Axon guidance, Neurotrophin signaling pathway, Pathogenic Escherichia coli infection, Shigellosis, Pathways in cancer, MicroRNAs in cancer, Chronic myeloid leukemia, Viral myocarditis",mRNA target,Transferases,"6NPV, 6NPU, 6NPE, 6BL8, 6AMW",.,0.0
"Cytokine-cytokine receptor interaction, Regulation of autophagy, PI3K-Akt signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, Cytosolic DNA-sensing pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, Tuberculosis, Hepatitis C, Hepatitis B, Measles, Influenza A, Herpes simplex infection, Autoimmune thyroid disease",Cytokine: interferon,,"4Z5R, 4YPG, 3SE3, 3S9D, 2LMS",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis",Kinase,Transferases,"5T89, 5EX3, 5ABD, 4CL7, 4CKV",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis",Kinase,Transferases,"5T89, 5EX3, 5ABD, 4CL7, 4CKV",Activator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis",Kinase,Transferases,"5T89, 5EX3, 5ABD, 4CL7, 4CKV",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis",Kinase,Transferases,"5T89, 5EX3, 5ABD, 4CL7, 4CKV",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis",mRNA target,Transferases,"5T89, 5EX3, 5ABD, 4CL7, 4CKV",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Focal adhesion, Transcriptional misregulation in cancer, Rheumatoid arthritis",mRNA target,Transferases,"5T89, 5EX3, 5ABD, 4CL7, 4CKV",.,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"6E2Q, 4Y5Y, 4Y5X, 4Y5V, 2MV6",Modulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"6E2Q, 4Y5Y, 4Y5X, 4Y5V, 2MV6",Stimulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"6E2Q, 4Y5Y, 4Y5X, 4Y5V, 2MV6",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"6E2Q, 4Y5Y, 4Y5X, 4Y5V, 2MV6",Agonist,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"6E2Q, 4Y5Y, 4Y5X, 4Y5V, 2MV6",Activator,1.0
"Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption",GPCR rhodopsin,,4JQI,Antagonist,1.0
"Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption",GPCR rhodopsin,,4JQI,Agonist,1.0
"Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption",GPCR rhodopsin,,4JQI,Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Vasopressin-regulated water reabsorption",GPCR rhodopsin,,4JQI,Modulator,1.0
Measles,Small GTPase superfamily,,1WMS,Inhibitor,1.0
"Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer, Basal cell carcinoma",GPCR frizzled,,"5V57, 5V56, 5L7I, 5L7D, 4QIN",Antagonist,1.0
"Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer, Basal cell carcinoma",GPCR frizzled,,"5V57, 5V56, 5L7I, 5L7D, 4QIN",Inhibitor,1.0
"Hedgehog signaling pathway, Pathways in cancer, Proteoglycans in cancer, Basal cell carcinoma",GPCR frizzled,,"5V57, 5V56, 5L7I, 5L7D, 4QIN",Modulator,1.0
"Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Leishmaniasis, Pathways in cancer, Chemical carcinogenesis, MicroRNAs in cancer, Small cell lung cancer",Paired donor oxygen oxidoreductase,Oxidoreductases,"5KIR, 5IKV, 5IKT, 5IKR, 5IKQ",Inhibitor,1.0
"Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Leishmaniasis, Pathways in cancer, Chemical carcinogenesis, MicroRNAs in cancer, Small cell lung cancer",Paired donor oxygen oxidoreductase,Oxidoreductases,"5KIR, 5IKV, 5IKT, 5IKR, 5IKQ",Regulator (upregulator),1.0
"Arachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Leishmaniasis, Pathways in cancer, Chemical carcinogenesis, MicroRNAs in cancer, Small cell lung cancer",Paired donor oxygen oxidoreductase,Oxidoreductases,"5KIR, 5IKV, 5IKT, 5IKR, 5IKQ",Modulator,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Inhibitor,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Antagonist,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Modulator,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Agonist,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Modulator (allosteric modulator),1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Binder,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Ligand,1.0
"Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Dopaminergic synapse, Parkinson's disease, Cocaine addiction, Alcoholism",GPCR rhodopsin,,"6CM4, 5AER, 1I15",Stimulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion",GPCR rhodopsin,,2CSA,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion",GPCR rhodopsin,,2CSA,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion",GPCR rhodopsin,,2CSA,Modulator (allosteric modulator),1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion",GPCR rhodopsin,,2CSA,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Cholinergic synapse, Regulation of actin cytoskeleton, Insulin secretion, Salivary secretion, Gastric acid secretion, Pancreatic secretion",GPCR rhodopsin,,2CSA,Modulator,1.0
"Neuroactive ligand-receptor interaction, Endocrine and other factor-regulated calcium reabsorption",GPCR secretin,,"6NBI, 6NBH, 6NBF, 5EMB, 4Z8J",Agonist,1.0
"Neuroactive ligand-receptor interaction, Endocrine and other factor-regulated calcium reabsorption",GPCR secretin,,"6NBI, 6NBH, 6NBF, 5EMB, 4Z8J",Modulator,1.0
"Inositol phosphate metabolism, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Focal adhesion, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Cholinergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption, Carbohydrate digestion and absorption, Bacterial invasion of epithelial cells, Chagas disease (American trypanosomiasis), Toxoplasmosis, Amoebiasis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6G6W, 5VLR, 5UBT, 5T8F, 5M6U",Inhibitor,1.0
"Inositol phosphate metabolism, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Focal adhesion, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Cholinergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption, Carbohydrate digestion and absorption, Bacterial invasion of epithelial cells, Chagas disease (American trypanosomiasis), Toxoplasmosis, Amoebiasis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6G6W, 5VLR, 5UBT, 5T8F, 5M6U",Modulator,1.0
"MAPK signaling pathway, ErbB signaling pathway, cAMP signaling pathway, Wnt signaling pathway, Osteoclast differentiation, Focal adhesion, Toll-like receptor signaling pathway, T cell receptor signaling pathway, B cell receptor signaling pathway, TNF signaling pathway, Neurotrophin signaling pathway, GnRH signaling pathway, Estrogen signaling pathway, Oxytocin signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Cocaine addiction, Amphetamine addiction, Epithelial cell signaling in Helicobacter pylori infection, Salmonella infection, Pertussis, Leishmaniasis, Chagas disease (American trypanosomiasis), Hepatitis B, Influenza A, HTLV-I infection, Herpes simplex infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Colorectal cancer, Renal cell carcinoma, Choline metabolism in cancer, Inflammatory bowel disease (IBD), Rheumatoid arthritis",Basic leucine zipper bZIP,,"5T01, 5FV8, 1T2K, 1S9K, 1JNM",Inhibitor,0.0
"Leukocyte transendothelial migration, GnRH signaling pathway, Estrogen signaling pathway, Pathways in cancer, Proteoglycans in cancer, Bladder cancer",Peptidase,Hydrolases,"3AYU, 1RTG, 1QIB, 1KS0, 1J7M",Inhibitor,1.0
"Leukocyte transendothelial migration, GnRH signaling pathway, Estrogen signaling pathway, Pathways in cancer, Proteoglycans in cancer, Bladder cancer",Peptidase,Hydrolases,"3AYU, 1RTG, 1QIB, 1KS0, 1J7M",Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis",GPCR rhodopsin,,"4MQW, 4AY9, 1XWD, 1XUN",Antagonist,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis",GPCR rhodopsin,,"4MQW, 4AY9, 1XWD, 1XUN",Modulator,1.0
"cAMP signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis",GPCR rhodopsin,,"4MQW, 4AY9, 1XWD, 1XUN",Binder,1.0
"Cell cycle, Notch signaling pathway, Thyroid hormone signaling pathway, Huntington's disease, Amphetamine addiction, Alcoholism, Epstein-Barr virus infection, Pathways in cancer, Transcriptional misregulation in cancer, Viral carcinogenesis, MicroRNAs in cancer, Chronic myeloid leukemia",Carbon-nitrogen hydrolase,Hydrolases,"5ICN, 4BKX, 1TYI",Inhibitor,1.0
"Cell cycle, Notch signaling pathway, Thyroid hormone signaling pathway, Huntington's disease, Amphetamine addiction, Alcoholism, Epstein-Barr virus infection, Pathways in cancer, Transcriptional misregulation in cancer, Viral carcinogenesis, MicroRNAs in cancer, Chronic myeloid leukemia",Carbon-nitrogen hydrolase,Hydrolases,"5ICN, 4BKX, 1TYI",Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5WS3, 5WQC, 4S0V",Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5WS3, 5WQC, 4S0V",Antagonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"5WS3, 5WQC, 4S0V",Agonist,1.0
"Citrate cycle (TCA cycle), Glutathione metabolism, Metabolic pathways, Biosynthesis of antibiotics, Carbon metabolism, 2-Oxocarboxylic acid metabolism, Biosynthesis of amino acids, Peroxisome, Central carbon metabolism in cancer",Short-chain dehydrogenases reductase,Oxidoreductases,"6BL2, 6BL1, 6BL0, 6BKZ, 6BKY",Inhibitor,1.0
"Glycine, serine and threonine metabolism, Tyrosine metabolism, Phenylalanine metabolism, beta-Alanine metabolism, Metabolic pathways",CH-NH(2) donor oxidoreductase,Oxidoreductases,"4BTY, 4BTX, 4BTW, 3ALA, 2Y74",Inhibitor,1.0
"Glycine, serine and threonine metabolism, Tyrosine metabolism, Phenylalanine metabolism, beta-Alanine metabolism, Metabolic pathways",CH-NH(2) donor oxidoreductase,Oxidoreductases,"4BTY, 4BTX, 4BTW, 3ALA, 2Y74",.,1.0
"Glycine, serine and threonine metabolism, Tyrosine metabolism, Phenylalanine metabolism, beta-Alanine metabolism, Metabolic pathways",CH-NH(2) donor oxidoreductase,Oxidoreductases,"4BTY, 4BTX, 4BTW, 3ALA, 2Y74",Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR secretin,,2XDG,Agonist,1.0
Neuroactive ligand-receptor interaction,GPCR secretin,,2XDG,Modulator,1.0
Neuroactive ligand-receptor interaction,GPCR secretin,,2XDG,Binder,1.0
"Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer",Growth factor,,"1RV6, 1FZV",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer",Growth factor,,"1RV6, 1FZV",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, PI3K-Akt signaling pathway, Focal adhesion, Pathways in cancer",Growth factor,,"1RV6, 1FZV",Modulator,1.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction",Neurotransmitter receptor,,"6CNK, 6CNJ, 5KXI, 2LLY, 2GVT",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction",Neurotransmitter receptor,,"6CNK, 6CNJ, 5KXI, 2LLY, 2GVT",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Cholinergic synapse, Nicotine addiction",Neurotransmitter receptor,,"6CNK, 6CNJ, 5KXI, 2LLY, 2GVT",Agonist,1.0
"Synaptic vesicle cycle, Insulin secretion",Synaptosomal vesicle fusion pore,,"5W7J, 5W7I, 3ZUR, 3RL0, 3RK3",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"5UWC, 5UV8, 4JZJ",Agonist,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"5UWC, 5UV8, 4JZJ",CAR-T-Cell-Therapy,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"5UWC, 5UV8, 4JZJ",.,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"5UWC, 5UV8, 4JZJ",Modulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"5UWC, 5UV8, 4JZJ",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Apoptosis, Jak-STAT signaling pathway, Hematopoietic cell lineage",Cytokine receptor,,"5UWC, 5UV8, 4JZJ",CAR-T-Cell-Therapy(Dual specific),1.0
RNA transport,,,"5XJU, 5XJT, 5XJS, 5XJR, 5XJQ",Modulator,1.0
RNA transport,,,"5XJU, 5XJT, 5XJS, 5XJR, 5XJQ",.,1.0
Aldosterone-regulated sodium reabsorption,Nuclear hormone receptor,,"6GGG, 6GG8, 6GEV, 5MWY, 5MWP",Inhibitor,1.0
Aldosterone-regulated sodium reabsorption,Nuclear hormone receptor,,"6GGG, 6GG8, 6GEV, 5MWY, 5MWP",Antagonist,1.0
Aldosterone-regulated sodium reabsorption,Nuclear hormone receptor,,"6GGG, 6GG8, 6GEV, 5MWY, 5MWP",Agonist,1.0
Aldosterone-regulated sodium reabsorption,Nuclear hormone receptor,,"6GGG, 6GG8, 6GEV, 5MWY, 5MWP",Modulator,1.0
Aldosterone-regulated sodium reabsorption,Nuclear hormone receptor,,"6GGG, 6GG8, 6GEV, 5MWY, 5MWP",Binder,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"2IQW, 2IQV, 2IQU, 2IQS, 2IQR",Agonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"2IQW, 2IQV, 2IQU, 2IQS, 2IQR",Antagonist,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"2IQW, 2IQV, 2IQU, 2IQS, 2IQR",Inhibitor,1.0
Neuroactive ligand-receptor interaction,GPCR rhodopsin,,"2IQW, 2IQV, 2IQU, 2IQS, 2IQR",Modulator,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Apoptosis, Osteoclast differentiation, Hematopoietic cell lineage, Inflammatory mediator regulation of TRP channels, Amoebiasis, HTLV-I infection",Cytokine receptor,,"4GAF, 4DEP, 1ITB, 1IRA, 1G0Y",Antagonist,1.0
"ECM-receptor interaction, Hepatitis B, Proteoglycans in cancer",,,"3SH5, 3SH4",Modulator,0.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Type I cytokine receptor family,,"4RS1, 4NKQ",Stimulator,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Type I cytokine receptor family,,"4RS1, 4NKQ",Modulator,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Type I cytokine receptor family,,"4RS1, 4NKQ",.,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Type I cytokine receptor family,,"4RS1, 4NKQ",Agonist,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Type I cytokine receptor family,,"4RS1, 4NKQ",Binder,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",CAR-T-Cell-Therapy(Dual specific),1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",CAR-T-Cell-Therapy,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",.,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",Immunostimulant,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",Modulator,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",Inhibitor,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",Stimulator,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",Antagonist,1.0
Hematopoietic cell lineage,CD20 calcium channel,,"3PP4, 3BKY, 2OSL, 1S8B",Agonist,1.0
Wnt signaling pathway,Peptidase,Hydrolases,"5UE5, 5UE2, 2Y6D, 2Y6C, 2MZI",Inhibitor,1.0
Complement and coagulation cascades,Serpin protein,,"4EB1, 3KCG, 3EVJ, 2ZNH, 2HIJ",Modulator,1.0
Complement and coagulation cascades,Serpin protein,,"4EB1, 3KCG, 3EVJ, 2ZNH, 2HIJ",Inhibitor,1.0
Complement and coagulation cascades,Serpin protein,,"4EB1, 3KCG, 3EVJ, 2ZNH, 2HIJ",Antagonist,1.0
Complement and coagulation cascades,Serpin protein,,"4EB1, 3KCG, 3EVJ, 2ZNH, 2HIJ",Activator,1.0
"Neuroactive ligand-receptor interaction, Glutamatergic synapse",Glutamate-gated ion channel,,"4MF3, 3FVO, 3FVN, 3FVK, 3FVG",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Glutamatergic synapse",Glutamate-gated ion channel,,"4MF3, 3FVO, 3FVN, 3FVK, 3FVG",Agonist,1.0
"Neuroactive ligand-receptor interaction, Glutamatergic synapse",Glutamate-gated ion channel,,"4MF3, 3FVO, 3FVN, 3FVK, 3FVG",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Glutamatergic synapse",Glutamate-gated ion channel,,"4MF3, 3FVO, 3FVN, 3FVK, 3FVG",Modulator,1.0
ECM-receptor interaction,Major facilitator superfamily,,4V11,Binder,1.0
ECM-receptor interaction,Major facilitator superfamily,,4V11,Inhibitor,1.0
ECM-receptor interaction,Major facilitator superfamily,,4V11,Modulator,1.0
"PPAR signaling pathway, Fat digestion and absorption",,,"6DRG, 6DO7, 6DO6, 3VG7, 3VG6",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Salmonella infection, Amoebiasis, HTLV-I infection, Transcriptional misregulation in cancer, Rheumatoid arthritis",Growth factor,,"6BFS, 6BFQ, 5D72, 5D71, 5D70",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Salmonella infection, Amoebiasis, HTLV-I infection, Transcriptional misregulation in cancer, Rheumatoid arthritis",Growth factor,,"6BFS, 6BFQ, 5D72, 5D71, 5D70",Modulator,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Salmonella infection, Amoebiasis, HTLV-I infection, Transcriptional misregulation in cancer, Rheumatoid arthritis",Growth factor,,"6BFS, 6BFQ, 5D72, 5D71, 5D70",.,1.0
"Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6IL3, 5X02, 4XUF, 4RT7, 3QS9",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6IL3, 5X02, 4XUF, 4RT7, 3QS9",.,1.0
"Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6IL3, 5X02, 4XUF, 4RT7, 3QS9",Modulator,1.0
"Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, Pathways in cancer, Transcriptional misregulation in cancer, Acute myeloid leukemia, Central carbon metabolism in cancer",Kinase,Transferases,"6IL3, 5X02, 4XUF, 4RT7, 3QS9",Binder,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer",GPCR rhodopsin,,"6DO1, 4ZUD, 4YAY, 1ZV0",.,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer",GPCR rhodopsin,,"6DO1, 4ZUD, 4YAY, 1ZV0",Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer",GPCR rhodopsin,,"6DO1, 4ZUD, 4YAY, 1ZV0",Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer",GPCR rhodopsin,,"6DO1, 4ZUD, 4YAY, 1ZV0",Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer",GPCR rhodopsin,,"6DO1, 4ZUD, 4YAY, 1ZV0",Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Renin-angiotensin system, Renin secretion, Pathways in cancer",GPCR rhodopsin,,"6DO1, 4ZUD, 4YAY, 1ZV0",Blocker,1.0
"ErbB signaling pathway, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6BCX, 6BCU, 5ZCS, 5WBY, 5WBU",Inhibitor,1.0
"ErbB signaling pathway, HIF-1 signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Insulin signaling pathway, Thyroid hormone signaling pathway, Adipocytokine signaling pathway, Type II diabetes mellitus, Pathways in cancer, Proteoglycans in cancer, MicroRNAs in cancer, Glioma, Prostate cancer, Acute myeloid leukemia, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6BCX, 6BCU, 5ZCS, 5WBY, 5WBU",Modulator,1.0
"Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus",Peptidase,Hydrolases,"6F1H, 6F1C, 4LOT, 4LOS, 4LOR",Inhibitor,1.0
"Complement and coagulation cascades, Pertussis, Staphylococcus aureus infection, Systemic lupus erythematosus",Peptidase,Hydrolases,"6F1H, 6F1C, 4LOT, 4LOS, 4LOR",Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation",GPCR rhodopsin,,1LBN,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation",GPCR rhodopsin,,1LBN,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation",GPCR rhodopsin,,1LBN,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation",GPCR rhodopsin,,1LBN,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Platelet activation",GPCR rhodopsin,,1LBN,Binder,1.0
"Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis, Metabolic pathways, Biosynthesis of amino acids",Paired donor oxygen oxidoreductase,Oxidoreductases,"6PAH, 6N1K, 5PAH, 5FII, 4PAH",Modulator,1.0
"Phenylalanine metabolism, Phenylalanine, tyrosine and tryptophan biosynthesis, Metabolic pathways, Biosynthesis of amino acids",Paired donor oxygen oxidoreductase,Oxidoreductases,"6PAH, 6N1K, 5PAH, 5FII, 4PAH",Inhibitor,1.0
"Drug metabolism - other enzymes, Metabolic pathways",Carboxylic ester hydrolase,Hydrolases,"5A7H, 5A7G, 5A7F, 4AB1, 3K9B",Modulator,1.0
"Drug metabolism - other enzymes, Metabolic pathways",Carboxylic ester hydrolase,Hydrolases,"5A7H, 5A7G, 5A7F, 4AB1, 3K9B",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"5EWM, 5EWL, 5EWJ, 2IPV, 1S2S",Antagonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"5EWM, 5EWL, 5EWJ, 2IPV, 1S2S",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"5EWM, 5EWL, 5EWJ, 2IPV, 1S2S",Agonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"5EWM, 5EWL, 5EWJ, 2IPV, 1S2S",Blocker (channel blocker),1.0
"Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"5EWM, 5EWL, 5EWJ, 2IPV, 1S2S",Modulator (allosteric modulator),1.0
"Ras signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Circadian entrainment, Long-term potentiation, Glutamatergic synapse, Dopaminergic synapse, Alzheimer's disease, Amyotrophic lateral sclerosis (ALS), Huntington's disease, Cocaine addiction, Amphetamine addiction, Nicotine addiction, Alcoholism, Systemic lupus erythematosus",Glutamate-gated ion channel,,"5EWM, 5EWL, 5EWJ, 2IPV, 1S2S",Inhibitor,1.0
"Pentose phosphate pathway, Glutathione metabolism, Metabolic pathways, Biosynthesis of antibiotics, Carbon metabolism",CH-OH donor oxidoreductase,Oxidoreductases,"5UQ9, 4GWK, 4GWG, 2JKV",Inhibitor,1.0
"Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling",GPCR rhodopsin,,"6N4B, 5XRA, 5XR8, 5U09, 5TGZ",Agonist,1.0
"Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling",GPCR rhodopsin,,"6N4B, 5XRA, 5XR8, 5U09, 5TGZ",Antagonist,1.0
"Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling",GPCR rhodopsin,,"6N4B, 5XRA, 5XR8, 5U09, 5TGZ",Modulator (allosteric modulator),1.0
"Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling",GPCR rhodopsin,,"6N4B, 5XRA, 5XR8, 5U09, 5TGZ",Inhibitor,1.0
"Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling",GPCR rhodopsin,,"6N4B, 5XRA, 5XR8, 5U09, 5TGZ",Modulator,1.0
"Rap1 signaling pathway, Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling",GPCR rhodopsin,,"6N4B, 5XRA, 5XR8, 5U09, 5TGZ",.,1.0
"Steroid hormone biosynthesis, Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse",Methyltransferase,Transferases,"5LSA, 4XUE, 4XUD, 4XUC, 4PYK",Inhibitor,1.0
"Steroid hormone biosynthesis, Tyrosine metabolism, Metabolic pathways, Dopaminergic synapse",Methyltransferase,Transferases,"5LSA, 4XUE, 4XUD, 4XUC, 4PYK",Modulator,1.0
"Oxidative phosphorylation, Metabolic pathways, Parkinson's disease",NADH/NADPH oxidoreductase,Translocases,"5XTD, 5XTC",Inhibitor,1.0
"Oxidative phosphorylation, Metabolic pathways, Parkinson's disease",NADH/NADPH oxidoreductase,Translocases,"5XTD, 5XTC",Binder,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson's disease, Alcoholism",GPCR rhodopsin,,"6MH8, 6GDG, 6AQF, 5WF6, 5WF5",Agonist,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson's disease, Alcoholism",GPCR rhodopsin,,"6MH8, 6GDG, 6AQF, 5WF6, 5WF5",Inhibitor,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson's disease, Alcoholism",GPCR rhodopsin,,"6MH8, 6GDG, 6AQF, 5WF6, 5WF5",Modulator,1.0
"Rap1 signaling pathway, Calcium signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, Parkinson's disease, Alcoholism",GPCR rhodopsin,,"6MH8, 6GDG, 6AQF, 5WF6, 5WF5",Antagonist,1.0
"Proteasome, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Regulation of autophagy, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Type I diabetes mellitus, Salmonella infection, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Epstein-Barr virus infection, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease",Cytokine: interferon,,"6E3L, 6E3K, 3BES, 1HIG, 1FYH",.,1.0
"Proteasome, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Regulation of autophagy, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Type I diabetes mellitus, Salmonella infection, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Epstein-Barr virus infection, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease",Cytokine: interferon,,"6E3L, 6E3K, 3BES, 1HIG, 1FYH",Inhibitor,1.0
"Proteasome, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Regulation of autophagy, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Type I diabetes mellitus, Salmonella infection, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Epstein-Barr virus infection, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease",Cytokine: interferon,,"6E3L, 6E3K, 3BES, 1HIG, 1FYH",Modulator,1.0
"Proteasome, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Regulation of autophagy, TGF-beta signaling pathway, Osteoclast differentiation, Antigen processing and presentation, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, Type I diabetes mellitus, Salmonella infection, Leishmaniasis, Chagas disease (American trypanosomiasis), African trypanosomiasis, Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Measles, Influenza A, Herpes simplex infection, Epstein-Barr virus infection, Inflammatory bowel disease (IBD), Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease",Cytokine: interferon,,"6E3L, 6E3K, 3BES, 1HIG, 1FYH",Binder,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,3RZE,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,3RZE,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,3RZE,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,3RZE,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,3RZE,Partial agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,3RZE,.,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"3VA2, 3QT2, 1HUL",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Jak-STAT signaling pathway, Hematopoietic cell lineage, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, Intestinal immune network for IgA production, Asthma, Autoimmune thyroid disease, Inflammatory bowel disease (IBD), Allograft rejection",Cytokine: interleukin,,"3VA2, 3QT2, 1HUL",Modulator,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules (CAMs), Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Leishmaniasis, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Integrin,,"5FPI, 5C7Z, 4HKC, 3V4V, 3V4P",Antagonist,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules (CAMs), Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Leishmaniasis, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Integrin,,"5FPI, 5C7Z, 4HKC, 3V4V, 3V4P",Inhibitor,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules (CAMs), Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Leishmaniasis, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Integrin,,"5FPI, 5C7Z, 4HKC, 3V4V, 3V4P",Binder,1.0
"PI3K-Akt signaling pathway, Focal adhesion, ECM-receptor interaction, Cell adhesion molecules (CAMs), Hematopoietic cell lineage, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Regulation of actin cytoskeleton, Leishmaniasis, Hypertrophic cardiomyopathy (HCM), Arrhythmogenic right ventricular cardiomyopathy (ARVC), Dilated cardiomyopathy",Integrin,,"5FPI, 5C7Z, 4HKC, 3V4V, 3V4P",.,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,1YTV,Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,1YTV,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,1YTV,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,1YTV,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction",GPCR rhodopsin,,1YTV,Stimulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Prolactin signaling pathway",GPCR rhodopsin,,"1XUL, 1LUT",Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Prolactin signaling pathway",GPCR rhodopsin,,"1XUL, 1LUT",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Prolactin signaling pathway",GPCR rhodopsin,,"1XUL, 1LUT",Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Ovarian steroidogenesis, Prolactin signaling pathway",GPCR rhodopsin,,"1XUL, 1LUT",Binder,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4LNX, 4LNW, 3JZB, 3ILZ, 3HZF",Agonist,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4LNX, 4LNW, 3JZB, 3ILZ, 3HZF",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4LNX, 4LNW, 3JZB, 3ILZ, 3HZF",Modulator,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4LNX, 4LNW, 3JZB, 3ILZ, 3HZF",Antagonist,1.0
"MAPK signaling pathway, Rap1 signaling pathway, FoxO signaling pathway, Sphingolipid signaling pathway, Oocyte meiosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, NOD-like receptor signaling pathway, RIG-I-like receptor signaling pathway, T cell receptor signaling pathway, Fc epsilon RI signaling pathway, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Retrograde endocannabinoid signaling, Dopaminergic synapse, Inflammatory mediator regulation of TRP channels, GnRH signaling pathway, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Amyotrophic lateral sclerosis (ALS), Epithelial cell signaling in Helicobacter pylori infection, Shigellosis, Salmonella infection, Pertussis, Leishmaniasis, Chagas disease (American trypanosomiasis), Toxoplasmosis, Tuberculosis, Hepatitis C, Influenza A, Epstein-Barr virus infection, Proteoglycans in cancer",Kinase,Transferases,"4QUM, 1CM8",Inhibitor,1.0
"Inositol phosphate metabolism, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Focal adhesion, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Cholinergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption, Carbohydrate digestion and absorption, Bacterial invasion of epithelial cells, Chagas disease (American trypanosomiasis), Toxoplasmosis, Amoebiasis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6NCT, 5XGJ, 5XGI, 5XGH, 5UL1",Inhibitor,1.0
"Inositol phosphate metabolism, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Focal adhesion, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Cholinergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption, Carbohydrate digestion and absorption, Bacterial invasion of epithelial cells, Chagas disease (American trypanosomiasis), Toxoplasmosis, Amoebiasis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6NCT, 5XGJ, 5XGI, 5XGH, 5UL1",Modulator,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,"6D6U, 6D6T",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,"6D6U, 6D6T",Blocker (channel blocker),1.0
"Neuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction",Neurotransmitter receptor,,"6D6U, 6D6T",Antagonist,1.0
"Estrogen signaling pathway, Prolactin signaling pathway",Nuclear hormone receptor,,"5TOA, 4ZI1, 4J26, 4J24, 3OMQ",Agonist,1.0
"Estrogen signaling pathway, Prolactin signaling pathway",Nuclear hormone receptor,,"5TOA, 4ZI1, 4J26, 4J24, 3OMQ",Modulator,1.0
"Estrogen signaling pathway, Prolactin signaling pathway",Nuclear hormone receptor,,"5TOA, 4ZI1, 4J26, 4J24, 3OMQ",Antagonist,1.0
"Estrogen signaling pathway, Prolactin signaling pathway",Nuclear hormone receptor,,"5TOA, 4ZI1, 4J26, 4J24, 3OMQ",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer",Kinase,Transferases,"6GQQ, 6GQP, 6GQO, 5OYJ, 5EW3",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer",Kinase,Transferases,"6GQQ, 6GQP, 6GQO, 5OYJ, 5EW3",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer",Kinase,Transferases,"6GQQ, 6GQP, 6GQO, 5OYJ, 5EW3",Antagonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer",Kinase,Transferases,"6GQQ, 6GQP, 6GQO, 5OYJ, 5EW3",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, Cytokine-cytokine receptor interaction, Endocytosis, PI3K-Akt signaling pathway, VEGF signaling pathway, Focal adhesion, Proteoglycans in cancer",Kinase,Transferases,"6GQQ, 6GQP, 6GQO, 5OYJ, 5EW3",Binder,1.0
,mRNA target,Transferases,"6GQQ, 6GQP, 6GQO, 5OYJ, 5EW3",.,0.0
"Steroid biosynthesis, Metabolic pathways, Biosynthesis of antibiotics",Alkyl aryl transferase,Transferases,"3WSA, 3WEK, 3WEJ, 3WEI, 3WEH",Inhibitor,0.0
"Steroid biosynthesis, Metabolic pathways, Biosynthesis of antibiotics",Alkyl aryl transferase,Transferases,"3WSA, 3WEK, 3WEJ, 3WEI, 3WEH",Modulator,0.0
Alzheimer's disease,Peptidase,Hydrolases,"6MQ3, 6EDS, 6BYZ, 6BFC, 6BF9",Inhibitor,1.0
Alzheimer's disease,Peptidase,Hydrolases,"6MQ3, 6EDS, 6BYZ, 6BFC, 6BF9",Modulator,1.0
"Renin-angiotensin system, Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM)",Glycosylase,Hydrolases,"6QS1, 6H5X, 6H5W, 6F9V, 6F9U",Inhibitor,1.0
"Renin-angiotensin system, Chagas disease (American trypanosomiasis), Hypertrophic cardiomyopathy (HCM)",Glycosylase,Hydrolases,"6QS1, 6H5X, 6H5W, 6F9V, 6F9U",Modulator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6O1S, 6O1G, 6I44, 5TJX, 5F8Z",Inhibitor,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6O1S, 6O1G, 6I44, 5TJX, 5F8Z",Modulator,1.0
"Rap1 signaling pathway, Wnt signaling pathway, Hippo signaling pathway, Focal adhesion, Adherens junction, Tight junction, Signaling pathways regulating pluripotency of stem cells, Leukocyte transendothelial migration, Melanogenesis, Thyroid hormone signaling pathway, Bacterial invasion of epithelial cells, Pathogenic Escherichia coli infection, HTLV-I infection, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Endometrial cancer, Prostate cancer, Thyroid cancer, Basal cell carcinoma, Arrhythmogenic right ventricular cardiomyopathy (ARVC)",Beta-catenin,,"6M94, 6M93, 6M92, 6M91, 6M90",.,1.0
"Rap1 signaling pathway, Wnt signaling pathway, Hippo signaling pathway, Focal adhesion, Adherens junction, Tight junction, Signaling pathways regulating pluripotency of stem cells, Leukocyte transendothelial migration, Melanogenesis, Thyroid hormone signaling pathway, Bacterial invasion of epithelial cells, Pathogenic Escherichia coli infection, HTLV-I infection, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Endometrial cancer, Prostate cancer, Thyroid cancer, Basal cell carcinoma, Arrhythmogenic right ventricular cardiomyopathy (ARVC)",Beta-catenin,,"6M94, 6M93, 6M92, 6M91, 6M90",Inhibitor,1.0
"Rap1 signaling pathway, Wnt signaling pathway, Hippo signaling pathway, Focal adhesion, Adherens junction, Tight junction, Signaling pathways regulating pluripotency of stem cells, Leukocyte transendothelial migration, Melanogenesis, Thyroid hormone signaling pathway, Bacterial invasion of epithelial cells, Pathogenic Escherichia coli infection, HTLV-I infection, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Endometrial cancer, Prostate cancer, Thyroid cancer, Basal cell carcinoma, Arrhythmogenic right ventricular cardiomyopathy (ARVC)",Beta-catenin,,"6M94, 6M93, 6M92, 6M91, 6M90",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Oocyte meiosis, Regulation of autophagy, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Regulation of actin cytoskeleton, Insulin signaling pathway, Insulin secretion, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Maturity onset diabetes of the young, Aldosterone-regulated sodium reabsorption, Prostate cancer",,,"6HN5, 6CK2, 6CEB, 6CE9, 6CE7",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Oocyte meiosis, Regulation of autophagy, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Regulation of actin cytoskeleton, Insulin signaling pathway, Insulin secretion, Ovarian steroidogenesis, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Type I diabetes mellitus, Maturity onset diabetes of the young, Aldosterone-regulated sodium reabsorption, Prostate cancer",,,"6HN5, 6CK2, 6CEB, 6CE9, 6CE7",Agonist,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"6FWC, 6FW0, 6FVZ, 5MRL, 4CRT",Inhibitor,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"6FWC, 6FW0, 6FVZ, 5MRL, 4CRT",Modulator,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"6FWC, 6FW0, 6FVZ, 5MRL, 4CRT",Antagonist,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"6FWC, 6FW0, 6FVZ, 5MRL, 4CRT",.,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6MV4, 5VYG, 5TNT, 5TNO, 5JBC",Modulator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6MV4, 5VYG, 5TNT, 5TNO, 5JBC",Inhibitor,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6MV4, 5VYG, 5TNT, 5TNO, 5JBC",.,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6MV4, 5VYG, 5TNT, 5TNO, 5JBC",Replacement,1.0
Endocytosis,Folate receptor,,"5IZQ, 4LRH, 4KMX, 4KM7, 4KM6",Inhibitor,1.0
Endocytosis,Folate receptor,,"5IZQ, 4LRH, 4KMX, 4KM7, 4KM6",Modulator,1.0
Endocytosis,Folate receptor,,"5IZQ, 4LRH, 4KMX, 4KM7, 4KM6",.,1.0
Endocytosis,Folate receptor,,"5IZQ, 4LRH, 4KMX, 4KM7, 4KM6",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6BQH, 6BQG",Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6BQH, 6BQG",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6BQH, 6BQG",Inhibitor,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels",GPCR rhodopsin,,"6BQH, 6BQG",Modulator,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"2Z5Y, 2Z5X, 2BXS, 2BXR, 1H8Q",Inhibitor,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"2Z5Y, 2Z5X, 2BXS, 2BXR, 1H8Q",Antagonist,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"2Z5Y, 2Z5X, 2BXS, 2BXR, 1H8Q",Modulator,1.0
"Glycine, serine and threonine metabolism, Arginine and proline metabolism, Histidine metabolism, Tyrosine metabolism, Phenylalanine metabolism, Tryptophan metabolism, Drug metabolism - cytochrome P450, Metabolic pathways, Serotonergic synapse, Dopaminergic synapse, Cocaine addiction, Amphetamine addiction, Alcoholism",CH-NH(2) donor oxidoreductase,Oxidoreductases,"2Z5Y, 2Z5X, 2BXS, 2BXR, 1H8Q",.,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,3J9P,Antagonist,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,3J9P,Activator,1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,3J9P,Inhibitor (gating inhibitor),1.0
Inflammatory mediator regulation of TRP channels,Transient receptor potential catioin channel,,3J9P,Inhibitor,1.0
"Other glycan degradation, Sphingolipid metabolism, Metabolic pathways, Lysosome",Glycosylase,Hydrolases,"6Q6N, 6Q6L, 6Q6K, 5LVX, 3RIL",Inhibitor,1.0
"Other glycan degradation, Sphingolipid metabolism, Metabolic pathways, Lysosome",Glycosylase,Hydrolases,"6Q6N, 6Q6L, 6Q6K, 5LVX, 3RIL",Modulator,1.0
"Steroid hormone biosynthesis, Metabolic pathways",Paired donor oxygen oxidoreductase,Oxidoreductases,6M7X,Inhibitor,1.0
"Steroid hormone biosynthesis, Metabolic pathways",Paired donor oxygen oxidoreductase,Oxidoreductases,6M7X,Modulator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6RK9, 5VOF, 5VOE, 5K0H, 5JZU",Modulator,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6RK9, 5VOF, 5VOE, 5K0H, 5JZU",Inhibitor,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6RK9, 5VOF, 5VOE, 5K0H, 5JZU",Antagonist,1.0
Complement and coagulation cascades,Peptidase,Hydrolases,"6RK9, 5VOF, 5VOE, 5K0H, 5JZU",Activator,1.0
"MAPK signaling pathway, Neurotrophin signaling pathway, Alcoholism",Kinase,Transferases,"5MO9, 4AT5, 4AT4, 4AT3, 4ASZ",Modulator,1.0
"MAPK signaling pathway, Neurotrophin signaling pathway, Alcoholism",Kinase,Transferases,"5MO9, 4AT5, 4AT4, 4AT3, 4ASZ",Inhibitor,1.0
,Kinase,Transferases,2DFM,Inhibitor,1.0
,Kinase,Transferases,2DFM,.,1.0
,Kinase,Transferases,2DFM,Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Modulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",.,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Inhibitor,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Agonist,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Activator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Enhancer,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Stimulator,1.0
"Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Adherens junction, Insulin signaling pathway, Ovarian steroidogenesis, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption",Kinase,Transferases,"6HN5, 6HN4, 5U1M, 5KQV, 5J3H",Binder,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Measles, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"5GJI, 5GJH, 5AUL, 3WA4, 1YJD",CAR-T-Cell-Therapy(Dual specific),1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Measles, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"5GJI, 5GJH, 5AUL, 3WA4, 1YJD",.,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Measles, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"5GJI, 5GJH, 5AUL, 3WA4, 1YJD",Inhibitor,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Measles, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"5GJI, 5GJH, 5AUL, 3WA4, 1YJD",Immunomodulator,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Measles, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"5GJI, 5GJH, 5AUL, 3WA4, 1YJD",Modulator,1.0
"Cell adhesion molecules (CAMs), T cell receptor signaling pathway, Intestinal immune network for IgA production, Type I diabetes mellitus, Measles, Autoimmune thyroid disease, Systemic lupus erythematosus, Rheumatoid arthritis, Allograft rejection, Graft-versus-host disease, Viral myocarditis",,,"5GJI, 5GJH, 5AUL, 3WA4, 1YJD",Antagonist,1.0
"Cell cycle, p53 signaling pathway, PI3K-Akt signaling pathway, Tight junction, T cell receptor signaling pathway, Hepatitis B, Measles, HTLV-I infection, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, Glioma, Melanoma, Bladder cancer, Chronic myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer",Kinase,Transferases,"5FWP, 5FWM, 5FWL, 5FWK, 3G33",Inhibitor,1.0
"Cell cycle, p53 signaling pathway, PI3K-Akt signaling pathway, Tight junction, T cell receptor signaling pathway, Hepatitis B, Measles, HTLV-I infection, Pathways in cancer, Viral carcinogenesis, Pancreatic cancer, Glioma, Melanoma, Bladder cancer, Chronic myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer",Kinase,Transferases,"5FWP, 5FWM, 5FWL, 5FWK, 3G33",Modulator,1.0
"ErbB signaling pathway, Rap1 signaling pathway, Chemokine signaling pathway, Endocytosis, VEGF signaling pathway, Focal adhesion, Adherens junction, Tight junction, Gap junction, Platelet activation, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Shigellosis, Tuberculosis, Hepatitis B, Viral carcinogenesis, Proteoglycans in cancer",Kinase,Transferases,"6EHJ, 6C4S, 6ATE, 4MXZ, 4MXY",Inhibitor,1.0
"ErbB signaling pathway, Rap1 signaling pathway, Chemokine signaling pathway, Endocytosis, VEGF signaling pathway, Focal adhesion, Adherens junction, Tight junction, Gap junction, Platelet activation, GABAergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, GnRH signaling pathway, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Bacterial invasion of epithelial cells, Epithelial cell signaling in Helicobacter pylori infection, Shigellosis, Tuberculosis, Hepatitis B, Viral carcinogenesis, Proteoglycans in cancer",Kinase,Transferases,"6EHJ, 6C4S, 6ATE, 4MXZ, 4MXY",Modulator,1.0
"Terpenoid backbone biosynthesis, Metabolic pathways, Biosynthesis of antibiotics",Alkyl aryl transferase,Transferases,"5YGI, 5KSX, 5JV2, 5JV1, 5JV0",Inhibitor,1.0
"Terpenoid backbone biosynthesis, Metabolic pathways, Biosynthesis of antibiotics",Alkyl aryl transferase,Transferases,"5YGI, 5KSX, 5JV2, 5JV1, 5JV0",Modulator,1.0
"PPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Hepatitis C",Nuclear hormone receptor,,"5HYK, 5AZT, 4CI4, 4BCR, 3VI8",Modulator,1.0
"PPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Hepatitis C",Nuclear hormone receptor,,"5HYK, 5AZT, 4CI4, 4BCR, 3VI8",Agonist,1.0
"PPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Hepatitis C",Nuclear hormone receptor,,"5HYK, 5AZT, 4CI4, 4BCR, 3VI8",Inhibitor,1.0
"PPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Hepatitis C",Nuclear hormone receptor,,"5HYK, 5AZT, 4CI4, 4BCR, 3VI8",Activator,1.0
"PPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Non-alcoholic fatty liver disease (NAFLD), Hepatitis C",Nuclear hormone receptor,,"5HYK, 5AZT, 4CI4, 4BCR, 3VI8",Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection",GPCR rhodopsin,,2B0X,Modulator,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection",GPCR rhodopsin,,2B0X,Antagonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection",GPCR rhodopsin,,2B0X,Agonist,1.0
"Calcium signaling pathway, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection",GPCR rhodopsin,,2B0X,Inhibitor,1.0
"Notch signaling pathway, Alzheimer's disease",Amyloid beta-protein peptide,,"6IYC, 6GFI, 6CO3, 5W3P, 5VZY",Inhibitor,1.0
"Notch signaling pathway, Alzheimer's disease",Amyloid beta-protein peptide,,"6IYC, 6GFI, 6CO3, 5W3P, 5VZY",Modulator,1.0
"Notch signaling pathway, Alzheimer's disease",Amyloid beta-protein peptide,,"6IYC, 6GFI, 6CO3, 5W3P, 5VZY",.,1.0
"Notch signaling pathway, Alzheimer's disease",Amyloid beta-protein peptide,,"6IYC, 6GFI, 6CO3, 5W3P, 5VZY",Agonist,1.0
"Notch signaling pathway, Alzheimer's disease",Amyloid beta-protein peptide,,"6IYC, 6GFI, 6CO3, 5W3P, 5VZY",Binder,1.0
"Notch signaling pathway, Alzheimer's disease",Amyloid beta-protein peptide,,"6IYC, 6GFI, 6CO3, 5W3P, 5VZY",Antagonist,1.0
"Hematopoietic cell lineage, T cell receptor signaling pathway, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Primary immunodeficiency",,,"2ROL, 1XIW, 1SY6, 1A81",.,1.0
"Hematopoietic cell lineage, T cell receptor signaling pathway, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Primary immunodeficiency",,,"2ROL, 1XIW, 1SY6, 1A81",Modulator,1.0
"Hematopoietic cell lineage, T cell receptor signaling pathway, Chagas disease (American trypanosomiasis), Measles, HTLV-I infection, Primary immunodeficiency",,,"2ROL, 1XIW, 1SY6, 1A81",Binder,1.0
Cytokine-cytokine receptor interaction,,,1D01,CAR-T-Cell-Therapy,1.0
Cytokine-cytokine receptor interaction,,,1D01,Modulator,1.0
Cytokine-cytokine receptor interaction,,,1D01,.,1.0
Cytokine-cytokine receptor interaction,,,1D01,CAR-T-Cell-Therapy(Dual specific),1.0
"Purine metabolism, cGMP-PKG signaling pathway, cAMP signaling pathway, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,1LRC,Inhibitor,1.0
"Purine metabolism, cGMP-PKG signaling pathway, cAMP signaling pathway, Morphine addiction",Phosphoric diester hydrolase,Hydrolases,1LRC,Modulator,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A",Peptidase,Hydrolases,"6D40, 6D3Z, 6D3Y, 6D3X, 5UGG",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A",Peptidase,Hydrolases,"6D40, 6D3Z, 6D3Y, 6D3X, 5UGG",Modulator,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Staphylococcus aureus infection, Influenza A",Peptidase,Hydrolases,"6D40, 6D3Z, 6D3Y, 6D3X, 5UGG",Activator,1.0
"Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway",Paired donor oxygen oxidoreductase,Oxidoreductases,"6CIZ, 6CIR, 6CHI, 5UYS, 5IRV",Inhibitor,1.0
"Steroid hormone biosynthesis, Metabolic pathways, Ovarian steroidogenesis, Prolactin signaling pathway",Paired donor oxygen oxidoreductase,Oxidoreductases,"6CIZ, 6CIR, 6CHI, 5UYS, 5IRV",Modulator,1.0
"Purine metabolism, Drug metabolism - other enzymes, Metabolic pathways",CH-OH donor oxidoreductase,Oxidoreductases,"6I0O, 6I0M, 1NFB, 1NF7, 1B3O",Inhibitor,1.0
"Cell cycle, p53 signaling pathway, PI3K-Akt signaling pathway, Hepatitis B, Measles, Pathways in cancer, Viral carcinogenesis, MicroRNAs in cancer, Pancreatic cancer, Glioma, Melanoma, Chronic myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer",Kinase,Transferases,"5L2T, 5L2S, 5L2I, 4TTH, 4EZ5",Inhibitor,1.0
"Cell cycle, p53 signaling pathway, PI3K-Akt signaling pathway, Hepatitis B, Measles, Pathways in cancer, Viral carcinogenesis, MicroRNAs in cancer, Pancreatic cancer, Glioma, Melanoma, Chronic myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer",Kinase,Transferases,"5L2T, 5L2S, 5L2I, 4TTH, 4EZ5",Modulator,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",Binder,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",Modulator,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",Inhibitor,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",.,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",Antagonist,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",Agonist,1.0
"Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Endocrine and other factor-regulated calcium reabsorption, Proteoglycans in cancer",Nuclear hormone receptor,,"6IAR, 6HMU, 6HKF, 6HKB, 6HHP",Degrader,1.0
"Tryptophan metabolism, Metabolic pathways, African trypanosomiasis",Oxygenase,Oxidoreductases,"6MQ6, 6F0A, 6DPR, 6DPQ, 6CXV",Inhibitor,1.0
"Tryptophan metabolism, Metabolic pathways, African trypanosomiasis",Oxygenase,Oxidoreductases,"6MQ6, 6F0A, 6DPR, 6DPQ, 6CXV",Binder,1.0
"Tryptophan metabolism, Metabolic pathways, African trypanosomiasis",Oxygenase,Oxidoreductases,"6MQ6, 6F0A, 6DPR, 6DPQ, 6CXV",Antagonist,1.0
"Tryptophan metabolism, Metabolic pathways, African trypanosomiasis",Oxygenase,Oxidoreductases,"6MQ6, 6F0A, 6DPR, 6DPQ, 6CXV",Modulator,1.0
"Tryptophan metabolism, Metabolic pathways, African trypanosomiasis",Oxygenase,Oxidoreductases,"6MQ6, 6F0A, 6DPR, 6DPQ, 6CXV",.,1.0
"MAPK signaling pathway, ErbB signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, FoxO signaling pathway, mTOR signaling pathway, Vascular smooth muscle contraction, Focal adhesion, Natural killer cell mediated cytotoxicity, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Alcoholism, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia, Acute myeloid leukemia, Non-small cell lung cancer",Kinase,Transferases,"6CAD, 6B8U, 5VYK, 5VR3, 5VAM",Inhibitor,1.0
"MAPK signaling pathway, ErbB signaling pathway, Rap1 signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, FoxO signaling pathway, mTOR signaling pathway, Vascular smooth muscle contraction, Focal adhesion, Natural killer cell mediated cytotoxicity, Long-term potentiation, Neurotrophin signaling pathway, Serotonergic synapse, Long-term depression, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Alcoholism, Hepatitis C, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Thyroid cancer, Melanoma, Bladder cancer, Chronic myeloid leukemia, Acute myeloid leukemia, Non-small cell lung cancer",Kinase,Transferases,"6CAD, 6B8U, 5VYK, 5VR3, 5VAM",Modulator,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer",Kinase,Transferases,"4K33, 2LZL, 1RY7",Inhibitor,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer",Kinase,Transferases,"4K33, 2LZL, 1RY7",.,1.0
"MAPK signaling pathway, Ras signaling pathway, Rap1 signaling pathway, Endocytosis, PI3K-Akt signaling pathway, Signaling pathways regulating pluripotency of stem cells, Regulation of actin cytoskeleton, Pathways in cancer, MicroRNAs in cancer, Bladder cancer, Central carbon metabolism in cancer",Kinase,Transferases,"4K33, 2LZL, 1RY7",Antagonist,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Morphine addiction",GPCR rhodopsin,,"6D9H, 5UEN, 5N2S",Inhibitor,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Morphine addiction",GPCR rhodopsin,,"6D9H, 5UEN, 5N2S",Modulator,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Morphine addiction",GPCR rhodopsin,,"6D9H, 5UEN, 5N2S",Antagonist,1.0
"cGMP-PKG signaling pathway, cAMP signaling pathway, Sphingolipid signaling pathway, Neuroactive ligand-receptor interaction, Morphine addiction",GPCR rhodopsin,,"6D9H, 5UEN, 5N2S",Agonist,1.0
"AMPK signaling pathway, Oxytocin signaling pathway",Kinase,Transferases,"5KS5, 5J8H",Inhibitor,1.0
"Galactose metabolism, Starch and sucrose metabolism, Metabolic pathways, Carbohydrate digestion and absorption",Glycosylase,,"3TOP, 3TON, 3L4Z, 3L4Y, 3L4X",Modulator,1.0
"Galactose metabolism, Starch and sucrose metabolism, Metabolic pathways, Carbohydrate digestion and absorption",Glycosylase,,"3TOP, 3TON, 3L4Z, 3L4Y, 3L4X",Inhibitor,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Pathways in cancer",GPCR rhodopsin,,"6IGL, 6IGK, 5XPR, 5X93, 5GLI",Modulator,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Pathways in cancer",GPCR rhodopsin,,"6IGL, 6IGK, 5XPR, 5X93, 5GLI",Antagonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Pathways in cancer",GPCR rhodopsin,,"6IGL, 6IGK, 5XPR, 5X93, 5GLI",Agonist,1.0
"Calcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Melanogenesis, Pathways in cancer",GPCR rhodopsin,,"6IGL, 6IGK, 5XPR, 5X93, 5GLI",Inhibitor,1.0
"Steroid biosynthesis, Sesquiterpenoid and triterpenoid biosynthesis, Metabolic pathways, Biosynthesis of secondary metabolites, Biosynthesis of antibiotics",Paired donor oxygen oxidoreductase,Oxidoreductases,"6C6R, 6C6P, 6C6N",Inhibitor,1.0
"Steroid biosynthesis, Sesquiterpenoid and triterpenoid biosynthesis, Metabolic pathways, Biosynthesis of secondary metabolites, Biosynthesis of antibiotics",Paired donor oxygen oxidoreductase,Oxidoreductases,"6C6R, 6C6P, 6C6N",Modulator,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Regulation of actin cytoskeleton",Peptidase,Hydrolases,"8KME, 7KME, 6EO9, 6EO8, 6EO7",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Regulation of actin cytoskeleton",Peptidase,Hydrolases,"8KME, 7KME, 6EO9, 6EO8, 6EO7",Modulator,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Regulation of actin cytoskeleton",Peptidase,Hydrolases,"8KME, 7KME, 6EO9, 6EO8, 6EO7",Cofactor,1.0
"Neuroactive ligand-receptor interaction, Complement and coagulation cascades, Regulation of actin cytoskeleton",Peptidase,Hydrolases,"8KME, 7KME, 6EO9, 6EO8, 6EO7",.,1.0
"Glycerolipid metabolism, Metabolic pathways, Pancreatic secretion, Fat digestion and absorption, Vitamin digestion and absorption",Carboxylic ester hydrolase,Hydrolases,"1N8S, 1LPB, 1LPA, 1GPL",Inhibitor,1.0
"Glycerolipid metabolism, Metabolic pathways, Pancreatic secretion, Fat digestion and absorption, Vitamin digestion and absorption",Carboxylic ester hydrolase,Hydrolases,"1N8S, 1LPB, 1LPA, 1GPL",Modulator,1.0
"Valine, leucine and isoleucine degradation, Tyrosine metabolism, Tryptophan metabolism, Vitamin B6 metabolism, Nicotinate and nicotinamide metabolism, Retinol metabolism, Drug metabolism - cytochrome P450, Metabolic pathways",Aldehyde/oxo donor oxidoreductase,Oxidoreductases,"6Q6Q, 5EPG, 4UHX, 4UHW",Inhibitor,1.0
"Endocytosis, Ovarian steroidogenesis, Bile secretion, Toxoplasmosis, Hepatitis C",Low density lipoprotein receptor,,"5OYL, 5OY9, 4NE9, 3SO6, 3P5C",Inhibitor,1.0
"Endocytosis, Ovarian steroidogenesis, Bile secretion, Toxoplasmosis, Hepatitis C",Low density lipoprotein receptor,,"5OYL, 5OY9, 4NE9, 3SO6, 3P5C",Modulator,1.0
Gastric acid secretion,Somatostatin cortistatin,,"2MI1, 1P2W",Binder,1.0
"Inositol phosphate metabolism, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Focal adhesion, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Cholinergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption, Carbohydrate digestion and absorption, Bacterial invasion of epithelial cells, Chagas disease (American trypanosomiasis), Toxoplasmosis, Amoebiasis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6GQ7, 6FH5, 6C1S, 6AUD, 5T23",Inhibitor,1.0
"Inositol phosphate metabolism, ErbB signaling pathway, Ras signaling pathway, Rap1 signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Chemokine signaling pathway, HIF-1 signaling pathway, FoxO signaling pathway, Phosphatidylinositol signaling system, Sphingolipid signaling pathway, mTOR signaling pathway, PI3K-Akt signaling pathway, AMPK signaling pathway, Apoptosis, Adrenergic signaling in cardiomyocytes, VEGF signaling pathway, Osteoclast differentiation, Focal adhesion, Signaling pathways regulating pluripotency of stem cells, Platelet activation, Toll-like receptor signaling pathway, Jak-STAT signaling pathway, Natural killer cell mediated cytotoxicity, T cell receptor signaling pathway, B cell receptor signaling pathway, Fc epsilon RI signaling pathway, Fc gamma R-mediated phagocytosis, TNF signaling pathway, Leukocyte transendothelial migration, Neurotrophin signaling pathway, Cholinergic synapse, Inflammatory mediator regulation of TRP channels, Regulation of actin cytoskeleton, Insulin signaling pathway, Progesterone-mediated oocyte maturation, Estrogen signaling pathway, Prolactin signaling pathway, Thyroid hormone signaling pathway, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Type II diabetes mellitus, Non-alcoholic fatty liver disease (NAFLD), Aldosterone-regulated sodium reabsorption, Carbohydrate digestion and absorption, Bacterial invasion of epithelial cells, Chagas disease (American trypanosomiasis), Toxoplasmosis, Amoebiasis, Hepatitis C, Hepatitis B, Measles, Influenza A, HTLV-I infection, Epstein-Barr virus infection, Pathways in cancer, Viral carcinogenesis, Proteoglycans in cancer, MicroRNAs in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Endometrial cancer, Glioma, Prostate cancer, Melanoma, Chronic myeloid leukemia, Acute myeloid leukemia, Small cell lung cancer, Non-small cell lung cancer, Central carbon metabolism in cancer, Choline metabolism in cancer",Kinase,Transferases,"6GQ7, 6FH5, 6C1S, 6AUD, 5T23",Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Axon guidance, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Pathways in cancer",GPCR rhodopsin,,"4RWS, 3OE9, 3OE8, 3OE6, 3OE0",Antagonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Axon guidance, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Pathways in cancer",GPCR rhodopsin,,"4RWS, 3OE9, 3OE8, 3OE6, 3OE0",Modulator,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Axon guidance, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Pathways in cancer",GPCR rhodopsin,,"4RWS, 3OE9, 3OE8, 3OE6, 3OE0",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Axon guidance, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Pathways in cancer",GPCR rhodopsin,,"4RWS, 3OE9, 3OE8, 3OE6, 3OE0",.,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Axon guidance, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Pathways in cancer",GPCR rhodopsin,,"4RWS, 3OE9, 3OE8, 3OE6, 3OE0",Agonist,1.0
"Cytokine-cytokine receptor interaction, Chemokine signaling pathway, Endocytosis, Axon guidance, Leukocyte transendothelial migration, Intestinal immune network for IgA production, Pathways in cancer",GPCR rhodopsin,,"4RWS, 3OE9, 3OE8, 3OE6, 3OE0",Binder,1.0
"Cytokine-cytokine receptor interaction, Viral protein interaction with cytokine and cytokine receptor",Cytokine: interleukin,,"6NCU, 5HN1",Inhibitor,1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",Inhibitor,1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",.,1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",Modulator,1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",Immunomodulator (Immunostimulant),1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",CAR-T-Cell-Therapy,1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",Agonist,1.0
"Alanine, aspartate and glutamate metabolism, Metabolic pathways, Vitamin digestion and absorption",Peptidase,Hydrolases,"6HKZ, 6HKJ, 6H7Z, 6H7Y, 6FE5",Binder,1.0
"Lysosome, Phagosome",Mannose 6-phosphate receptor,,1JUQ,Inhibitor,1.0
"Lysosome, Phagosome",Mannose 6-phosphate receptor,,1JUQ,Binder,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, FoxO signaling pathway, Cell cycle, Endocytosis, TGF-beta signaling pathway, Osteoclast differentiation, Hippo signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease (NAFLD), Leishmaniasis, Chagas disease (American trypanosomiasis), Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis B, HTLV-I infection, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Chronic myeloid leukemia, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",Growth factor,,"5VQP, 5FFO, 4KV5, 3KFD, 1KLD",Modulator,1.0
"MAPK signaling pathway, Cytokine-cytokine receptor interaction, FoxO signaling pathway, Cell cycle, Endocytosis, TGF-beta signaling pathway, Osteoclast differentiation, Hippo signaling pathway, Intestinal immune network for IgA production, Non-alcoholic fatty liver disease (NAFLD), Leishmaniasis, Chagas disease (American trypanosomiasis), Malaria, Toxoplasmosis, Amoebiasis, Tuberculosis, Hepatitis B, HTLV-I infection, Pathways in cancer, Proteoglycans in cancer, Colorectal cancer, Renal cell carcinoma, Pancreatic cancer, Chronic myeloid leukemia, Inflammatory bowel disease (IBD), Rheumatoid arthritis, Hypertrophic cardiomyopathy (HCM), Dilated cardiomyopathy",Growth factor,,"5VQP, 5FFO, 4KV5, 3KFD, 1KLD",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME5, 6ME4, 6ME3, 6ME2",Antagonist,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME5, 6ME4, 6ME3, 6ME2",Agonist,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME5, 6ME4, 6ME3, 6ME2",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME5, 6ME4, 6ME3, 6ME2",Modulator,1.0
"Neuroactive ligand-receptor interaction, Circadian entrainment",GPCR rhodopsin,,"6ME5, 6ME4, 6ME3, 6ME2",Binder,1.0
,,Transferases,1Z8D,Inhibitor,0.0
,,Transferases,1Z8D,Modulator,0.0
"Sphingolipid metabolism, Lysosome",Sulfuric ester hydrolase,Hydrolases,"2HI8, 2AIK, 2AIJ, 1N2L, 1N2K",Modulator,1.0
"Sphingolipid metabolism, Lysosome",Sulfuric ester hydrolase,Hydrolases,"2HI8, 2AIK, 2AIJ, 1N2L, 1N2K",Replacement,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Cytokine receptor,,"2D9Q, 1AZ7",Stimulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Cytokine receptor,,"2D9Q, 1AZ7",Inhibitor,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Cytokine receptor,,"2D9Q, 1AZ7",.,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Cytokine receptor,,"2D9Q, 1AZ7",Modulator,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Cytokine receptor,,"2D9Q, 1AZ7",Agonist,1.0
"Cytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, Jak-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer",Cytokine receptor,,"2D9Q, 1AZ7",Binder,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4ZO1, 3JZC, 3IMY, 3GWS, 3D57",Agonist,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4ZO1, 3JZC, 3IMY, 3GWS, 3D57",Inhibitor,1.0
"Neuroactive ligand-receptor interaction, Thyroid hormone signaling pathway",Nuclear hormone receptor,,"4ZO1, 3JZC, 3IMY, 3GWS, 3D57",Modulator,1.0
Cell adhesion molecules (CAMs),Immunoglobulin,,"6R3K, 6NP9, 6NOS, 6NOJ, 6NNV",CAR-T-Cell-Therapy(Dual specific),1.0
Cell adhesion molecules (CAMs),Immunoglobulin,,"6R3K, 6NP9, 6NOS, 6NOJ, 6NNV",Inhibitor,1.0
Cell adhesion molecules (CAMs),Immunoglobulin,,"6R3K, 6NP9, 6NOS, 6NOJ, 6NNV",Agonist,1.0
Cell adhesion molecules (CAMs),Immunoglobulin,,"6R3K, 6NP9, 6NOS, 6NOJ, 6NNV",.,1.0
Cell adhesion molecules (CAMs),Immunoglobulin,,"6R3K, 6NP9, 6NOS, 6NOJ, 6NNV",CAR-T-Cell-Therapy,1.0
Cell adhesion molecules (CAMs),Immunoglobulin,,"6R3K, 6NP9, 6NOS, 6NOJ, 6NNV",Modulator,1.0
,,,"6DLN, 6DE7, 6BXQ, 6BXP, 6B9K",Modulator,1.0
,,,"6DLN, 6DE7, 6BXQ, 6BXP, 6B9K",Inhibitor,1.0
,,,"6DLN, 6DE7, 6BXQ, 6BXP, 6B9K",.,1.0
,mRNA target,,"6DLN, 6DE7, 6BXQ, 6BXP, 6B9K",.,1.0
,Sulfuric ester hydrolase,Hydrolases,1FSU,Modulator,1.0
,,,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Modulator,1.0
,,,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Inhibitor,1.0
,Peptidase,Transferases,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Modulator,1.0
,Peptidase,Transferases,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Inhibitor,1.0
,Peptidase,Hydrolases,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",.,1.0
,Peptidase,Hydrolases,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Inhibitor,1.0
,Peptidase,Hydrolases,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Modulator,1.0
,Hepacivirus polyprotein,,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Inhibitor,1.0
,Hepacivirus polyprotein,,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",Modulator,1.0
,,Hydrolases,"3SU4, 3RC5, 3RC4, 3QGI, 3QGH",.,0.0
,Neurotransmitter receptor,,"5HBT, 4ZJS, 1Y6C, 1Y5T, 1Y5P",Modulator,1.0
,Paired donor oxygen oxidoreductase,Oxidoreductases,"4RUI, 4EJJ, 3T3R, 3T3Q, 3EBS",Binder,1.0
,GPCR duffy,,"4NUV, 4NUU",Modulator,1.0
,,,"6OE5, 6OE4, 6APD, 6APB, 5W23",Inhibitor,1.0
,,,"6OE5, 6OE4, 6APD, 6APB, 5W23",.,1.0
,,,"6OE5, 6OE4, 6APD, 6APB, 5W23",Modulator,1.0
,,Transferases,5I82,Binder,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Inhibitor,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Modulator,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Stimulator,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Activator,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Binder,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Intercalator,1.0
,Topoisomerase,Isomerases,"1TL8, 1T8I, 1SEU, 1SC7, 1RRJ",Inducer,1.0
,Phosphoric monoester hydrolase,Hydrolases,"4PBX, 4BPC, 2YD9, 2YD3, 2YD2",Inhibitor,1.0
,mRNA target,,"1TUE, 1QQH, 1JJ4, 1F9F",.,0.0
,,Transferases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",Inhibitor,1.0
,,Transferases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",Modulator,1.0
,,Transferases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",.,1.0
,Integrase,Transferases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",Inhibitor,1.0
,Integrase,Transferases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",Modulator,1.0
,Peptidase,Hydrolases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",Inhibitor,1.0
,Peptidase,Hydrolases,"6OE3, 6HAK, 6ELI, 6DUH, 6DUG",Modulator,1.0
,,Hydrolases,"6C0B, 6AR6, 5UQT, 5UQN, 5UQM",.,1.0
,,Hydrolases,"6C0B, 6AR6, 5UQT, 5UQN, 5UQM",Modulator,1.0
,Peptidase,Hydrolases,"5WI6, 5F03, 4MQA, 4MPX, 4MPW",Inhibitor,1.0
,Peptidase,Hydrolases,"5WI6, 5F03, 4MQA, 4MPX, 4MPW",Modulator,1.0
,Growth factor,,"5W21, 2P39",Modulator,1.0
,Paired donor oxygen oxidoreductase,Oxidoreductases,"5XXI, 5X24, 5X23, 5W0C, 5K7K",Modulator,1.0
,,Lyases,1AWL,Inhibitor,1.0
,,Lyases,1AWL,Activator,1.0
,,Lyases,1AWL,Modulator,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Blocker,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Opener,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Activator,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Inhibitor,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Modulator,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Ligand,1.0
,Voltage-gated ion channel,,"5VA3, 5VA2, 5VA1, 4HQA, 4HP9",Antagonist,1.0
,Immunoglobulin,,"6AW3, 6AW1, 6AW0, 6AVZ",.,1.0
,mRNA target,,"6IMY, 6IMX, 6GRP, 6GR7, 6FZL",.,1.0
,mRNA target,,"6IMY, 6IMX, 6GRP, 6GR7, 6FZL",Inhibitor,1.0
,,,"6IMY, 6IMX, 6GRP, 6GR7, 6FZL",Inhibitor,1.0
,,,"6IMY, 6IMX, 6GRP, 6GR7, 6FZL",Antisense ,1.0
,,,5NJ8,Antagonist,1.0
,,,5NJ8,Agonist,1.0
,,,5NJ8,Modulator,1.0
,Serpin protein,,"5DUQ, 5DU3, 2OAY, 1M6Q",Modulator,1.0
,Alkyl aryl transferase,,"3SWD, 3KR6, 3KQJ, 3ISS, 2Z2C",Inhibitor,1.0
,Cis-trans-isomerase,Isomerases,"3ICI, 3ICH, 1CYN",Inhibitor,1.0
,Cis-trans-isomerase,Isomerases,"3ICI, 3ICH, 1CYN",Binder,1.0
,Kinase,Transferases,"6AS7, 5IUD, 5EXR, 4Y97, 4QCL",Modulator,0.0
,Bacillus anthracis protective antigen,,"5FR3, 4NAM, 4H2A, 4EE2, 3TEZ",.,1.0
,Bacillus anthracis protective antigen,,"5FR3, 4NAM, 4H2A, 4EE2, 3TEZ",Modulator,1.0
,,,"5FR3, 4NAM, 4H2A, 4EE2, 3TEZ",Modulator,1.0
,,,"5FR3, 4NAM, 4H2A, 4EE2, 3TEZ",.,1.0
,Carbon-nitrogen hydrolase,,"4EPE, 4EPD, 4EPB, 4EP8, 2KAU",Inhibitor,1.0
,Kinase,Transferases,"2WVJ, 2ORV, 1XBT, 1W4R",Inhibitor,1.0
,Kinase,Transferases,"2WVJ, 2ORV, 1XBT, 1W4R",Modulator,1.0
,Peptidase,Hydrolases,"4XUI, 4W5C, 4W5B, 4QH6, 4PI3",Inhibitor,1.0
,Peptidase,Hydrolases,"4XUI, 4W5C, 4W5B, 4QH6, 4PI3",Binder,1.0
,,Transferases,3PTY,Inhibitor,1.0
,Short-chain dehydrogenases reductase,Oxidoreductases,"4KP7, 4GAE, 3WQS, 3WQR, 3WQQ",Inhibitor,1.0
,Short-chain dehydrogenases reductase,Oxidoreductases,"4KP7, 4GAE, 3WQS, 3WQR, 3WQQ",Binder,1.0
,,Hydrolases,"5JHV, 5JHT, 5I13, 5FDG, 5FDD",Inhibitor,1.0
,,Oxidoreductases,"4IVO, 4IVM, 3NKS",Modulator,1.0
,Intramolecular oxidoreductases,,"5NW7, 1PMI",Inhibitor,1.0
,,,"5XOC, 5ODG, 5OD6, 2LB2, 2LAJ",Inhibitor,1.0
,,,"4QTI, 4K24, 3U74, 3U73, 3BT2",Inhibitor,1.0
,,,"5VFW, 1QLS, 1BO9, 1AIN",Agonist,1.0
,Carbon-nitrogen hydrolase,Hydrolases,"3BLM, 1PIO, 1OME, 1KGG, 1KGF",Inhibitor,1.0
,Carbon-nitrogen hydrolase,Hydrolases,"3BLM, 1PIO, 1OME, 1KGG, 1KGF",Modulator,1.0
,Carbon-nitrogen hydrolase,Hydrolases,"3BLM, 1PIO, 1OME, 1KGG, 1KGF",.,1.0
,CH-OH donor oxidoreductase,Oxidoreductases,1JCN,Inhibitor,1.0
,Topoisomerase GyrA ParC,Isomerases,2INR,Inhibitor,1.0
,Topoisomerase GyrA ParC,Isomerases,2INR,Modulator,1.0
,Carbon-carbon lyase,,2O90,Inhibitor,0.0
,Peptidase,Hydrolases,"1ITU, 1ITQ",Inhibitor,1.0
,,,"4G94, 4G8X, 4G6D",Modulator,1.0
,Glutamate-gated ion channel,,"5ZG3, 5ZG2, 5ZG1, 5ZG0, 5YBG",Agonist,1.0
,Glutamate-gated ion channel,,"5ZG3, 5ZG2, 5ZG1, 5ZG0, 5YBG",Antagonist,1.0
,Glutamate-gated ion channel,,"5ZG3, 5ZG2, 5ZG1, 5ZG0, 5YBG",Modulator,1.0
,Glutamate-gated ion channel,,"5ZG3, 5ZG2, 5ZG1, 5ZG0, 5YBG",Inhibitor,1.0
,Acyltransferase,Transferases,"1S5O, 1NM8",Inhibitor,0.0
,GPCR rhodopsin,,"6DK1, 6DK0, 6DJZ, 5HK2, 5HK1",Agonist,1.0
,GPCR rhodopsin,,"6DK1, 6DK0, 6DJZ, 5HK2, 5HK1",Modulator,1.0
,GPCR rhodopsin,,"6DK1, 6DK0, 6DJZ, 5HK2, 5HK1",Antagonist,1.0
,GPCR rhodopsin,,"6DK1, 6DK0, 6DJZ, 5HK2, 5HK1",Inhibitor,1.0
,GPCR rhodopsin,,"6DK1, 6DK0, 6DJZ, 5HK2, 5HK1",Binder,1.0
,GPCR rhodopsin,,"6DK1, 6DK0, 6DJZ, 5HK2, 5HK1",Ligand,1.0
,,,"2Q7R, 2Q7M",Inhibitor,0.0
,,,"2Q7R, 2Q7M",Modulator,0.0
,Cis-trans-isomerases,Isomerases,"6GJY, 6GJR, 6GJP, 6GJN, 6GJM",Inhibitor,1.0
,Cis-trans-isomerases,Isomerases,"6GJY, 6GJR, 6GJP, 6GJN, 6GJM",Binder,1.0
,,,"3VLG, 1YXK, 1YXJ, 1YPU, 1YPQ",Modulator,0.0
,Kinase,Transferases,"4YMJ, 3V5Q, 1WWC",Inhibitor,1.0
,Kinase,Transferases,"4YMJ, 3V5Q, 1WWC",Modulator,1.0
,Fibrinogen protein,,6EUA,Inhibitor,1.0
,Peptidase,Hydrolases,"3EE6, 3EDY, 1R60",Modulator,1.0
,ABC transporter,,"6HZM, 6HIJ, 6HCO, 6HBU, 6FFC",Inhibitor,1.0
,mRNA target,Transferases,1YYP,.,0.0
,,,"1QA9, 1CI5, 1CCZ",Modulator,1.0
,Acid anhydride hydrolase,Hydrolases,"6FIT, 5FIT, 4FIT, 3FIT, 2FIT",Inhibitor,1.0
,Phosphoric monoester hydrolase,Hydrolases,"6GHM, 6G0J, 6G0I, 6DNO, 6DCX",Inhibitor,1.0
,Nuclear hormone receptor,,"5KYJ, 5KYA, 5I4V, 5HJP, 1UHL",Antagonist,1.0
,Nuclear hormone receptor,,"5KYJ, 5KYA, 5I4V, 5HJP, 1UHL",Inhibitor,1.0
,Nuclear hormone receptor,,"5KYJ, 5KYA, 5I4V, 5HJP, 1UHL",Agonist,1.0
,Carbon-carbon lyase,Lyases,"5BWA, 4ZGY, 2OO0, 2ON3, 1D7K",Inhibitor,1.0
,Lentiviruses Tat family,,"6MCF, 6MCE, 5V61, 4OR5, 3MIA",Inhibitor,1.0
,Lentiviruses Tat family,,"6MCF, 6MCE, 5V61, 4OR5, 3MIA",Modulator,1.0
,Peptidase,Hydrolases,"6MV5, 6F5G, 6E4Z, 6E4Y, 5VLP",.,1.0
,Peptidase,Hydrolases,"6MV5, 6F5G, 6E4Z, 6E4Y, 5VLP",Inhibitor,1.0
,Peptidase,Hydrolases,"6MV5, 6F5G, 6E4Z, 6E4Y, 5VLP",Modulator,1.0
,,,"6JE7, 6EZQ, 6A7P, 5Z0B, 5YOQ",Modulator,1.0
,,,"6JE7, 6EZQ, 6A7P, 5Z0B, 5YOQ",Inhibitor,1.0
,,,"6JE7, 6EZQ, 6A7P, 5Z0B, 5YOQ",Binder,1.0
,Peptidase,Hydrolases,"6A6A, 5ZHW, 5ZHF, 5HNM",Inhibitor,1.0
,Peptidase,Hydrolases,"6A6A, 5ZHW, 5ZHF, 5HNM",Binder,1.0
,Aldehyde/oxo donor oxidoreductase,Oxidoreductases,4QGK,Inhibitor,1.0
,Aldehyde/oxo donor oxidoreductase,Oxidoreductases,4QGK,Modulator,1.0
,,Oxidoreductases,"1U3T, 1HSO",Modulator,1.0
,,Hydrolases,6G9S,Binder,1.0
,,Hydrolases,6G9S,Inhibitor,1.0
,,Hydrolases,6G9S,Modulator,1.0
,,,"6J7W, 4ZFO, 2KN1, 1XU2, 1OQD",CAR-T-Cell-Therapy,1.0
,,,"6J7W, 4ZFO, 2KN1, 1XU2, 1OQD",Immunomodulator,1.0
,,,"6J7W, 4ZFO, 2KN1, 1XU2, 1OQD",.,1.0
,,,"6J7W, 4ZFO, 2KN1, 1XU2, 1OQD",CAR-T-Cell-Therapy(Dual specific),1.0
,,,"6J7W, 4ZFO, 2KN1, 1XU2, 1OQD",Inhibitor,1.0
,Kinase,Transferases,"4UXL, 3ZBF",Inhibitor,1.0
,Kinase,Transferases,"4UXL, 3ZBF",Modulator,1.0
,Nuclear hormone receptor,,"1XVP, 1XV9",Agonist,1.0
,Nuclear hormone receptor,,"1XVP, 1XV9",Antagonist,1.0
,Nuclear hormone receptor,,"1XVP, 1XV9",Inhibitor,1.0
,Nuclear hormone receptor,,"1XVP, 1XV9",Modulator,1.0
,Shiga-like toxin beta,,"6FE4, 2GA4, 1R4P",.,0.0
,Aldehyde/oxo donor oxidoreductase,,"2QTC, 2QTA, 2IEA, 2G67, 2G28",Cofactor,1.0
,Topoisomerase GyrA ParC,Isomerases,"4MN4, 1ZVU, 1ZVT",Inhibitor,1.0
,Nuclear hormone receptor,,"3K6P, 3D24, 2PJL, 1XB7",Modulator,1.0
,Nuclear hormone receptor,,"3K6P, 3D24, 2PJL, 1XB7",Agonist,1.0
,Nuclear hormone receptor,,"3K6P, 3D24, 2PJL, 1XB7",Antagonist,1.0
,Nuclear hormone receptor,,"3K6P, 3D24, 2PJL, 1XB7",Inhibitor,1.0
,Paired donor oxygen oxidoreductase,,"5V5Z, 5TZ1, 5FSA",Inhibitor,1.0
,Paired donor oxygen oxidoreductase,,"5V5Z, 5TZ1, 5FSA",Binder,1.0
,Paired donor oxygen oxidoreductase,,"5V5Z, 5TZ1, 5FSA",Modulator,1.0
,Voltage-gated ion channel,,"2NZ0, 1S1G",Antagonist,1.0
,Voltage-gated ion channel,,"2NZ0, 1S1G",Blocker,1.0
,,Isomerases,"5BS3, 4PLB",Inhibitor,1.0
,Diphenol donor oxidoreductase,Oxidoreductases,"5LBZ, 5LBY, 5LBW, 5LBU, 5LBT",Inhibitor,1.0
,Cis-trans-isomerase,Isomerases,"5I7Q, 5I7P, 4ODR, 4ODQ, 4ODP",Inhibitor,1.0
,Cis-trans-isomerase,Isomerases,"5I7Q, 5I7P, 4ODR, 4ODQ, 4ODP",Modulator,1.0
,Cis-trans-isomerase,Isomerases,"5I7Q, 5I7P, 4ODR, 4ODQ, 4ODP",Binder,1.0
,Peroxide acceptor oxidoreductase,Oxidoreductases,"4MMM, 4K7O, 4K7N, 4K7I, 3MNG",Inhibitor,1.0
,Peroxide acceptor oxidoreductase,Oxidoreductases,"4MMM, 4K7O, 4K7N, 4K7I, 3MNG",Modulator,1.0
,Peroxide acceptor oxidoreductase,Oxidoreductases,"4MMM, 4K7O, 4K7N, 4K7I, 3MNG",.,1.0
,,,"5O9M, 5O9L, 4Z9V, 3EBM, 2HR9",Inhibitor,0.0
,Peptidase,Hydrolases,"4ZM9, 4PVS, 4PVR, 4PVQ, 4PVP",Modulator,1.0
,Peptidase,Hydrolases,"4ZM9, 4PVS, 4PVR, 4PVQ, 4PVP",Inhibitor,1.0
,CH-CH donor oxidoreductase,,"6GHN, 6GH4, 6GH1, 6GGM, 6EP8",Inhibitor,1.0
,mRNA target,Transferases,"6R2E, 6QYQ, 6QXH, 6QXG, 5X69",.,1.0
,,,1XR6,Modulator,0.0
,,,2B6Q,Agonist,0.0
,,,2B6Q,Antagonist,0.0
,Nuclear hormone receptor,,"6FX0, 5M24, 4LBD, 3LBD, 2LBD",Antagonist,1.0
,Nuclear hormone receptor,,"6FX0, 5M24, 4LBD, 3LBD, 2LBD",Agonist,1.0
,Nuclear hormone receptor,,"6FX0, 5M24, 4LBD, 3LBD, 2LBD",Inhibitor,1.0
,Nuclear hormone receptor,,"6FX0, 5M24, 4LBD, 3LBD, 2LBD",Binder,1.0
,Nuclear hormone receptor,,"6FX0, 5M24, 4LBD, 3LBD, 2LBD",Modulator,1.0
,Kinase,Transferases,"5VXZ, 5U6B, 4RA0, 2C5D",.,1.0
,Kinase,Transferases,"5VXZ, 5U6B, 4RA0, 2C5D",Inhibitor,1.0
,Kinase,Transferases,"5VXZ, 5U6B, 4RA0, 2C5D",Modulator,1.0
,MHC class II,,"6CQR, 6CQJ, 4X5X, 4X5W, 4OV5",Binder,1.0
,Sulfur donor oxidoreductase,Oxidoreductases,"3QFB, 3QFA, 2ZZC, 2ZZB, 2ZZ0",Inhibitor,1.0
,ATP-hydrolyzing DNA topoisomerase,Isomerases,"5ZRF, 5ZQF, 5ZEN, 5ZAD, 5GWJ",Inhibitor,1.0
,ATP-hydrolyzing DNA topoisomerase,Isomerases,"5ZRF, 5ZQF, 5ZEN, 5ZAD, 5GWJ",Modulator,1.0
,Influenza viruses hemagglutinin,,"1RVZ, 1RVX, 1RU7",Inhibitor,1.0
,Influenza viruses hemagglutinin,,"1RVZ, 1RVX, 1RU7",Modulator,1.0
,Influenza viruses hemagglutinin,,"1RVZ, 1RVX, 1RU7",.,1.0
,,,"4JHS, 3OP8, 2KRI, 1QUB, 1G4G",Inhibitor,0.0
,Alkyl aryl transferase,Transferases,"1AJZ, 1AJ2, 1AJ0",Inhibitor,1.0
,Alkyl aryl transferase,Transferases,"1AJZ, 1AJ2, 1AJ0",Binder,1.0
,Alkyl aryl transferase,Transferases,"1AJZ, 1AJ2, 1AJ0",Breaker,1.0
,Alkyl aryl transferase,Transferases,"1AJZ, 1AJ2, 1AJ0",Modulator,1.0
,Serpin protein,,"4C49, 4C41, 4BB2, 2VDY, 2VDX",Modulator,1.0
,Serpin protein,,"4C49, 4C41, 4BB2, 2VDY, 2VDX",Binder,1.0
,CH-NH donor oxidoreductase,Hydrolases,"3G5P, 3G5K",Inhibitor,1.0
,Cytokine receptor,,"6H41, 3VA2, 3QT2, 1OBZ, 1OBX",Antagonist,1.0
,Cytokine receptor,,"6H41, 3VA2, 3QT2, 1OBZ, 1OBX",Modulator,1.0
,GPCR glutamate,,"5K5T, 5K5S, 5FBK, 5FBH",Antagonist,1.0
,GPCR glutamate,,"5K5T, 5K5S, 5FBK, 5FBH",Modulator (allosteric modulator),1.0
,GPCR glutamate,,"5K5T, 5K5S, 5FBK, 5FBH",Inhibitor,1.0
,GPCR glutamate,,"5K5T, 5K5S, 5FBK, 5FBH",Modulator,1.0
,GPCR glutamate,,"5K5T, 5K5S, 5FBK, 5FBH",Agonist,1.0
,,,"5YZB, 5YZA, 5YZ5, 5X1D, 5X1C",Modulator,1.0
,,,2B6S,Agonist,0.0
,,,2B6S,Antagonist,0.0
,NADH/NADPH oxidoreductase,Oxidoreductases,"5FA6, 5EMN, 3QFT, 3QFS, 3QFR",Modulator,0.0
,NADH/NADPH oxidoreductase,Oxidoreductases,"5FA6, 5EMN, 3QFT, 3QFS, 3QFR",Inhibitor,0.0
,Influenza viruses matrix protein,,5DLM,Inhibitor,1.0
,Influenza viruses matrix protein,,5DLM,.,1.0
,,Hydrolases,"3HN3, 1BHG",Modulator,1.0
,,,"3C4M, 2L1X, 1ZWG, 1ZWF, 1ZWE",Modulator,1.0
,,,"3C4M, 2L1X, 1ZWG, 1ZWF, 1ZWE",.,1.0
,Methyltransferase,Transferases,2NYU,Inhibitor,1.0
,Sulfur donor oxidoreductase,Oxidoreductases,2WBA,Inhibitor,1.0
,Sulfur donor oxidoreductase,Oxidoreductases,2WBA,Binder,1.0
,Type-B carboxylesterase/lipase,Hydrolases,"6QAE, 6QAD, 6QAC, 6QAB, 6QAA",Inhibitor,1.0
,Type-B carboxylesterase/lipase,Hydrolases,"6QAE, 6QAD, 6QAC, 6QAB, 6QAA",Modulator,1.0
,Type-B carboxylesterase/lipase,Hydrolases,"6QAE, 6QAD, 6QAC, 6QAB, 6QAA",Reactivator,1.0
,Kinase,Transferases,"4HOK, 4HNI",Inhibitor,1.0
